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 Abstract 
 
The current focus of organometallic chemistry is based upon their synthesis, 
eloectrochemical properties, diverse biological behavior and their facet towards a new field of 
bioorganometallics concerning both organometallic and coordination chemistry.  Organometallic 
complexes involving metal - cyclopentadienyl linkages have been an important fragment due to 
their unique structural variety, stability and their potential applications in organic synthesis, 
catalysis, bioorganometallic, advance materials, molecular recognition etc.  Ferrocene and its 
derivatives are the most versatile aspect in organometallic chemistry because of their unique 
structural integrity, reversible redox behavior and have been responsible for the development of 
material science, molecular wires, catalysis, molecular recognition, sensing, electronic 
communication, bio-conjugates and medicinal chemistry.  The use of ferrocenyl compounds as 
bioactive molecule has been established recently and several reports show that a large number of 
ferrocene containing compounds display interesting cytotoxic and DNA cleaving activities.  
Ferrocene substituted tamoxifen and chloroquine derivatives are among the many examples 
where systematic functionalization of ferrocene has improved the cytotoxic activity of the 
standard drug itself.  In parallel, the half sandwich based organometallic compounds are also 
drawing interest because their various biological properties ranging from antimalarial, 
antimicrobial, anticancer, enzyme inhibitors and phototoxicity.  Half sandwich compounds 
containing metal carbonyls are the most significant ligands in medicinal chemistry  and can play 
a vital role as tracers in immunological analysis based on several analytical methods like FTIR, 
electrochemical, atomic absorption techniques etc.  Moreover, ferrocenyl Schiff base compounds 
have been reported for their interesting coordination features and exciting biological properties.  
In view of the enormous potential applications of ferrocenyl and half sandwich based 
organometallic compounds, we focused our study to synthesize some sandwich and half 
sandwich based Schiff base compounds and to study their biological properties.  We have been 
able to synthesize a range of novel ferrocene and cymantrene based Schiff base compounds and 
characterize by spectroscopic and crystallographic technique.  We have also described the 
synthesis of hetero-bimetallic chalcones containing both ferrocenyl and cymantrenyl fragments 
and studied their reactivity towards mono- and diphosphine substitution.  In addition, compounds 
 containing multiple redox centers have also been highly focused due to their various application 
related to electronic communication, sensors and molecular wires.  In this regard, we focused on 
the synthesis of diferrocenyl bifunctional molecular systems containing both hydrazone and 
enone units using simple and systematic synthetic route.  Efforts have been made to study the 
unique structural feature and to understand the biological and sensing properties of some of the 
compounds.  We have carried out cyclic-voltammetric studies with different analogs of the 
diferrocenyl compounds to understand the electronic communication behavior inside the 
molecule.  DFT calculation was also performed to establish some of the interesting features 
related to structural stability, metal ion interaction and molecular orbital energies. 
 
Keywords: Ferrocenyl, Cymantrenyl, Chalcone, Hydrazone, Bioorganometallic, Electronic 
communication 
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CHAPTER 1 
INTRODUCTION 
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1.1. Metal -cyclopentadienyl complex 
 
Organometallic complex containing metal - cyclopentadienyl linkage has been an 
important fragment in the chemistry of organometallic molecules since the discovery of 
ferrocene.  Electrophilic aromatic-type substitution reaction on ferrocene by Woodward 
and coworkers in 1952 played a key role and led to the development of metal 
cyclopentadienyl chemistry.[1, 2]  Similar substitution reaction was subsequently 
extended to other cyclopentadienyl – metal complexes like ruthenocene, osmocene, (5-
cyclopentadienyl)tricarbonylmanganese, rhenium and technetium, (5-
cyclopentadienyi)tetra -carbonylvanadium, (5-cyclopentadienyl)dicarbonylcobalt etc.[3-
16]  For the last 60 years, research on metal cyclopentadienyl chemistry has continued to 
develop at a rapid pace giving rise to structurally unique molecules and novel compounds 
containing sandwich and open sandwich entities.  The non ending interest on these 
organometallic moieties is because of their immense potential to various applications 
related to organic synthesis, catalysis, bioorganometallic, advance materials, molecular 
recognition etc.[17]  However, the synthesis of substituted ferrocene and derivatization of 
cyclopentadienyl ring in various different metallocenes and half sandwich complexes 
pose numerous challenges in regard to reaction condition, reagents and methodologies.  
Therefore, it is highly required to optimize the strategies based upon facile synthetic 
methods and suitability of the precursors for the functionalization of different Cp based 
organometallic compounds.  Different types of substituent on the Cp ring often result in 
significant changes in reactivity and properties of the complex due to the electronic and 
steric factor that influences the molecular entity.  Cyclopentadienyl ligand has the ability 
to stabilize high as well as low oxidation states of metals and a range of different 
derivatives with varying hapticity are well known.  Remarkably, these variations result in 
extensive complex chemistry with flexible electronic, structural and steric behavior.  
Therefore, it has been very important to deeply understand such organometallic 
complexes containing cyclopentadienyl - metal linkages and their derivatives and explore 
the opportunities for related application. 
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1.1.1. Cyclopentadienyl ligand 
 
Cyclopentadienyl group (C5H5 or Cp), the deprotonated form of cyclopentadiene, 
has been one of the versatile and widely used ligand in organometallic chemistry.  It is a 
monoanionic, aromatic, electron rich species containing six-electrons and forms a variety 
of complexes with main group and transition metals.  The cyclopentadienyl group is a 
significant ligand because of its aromaticity and high stability and plays an active role in 
stabilizing organometallic complexes.  Reaction of cyclopentadiene with sodium hydride 
and bases like amines, hydroxides, alkyllithium compounds and Grignard reagents 
furnishes the reactive cyclopentadienyl anion by losing a proton.  Cyclopentadiene can be 
obtained by distilling (“cracking”) it from commercially available dimer solution and 
stored at lower temperature for further use.  Free neutral cyclopentadiene, which is used 
to deprotonate with a strong base to generate the Cp
-
 is unstable and reacts with itself via 
Diels-Alder reaction to generate the dimerised product, dicyclopentadiene (Scheme 1.1).   
 
H
+
+
-
+
Cp
-
CpHCpHdicyclopentadiene
 
Scheme 1.1. Cracking of dicyclopentadiene 
 
Cyclopentadienyl anion creates a stable and strong metal-ligand bond with five 
almost equal metal-carbon bond distances.  The wide range of reactions that can be 
performed on cyclopentadienyl complexes reveals the unique stability of the metal-Cp 
bond including functionalization of the Cp ring and modification of other ligands without 
disturbing the M – Cp structural framework.[18]   
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1.1.2. Bonding modes of Cyclopentadienyl ligand 
 
Cyclopentadienyl ligand can adopt η5 (pentahapto), η3 (trihapto) and η1 
(monohapto) coordination modes with metals.  Among the three coordinations, η5 is the 
most common mode of bonding forming a six electrons donating ligand (Figure 1.1).  
The change in heptacity modifies the electronic and steric factor of the metal resulting in 
alteration in properties of the whole complex system.  When attached to main group 
metals, the ligand generally behaves as good leaving group, while they are found to be 
firmly coordinated to transition metals in high and low oxidation states. 
 
M
M
M
 
          5             3             1 
Figure 1.1. Binding modes of cyclopentadienyl group 
 
The frontier molecular orbital of the cyclopentadienyl ligand contains five orbitals 
(Ψ1−Ψ5) residing in three different energy levels as shown in Figure 1.2.  The lowest 
energy orbital Ψ1 is represented by an a1 state which does not contain any node, followed 
by a doubly degenerate e1 states that comprise of the Ψ2 and Ψ3 orbitals having a single 
node, and another doubly degenerate e2 states consisting of Ψ4 and Ψ5 orbitals having two 
nodes.  The energy of the states increases as the number of nodes increases from 0 to 2. 
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E
e2
e1
a1
 
Figure 1.2. Molecular orbital diagram of cyclopentadienyl ligand. 
 
The atomic orbitals of metal which are involved in the interaction with the orbitals of 
cyclopentadienyl ligand to form Metal-Cp molecular orbitals are shown in the Figure 1.3.  
 
d z
2
x
z
y
z
y
x
dxz dyz dxy
y
z
dx2- y2
x
 
+
s pz px py
y
z
x
 
Figure 1.3. Atomic orbitals of metal 
 
The metal d- orbitals which are mainly found to overlap with the Cp MOs having the 
matching symmetry are shown in Figure 1.4.  The orbital dz
2
 interact with the a1 type 
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orbital of cyclopentadienyl ligand, while dyz and dxz overlaps compatibly with the e1 - 
symmetry orbitals.  The metal orbitals dx
2
-y
2
 and dxy overlaps with e2 type orbitals having 
similar symmetry. 
 
dx2-y2 dxy
dyz dxz
dz2  
 
Figure 1.4. Metal-cyclopentadienyl bonding interactions. 
 
In the Cp2M system, (e. g. ferrocene) each of these five molecular orbitals of the 
two cyclopentadienyl ligands combines to give ten ligand molecular orbitals in three 
energy levels.  During combination, all these ligand groups undergo addition and 
subtraction of wave functions which can be labeled as g (gerade) having centre of 
symmetry or u (ungerade) without centre of symmetry.  All these ligand group orbitals on 
combination gives rise to a1g, a1u, e1g, e1u, e2g, e2u ligand group orbitals.   
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Figure 1.5. Symmetrical interaction in Cp2M type molecules 
dz2s
x
z
y
z
dxz
dyz
pz
z
a2u
e1g
a1g
px
py
y
x
e1u
y
x
dxy
y
z
dx2- y2
x
e2g e2u
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The ligand group of both the cyclopentadienyl ligand and atomic orbital of metal 
atom with matching symmetry overlaps during combination to form molecular orbital of 
metallocene molecule (Figure 1.5).  Overlap of a1g and a2u of Cp ring with the s and dz
2
 
metal orbitals form  bond with lowest energy as shown in the molecular orbital energy 
diagram.  The 4p orbital of metal lies above the energy diagram due to their higher 
energy and contribute a little to the bonding.  The well matched e1g and e2u of Cp ring and 
dxz, dyz, 4px and 4py forms -bonds by means of their overlap while interaction of e2g of 
Cp ring with dxy, dx
2
-y
2
 or bitals of metal gives rise to -bond.  The e1u orbital remains non 
bonding as there are no metal orbital of suitable symmetry and energy.  The electron 
distribution in the molecular orbitals of ferrocene, shown in Figure 1.6, reveals the 
presence of paired electronic arrangement giving rise to diamagnetic character of the 
molecule.  Both the highest occupied molecular orbital containing the pair of electrons 
and the lowest unoccupied molecular orbital lying above the filled orbitals are largely 
metal-based with the minor contribution from the molecular orbital of ligands. 
Fe
Fe
II
Atomic 
orbitals
a2u, e1u
a1g
a1g,e1g,e2g
e2g e2u
e1g e1u
a1g , a2u
3d
4s
4p
 
Figure 1.6. Molecular orbital of ferrocene 
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Cyclopentadienyl ring are well known to undergo ring slippage in which the 
bonding shift from one coordination mode to other modes by variation of the number of 
electrons of the metal attached to the Cp ring.  For instance, Cp ring can move from a  
(pentahapto) to  (trihapto) coordination mode which reduces the electron of the metal 
attached to the Cp ring by two, resulting in creation of an empty space for an incoming 
ligand to coordinate and acquire 18 electron configuration.  Ring slippages are common 
in transition metal based Cp complexes and give rise to different types of organic 
transformation.  Casey and coworkers have explained the monohapto nature of [(-
C5H5)Re(CO)3(PMe3)2] complex obtained from the ring slippage reaction in which the 

 
coordination mode transforms to a stable coordinated rhenium complex.[19]  The ring 
slippage is also accompanied by an extra phosphine coordination to obtain stable 18 
electron complex (Scheme 1.2).  Ring slippage transformation from  coordination 
mode to  mode may also result in decarbonylation of the complex to give [(-
C5H5)Re(CO)2(PMe3)]. 
 
Re
CO
PMe3OC
OC
PMe3
OC
Re
CO
Re
OC CO
OC
PMe3 PMe3 H
Re
PMe3
OC PMe3CO
OC
 
Scheme 1.2. Ring slippage in Rhenium based half sandwich compound 
Early studies on fluxional behavior reveals that the monohapto cyclopentadienyl 
ring in the compounds [(-C5H5)(

-C5H5)Fe(CO)2] and [(

-C5H5)HgX], (X = Cl, Br, I, 
-C5H5) have been shown to undergo reorientation of the organic moieties by solid state 
nuclear magnetic resonance studies (Figure 1.7).[20]  The room-temperature proton NMR 
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spectrum of [(1-C5H5)(

-C5H5)Fe(CO)2] showed only two proton resonances which 
revealed that the sigma bond of the monohapto ring with the metal was in a dynamic 
equilibrium giving rise to fluxional property in the molecule.  The proton resonance of all 
these Cp based compounds is found to be temperature dependent.  
Fe
CO
CO
H
Hg
X
H
 
Figure 1.7. Ring slippage in [(-C5H5)(

-C5H5)Fe(CO)2] and [(

-C5H5)HgX] 
Recently, Elizabeth and coworkers have synthesized a series of nickel complexes 
5-C5H5)(
1
-C5H4){(CH3)2C}Ni] and 
5
-C5H5)(
1
-C7H9){(CH3)2C}Ni] by the 
reaction of 1,3-bis(2,6-diisopropylphenyl)-1,3-dihydro-2H-imidazol-2-ylidene and the 
mixture of 1,3-bis(2,6-diisopropylphenyl)-1,3-dihydro-2H-imidazol-2-ylidene and 
lithium indenyl with nickelocene respectively.  Similarly, palladium complexes 5-
C5H5)(
1
-C7H9){(CH3)2C}Pd] and 
5
-C5H5)(
1
-C5H4){(CH3)2C}Pd] have been 
prepared by the reaction of sodium cylopentadienyl with [(3-C7H9){(CH3)2C}PdCl] and 
[(5-C5H5){(CH3)2C}PdCl] respectively.[21]  Nickel and palladium complexes contains 
both 1 and 5 binding modes in the molecule and obey 18 electron rule as confirmed by 
the NMR and structural studies.  X-ray crystallographic investigation showed the 
existence of five similar C-C bonds between 1.381(4) Å and 1.426(3) Å for 5 bound Cp 
ring and three long C−C bonds between 1.426(4) Å and 1.448(4) Å and two short C−C 
bonds between 1.335(2) and 1.363(4) Ǻ for the 1 bound Cp ring in case of 5-
C5H5)(
1
- C5H4){(CH3)2C}M], (M = Ni. Pd) complexes. 
 
 
 
 
Figure 1.8. 1 and 5 binding modes of Cp 
M
M= Ni, Pd
M
CHH3C
H3C
CHH3C
H3C
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1,4- diphenylcyclopentadiene on treatment with thalium ethoxide (TlOC2H5) or 
NaNH2 in tetrahydrofuran has given the half-sandwich compounds Tl(C5H3Ph2) and 
Na(C5H3Ph2) respectively which further reacted with FeCl2 to give Fe(C5H3Ph)2.[22]  
The molecular structure of the half-sandwich Tl(C5H3Ph2) showed the presence of two 
phenyl rings on the 1,4 position of Cp ring, each of the thallium attached to the oxygen 
atom of the tetrahydrofuran solvent molecule and another thallium atom of the adjacent 
molecule forming a square planar structure containing two thallium atoms and two 
adjacent atoms and also a honeycomb layered like structure with the adjacent six thallium 
atoms.  In case of Fe(C5H3Ph)2, iron atom was found sandwiched in between two Cp 
rings with an angle of 178.3
0
C and each Cp containing two phenyl rings. 
 
In
NaNH2
InCl Ph
Ph
Ph Ph
Ph
Ph
H Na
TlOC2H5
Tl
Ph
Ph
FeCl2
FeCl2
Fe
PhPh
Ph
Ph
 
Scheme 1.3 
 
Ring slippage of osmocene, [(C)2Os] and ruthenium indenyl 
[Ru(ind)2] complexes has been reported by Cheung and coworkers.[23]  However, 
ring slippage type of transformation for Group 8 metallocenes has been thought to be 
unusual as they are expected to be stable due to 18 electron rule.  They found that both 
osmocene and [Ru(ind)2] did not react with nitrogen based ligands such as aniline, 
pyridine, acetonitrile but the compounds underwent ring slippage by reacting with 
ruthenium (VI) nitride ligand (Scheme 1.3).  DFT calculation explained the complexes 
involving Ru
IV−OsVI−RuIV and RuIV−RuVI−RuIV metal interaction via metal-N multiple 
12 
 
bond indicating that the ruthenium (VI) nitride ligand is crucial for ring slippage due to 
its electrophilic character.  The ring slippage has been found energetically more 
favorable than the  ring slippage.  The linearity of Ru-N-Os and Ru-N-Ru has been 
confirmed by single crystal X-ray diffraction study in both the cyclopentadienyl based 
ruthenium and osmium complexes  
 
Os
N N
Ru Ru
O
O
O Cl
Cl
Cl
O
O
OCl
N
Ru
Cl
Cl
O
O
O
Ru Os
Ru
N N
Ru Ru
O
O
O Cl
Cl
Cl
O
O
O
Cl
Co(EtO)2P
O
O
O
O =
-
P
(OEt)2
O
P
(OEt)2
O
 
Scheme 1.4. ring slippage in osmocene and ruthenium indenyl complexes 
 
1.1.3. Classification of cyclopentadienyl complexes  
 
A range of different metal-cyclopentadienyl complexes are known with unlike metal 
– carbon bonds or having diverse ligands attached to the metal center.  However, in view 
of the extensive variety of these compounds, cyclopentadienyl complexes can be 
classified into the following three categories based on the type of bonding between the 
metals and the cyclopentadienyl moieties: a) π-complexes, b) σ-complexes and c) ionic 
complexes. 
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(a) π-complexes  
In complexes, metals and cyclopentadienyl anions are connected through -
bonds, especially in the η5-type coordination mode.  This is the most common mode of 
bonding found mostly with the transition metals.  η3-type π-complexes are also known, 
depending on the electronic configuration of the metal centre.  In this mode, three atoms 
are bonded to the metal as an allyl-anion ligand, and the remaining two atoms of the Cp 
resemble a simple alkene.   
Tetraphenyl-1,5- diketones on treatment with zinc in acetic acid has formed 
tetraphenylcyclopentadiene (5-C5Ph4H2)Fe [24] which further reacted with iron 
pentacarbonyl to yield (4-C5Ph4H2)Fe(CO)3, (
5
-C5Ph4H)2Fe and [(
5
-
C5Ph4H)Fe(CO)2]2.pi-complexes as depicted in Scheme1.5.[25]  The molecular structure 
of the pi-complex (4-C5Ph4H2)Fe(CO)3 has been shown the bonding of Fe to 
cyclopentadiene group in a 4 fashion and bonds between Fe and and two carbon atoms 
on the Cp was found to be shorter (2.03 Ǻ -2.08 Ǻ) than the other three carbons of the 
cyclopentadiene group (2.15 Ǻ -2.25 Ǻ). 
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Scheme 1.5. Metal carbonyl mediated cyclization 
 
(b) σ-complexes 
 σ-Complexes have a direct -bond between the metal and one of the carbon atoms 
of the cyclopentadienyl moiety.  The piano-stool-type iron complex [Fe{(5 -C5H4)(
1
-
C5H4)P(=S)Ph}{P(OMe)2Ph}2] where the iron atom was attached to 
5
 - C5H5, 
1
 - C5H4 
and two P(OMe)2Ph ligands as legs has been formed by photolysis of [Fe{(
5
-
C5H4)2P(=S)Ph}] in presence of P(OMe)2Ph (Figure 1.9).[26]  The 
1
H NMR analysis 
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carried out for compound [Fe{(5 -C5H4)(
1
-C5H4)P(=S)Ph}{P(OMe)2Ph}2] showed 
peaks for the presence of CH2 and two olefin protons of 
1
-C5H4 ring at  3.09 and  3.22 
and at  6.46 and  6.53 respectively.  The piano stool structure of the complex bearing a 
sigma bond in between 1-C5H4 group and iron atom has been further confirmed by 
single X-ray crystallography where the bond distance between the Fe-C (1.979 Å) was 
found to be shorter than that in 5 - C5H5 (2.088 Å).  Some of these sigma complexes 
having 1-C5H4 moiety can lead to 
5
-C5H4 coordination with another metal atom and 
considered as promising precursors for bridged heterodinuclear complexes. 
 
Fe
(MeO)2P
(MeO)2P
P Ph
S
Ph
Ph
 
 
Figure 1.9. Fe(1 - C5H4) sigma complex 
 
(c) Ionic complexes 
 Cp based ionic complexes mostly involves metal cations of the alkali metal and 
alkali earth metal.  These complexes are generally synthesized by reaction of 
cyclopentadiene and the metal in a non- aromatic solvent like benzene and are used as 
precursors for a range of π-type cyclopentadienyl complexes.[27]  The binding affinity of 
cyclopentadienyl anion with K
+
 and Na
+
 ions in aqueous phase has been studied by Desai 
et al. to separate these cations from their mixture using the cyclopentadienyl as receptor 
by optimizing the geometry by density functional method in half sandwich, sandwich, 
inversed sandwich and multidecker chain.[26]  The study showed strong ionic interaction 
between the metal cation and cyclopentadienyl anion (Figure 1.10). 
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Figure 1.10. Ionic metal-Cp interation 
 
1.2. Structural variety of metal cyclopentadienyl complex 
 
Different types of structural framework for metal – cyclopentadienyl units are 
known in the literature and shows diverse properties depending upon the structural 
integrity.  Some of the general types of metal complexes containing the Cp ligand are 
shown in the Figure 1.11.  Metallocenes or "sandwich" compounds (Cp2M) in which the 
metal remains in between the two cyclopentadienyl moieties are among the widely 
recognized complexes.  The two cyclopentadienyl rings are known to form staggered or 
eclipsed conformation with a range of different torsional angle.  A second category 
contains a bent metallocene compounds (Cp2MLx), which have two Cp ring in non- 
parallel position and are slightly bent with an angle.  Bent metallocenes may contain 
ligands attached to the metal centers along with two 5 cyclopentadienyl group.  Another 
category consists of a half metallocenes or half sandwich complexes (CpMLy), 
sometimes also referred to as "piano stool" complexes.  These complexes have one 5 - 
cyclopentadienyl moiety bonded to the metal unit, while the other half contains different 
other ligands linked to the metal atom.  Depending upon the number of ligands, L, bound 
to the metal center, the complex can be named as two leg, three leg etc piano stool (or 
half sandwich) complexes.  In addition, bimetallic, multimetallic half sandwich 
compounds and multi-decker compounds containing (CpxMy) are also well known.  
Bimetallic and multimetallic half sandwich compounds have more than one metal-Cp 
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fragment bound together by one or more than one metal –metal bonds.  Such system has 
been categorized as a different area of metal complexes, usually referred to as metal 
cluster complexes.  Multi-decker type of compounds are relatively less known than other 
metal cp complexes but requires prime attention because of their unique structural 
identity and complicated synthetic processes. 
 
MM
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L
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Metallocene 
or Sandwich Bent metallocene
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Multidecker
 compounds
M
M
Bimetallic half sandwich
or piano stool compounds
M
L
L
M
L
M
LL
L
L L
 
Figure 1.11. Structural varieties of Cp based metal complexes 
 
1.2.1. Half sandwich and Piano stool complexes 
 
Half sandwich or piano stool compounds are organometallic complexes 
containing cyclic polyhapto ligand attached to a MLn centre, with the general formula 
((x-C5H5)MLn) in which the number (n) of unidentate ligands L may vary from one to 
four and the heptacity may be 5 or 3.  Half sandwich compounds containing 
cyclopentadienyl group are also called 2-, 3- or 4- legged piano stools depending upon 
the number of ancillary ligands, with the Cp being regarded as the seat and the other 
ligands as the legs.  Ligand, L is usually a 2-electron anionic or neutral ligand like CO, 
PR3, Cl etc.  In the last two decades, a range of half sandwich compounds with C5 and 
C6 carbocyclic rings with a variety of ligands have been synthesized which showed 
remarkable properties, structural variety and reactivity.  However, our discussion will 
only be concentrated on half sandwiches containing cyclopentadienyl (C5) carbocyclic 
rings to suit the title of the report.   
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Simple half sandwich complexes, like [(5-C5H5)M(CO)3Cl], (M= Mo, W) have 
been prepared by a mutistep reaction process using CpNa and M(CO)6 under thermolytic 
conditions.  Cyclopentadienyl metalcarbonyl halide complexes of the type [CpM(CO)nX] 
are used as precursor molecule for a variety of representative reaction to incorporate 
groups like alkyl, olefine, alkynyl etc.  Some of these complexes of iron and ruthenium 
are also prepared by the cleavage of their dimers, [(5-C5H5)M(CO)2]2 with halogen or 
using photochemical reaction condition in presence of halogenated hydrocarbons.[28-33] 
A variety of half sandwich derivatives having interesting coordination features 
have been synthesized from cyclopentadienyl metalcarbonyl halide complexes.  
Ruthenium based piano stool compound, [(5-C5H5)Ru(PPh3)2Cl] has been prepared by 
the addition of cyclopentadiene to the mixture of triphenylphosphine, ruthenium 
trichloride in ethanol.[34]  Further reaction of [(5-C5H5)Ru(PPh3)2Cl] and phosphine 
ligands (1,2-bis(diphenylphosphino)ethane, 1,1-bis(diphenylphosphino)methane) with 
ethanolic solution of 2-mercaptopyrimidine or 4-mercaptopyrimidine and sodium metal 
and gave a phosphine chelated thiolato ruthenium complex [(5-C5H4)Ru(Ph2P-(CH2)n-P 
Ph2)-4-S-(C6H4N)] and [(
5
-C5H4)Ru(Ph2P-(CH2)n-P Ph2)2-4-S-(C6H3N2)] in which the 
half sandwich CpRu framework was retained, while a heterocycle based thiolato moiety 
gets attached to the ruthenium centre as confirmed by single X-ray crystallography 
(Scheme1.6 ). [35]  Presence of a bidentate diphosphine group attached to the ruthenium 
atom has variable spacers, which regulates the P-Ru-P bond angle.  Metal complex [(5-
C5H4)Ru(Ph2P-CH2-P Ph2)-4-S-(C6H4N)] with n = 1, having a four membered Ru-P-C-P 
ring reveals a strained system with P-Ru-P bond angle of 71º in comparison to that of five 
membered ring complex. 
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Scheme 1.6. Diphosphine substituted ruthenium half sandwich complexes 
 
Substitution on the cyclopentadienyl ring and formation of a chelated ring system 
attached to the metal has the potential to impart remarkable effect on chemical and 
biological activities of the organometallic complexes.[36-40]  Therefore, a large of the 
research has been concentrated on substitution of the cyclopentadienyl ring and on the 
variation of the ligand attached to the metal center.  Systematic derivatization leads to 
useful molecules with unique structural behavior and photophysical properties. 
Recently, photolytic properties of a bifunctionalized monosubstituted cymantrenyl 
complex, [(CO)3Mn{
5
-(C5H4)CH(O-allyl)(CH2-C5H4N)}], containing an allyl fragment 
and N- donating pyridine group has been explored.[41]  Compound [(CO)3Mn{
5
-
(C5H4)CH(O-allyl)(CH2-C5H4N)}] was prepared by reaction of -picoline with n-
butyllithium and subsequent reaction with cymantrenecarbaldehyde, followed by 
alkylation reaction with allyl bromide.  Irradiation of the bifunctionalized cymantrenyl 
derivative led to the formation of two structurally different molecules obtained by 
decarbonylation and subsequent binding of pyridine or allylic group to the manganese 
metal center.  A six membered chelate ring involving either manganese – nitrogen bond 
or manganese – olefin pi- bond was formed and has been observed to undergo 
photoinduced linkage isomerization (Scheme 1.7).   
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Scheme 1.7. Photolytic behavior of bifunctionalized cymantrenyl derivative 
 
Reaction of [(CO)2Co{
5
-(C5Me4)CH2CH2N(CH3)2}] with iodine in ethereal 
solution gave a cobalt (III) chelated complex, [(I)2Co{
5
-(C5Me4)CH2CH2N(CH3)2}], via 
the non-chelated intermediate, [{I2(CO)Co{
5
-(C5Me4)CH2CH2N(CH3)2}].[42]  The 
formation of the metal-chelate ring between the Cp* and N(CH3)2 result in downfield 
shift of the ethyl proton in 
1
H NMR compared to that of the reactant due to the different 
environment caused by the chelate formation.  The structural analysis showed the 
presence of four methyl groups and a side chain, (CH2)2N(CH3)2, attached to the 
cyclopentadienyl ring.  The central cobalt atom is bonded to the cyclopentadienyl ring in 
5 mode and coordinated to the amine group of the side chain with a Co-N bond distance 
of 2.115 Å and two iodides with Co-I bond distances of 2.630 Å and 2.613 Å. 
 
Co
I
NI
Me Me  
Figure 1.12. Cobalt N-chelated half sandwich complex 
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A O-chelated five membered ring complex, [Cl3Ti{
5
-(C5H4)CH2CH2O(Me)}] 
has been synthesized from[Cl2Ti{
5
-(C5H4)CH2CH2O(Me)}], thionyl chloride and 
sulfuryl chloride.[43]  The ethereal oxygen atom attached to the side chain of Cp 
coordinates with titanium metal centre forming a five membered O-chelate ring having a 
Ti-O bond length of 2.214 Å (Figure 1.13).  Two independent molecules in the 
asymmetric unit cell with the sterically free titanium metal (II) were able to form chelate 
with the substituted cyclopentadienyl moiety itself. 
 
Ti OCl
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Figure 1.13. Titanium O-chelated half sandwich complex 
 
Piano stool complexes are also regarded as a type of half sandwich complexes 
having a general formula (CpMLn), where Cp is regarded as the seat and the ligands, L, 
as the legs of the stool where n can be two to four.  A large variety of such complexes has 
been known and shows interesting reactivity and electrochemical properties.  
[CpFe(CO)2(I)] reacted with MeS ( MeS= 1,3-bis(2,4,6-trimethylphenyl)imidazol-2-
ylidene) followed by the addition of dichloromethane to give the [CpFe(CO)(MeS)I] 
through the ionic intermediate [CpFe(CO)2MeS]
+
I
-
.[44]  Molecular structure of the 
pianostool compound [CpFe(CO)(MeS)I] has been revealed the presence of a Fe atom 
attached with a Cp ring, carbonyl carbon, Iodine atom and to a heterocyclic imidazole 
carbene atom.  The bond length 1.641 Ǻ of Fe-C(O) has found to be shorter than that of 
Fe-C bond distances (1.71 - 1.76 Ǻ) of piano-stool compounds which indicated the 
increase of Fe-CO pi- back bonding due to the presence of electron rich heterocyclic 
carbene ligand.  Further investigation using cyclic voltammetry also showed the lower 
oxidation potential of [CpFe(CO)(MeS)I] at 0.416 V compared to that of similar type 
substituted phenyl derivative [CpFe(CO)(PPh3)I] (0.69 V).  [42] 
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Scheme 1.8. Synthesis of [CpFe(CO)(MeS)I], L= 1,3-bis(2,4,6-Me3Ph)-N2C3H4  
A half sandwich based heteronuclear cluster compound [(5-C5H5)M(
1–CCPh) 
(CO)Fe2(CO)6(3-E)2], (M= Mo, W; E= Se, Te) has been synthesized by the reaction of 
iron chalcogenide, [Fe3(CO)9(3-E)2] with a metal acetylide [(
5
-C5H5)M(CO)3(CCPh)] 
in presence of trimethylamine-oxide.[45]  The structural analysis revealed a unique 
cluster-acetylide type of compound with distorted square pyramidal core, Fe2MoSe2, and 
the presence of a cyclopentadienyl ring and an acetylide group attached to the 
molybdenum metal centre.  The metals obey 18 electron rule when the bridged 
chalcogens were considered as 4-electron donor species.  The molecule has shown its 
potential to react with unsaturated metallic fragments to ligate with the pi electrons of the 
alkyne moiety resulting in the growth of the cluster framework. 
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Figure 1.14. Half sandwich heterometallic cluster 
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Some half sandwich moieties are known to support the formation of unique 
fragments, which are otherwise difficult to stabilize.  Species containing group 15 and 16 
elements are one of rare combination which requires special metallic framework to 
stabilize different types of Group 15 -16 fragments.  Mathur and group observed the 
formation of a half sandwich based trichalcogenophosphonato compounds, 
[{Fe2(CO)6}(3-Y3P){CpCr(CO)2}], (Y.= S or Se) by the reaction of [Fe3(CO)9(3-Y)2] 
(Y =.S or Se) and [CpCr(CO)2(
3
-P3)] in presence of trimethylamineoxide.[46]  The 
trichalcogenophosphonato compound contains a rarely known -PY3 fragment (with two 
P-Y and one P═Y) stabilized in between the cluster and half sandwich framework.  The 
31
P NMR for the compound showed a phosphorus peak at 230-261 region, while proton 
NMR showed a very distinct splitting of Cp protons into doublet due to the coupling of 
Cp protons with the Phosphorus atom.  Single crystal X-ray diffraction study revealed the 
unique Group 15 -16 fragment, PY3, attached to Fe2CO6 unit at one end and CpCr(CO)2 
half sandwich moiety at the other end.  The structural analysis also showed the presence 
of two long (2.11 – 2.29 Å) and one short (1.978 – 2.133Å) P-Y bonds of the stable PY3 
fragment. 
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Figure 1.15. [{Fe2(CO)6}(3-Y3P){CpCr(CO)2}] 
 
1.2.2. Sandwich complexes  
 
When the two cyclopentadienyl rings are parallel to each other with the metal 
atom in between, then the complex is known as sandwich compound.  Metallocenes are 
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the unique class of sandwich compounds with the general formula (C5H5)2M or Cp2M, 
where two cyclopentadienyl anions (Cp, which is C5H5
-
) are bound to a metal center (M) 
in +2 oxidation state.  The first sandwich structure was obtained for ferrocene in 1952 by 
Wilkinson and Woodward in which two Cp rings are perfectly parallel to each other and 
bound to iron atom through pi bonds having aromatic character and found to be highly 
stable due to 18 electron rule.[2]  Synthetic study of sandwich complexes with other 
transition metals opens up a route to organometallic chemistry of different pi complexes.  
The ability of sandwich or metallocene complexes to exist in different oxidation states 
having variable number of valence electrons makes them an exceptional molecule from 
the other families of inorganic and organometallic complexes.  The different oxidation 
states are characterized by cyclic voltammetry techniques where each of the oxidation 
state indicates different wave or peak.  Metallocenes with their magnetic behavior, charge 
transfer property and redox behavoiur makes them unique from the other organometallic 
complexes.[47 - 49]  9Metallocenes with various metal atoms like chromium, iron, cobalt 
and nickel have been well studied for their diverse reactivity and could well be suited for 
variety of applications.  Importantly, the steric and electronic properties of these 
metallocenes can be suitably tuned by the variation of the substituents on the 
cyclopentadienyl ring.  The influences of alkyl or silyl substituents on the steric and 
electronic properties of the metallocenes can by itself lead to significant information for 
several future applications.  However, synthetic strategies to prepare substituited 
metallocenes are still not very well known except for ferrocene compound.  A recent 
synthetic strategy shows that the reaction of sodium 2, 3-diisopropyl-1,4-dimethyl-
cyclopentadienide with [MBr2(dimethoxyethane)] (M = Fe, Co, Ni) at room temperature 
gave the corresponding ferrocene, cobaltocene and nickelocene compounds (Scheme 
1.9).[50] 
O
M
O
Br Br
CH3H3C+
THF
RT
-2NaBr
Na M
M= Fe, Co, Ni  
Scheme 1.9. Synthesis of substituted metallocenes 
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Ruthenium chloride with acetylacetonate and potassium bicarbonate has afforded 
ruthenium(III) acetylacetonate which on further treatment with cyclopentadienyl 
magnesium bromide has yielded ruthenocene.[51]  Reaction of ruthenocene with 
substituted arenes has given mixed sandwich type compounds (Scheme 1.10).[52] 
 
Ru
Ru
R
R
+
+
 Cl-
2AlCl3/Al
R = H, CH3, Ph, Cl  
Scheme 1.10 
 
1.2.3. Other variety of metallocenes 
 
Metallametallocenes are the compounds in which one or both the Cp rings are 
replaced by metallacyclopentadienyl group.  The first metallametallocene was reported in 
1972 which was a cobalt derivative synthesised by the photolysis of photo-l-pyrone and 
cyclopentadienyl cobalt dicarbonyl through the intermediate product cyclobutadiene 
(cyclopentadienyl) cobalt (Scheme 1.11).[53]  
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Scheme 1.11 
Buchalski and co-workers have synthesized some dinickel metallocene complexes 
of iron, cobalt and nickel.[54]  The X-ray single crystal structure revealed the presence of 
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two nickel based metallacyclopentadienyl groups bonded to metal ion in sandwich type 
framework.  Zeng et al. have reported the theoretical study of these nickel metallocenes 
and found that the spin states of these metallametallocenes are similar to that of the 
metallocenes.  Similar, metallametallocenes with fused benzene rings has also been 
syntheized and showed sandwich type structure as shown in Figure 1.16. 
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Figure 1.16. Metallametallocenes  
 
Room temperature reaction of iron(II) acetylacetonate and Li2C8Me6 has been 
carried out to afford the homoleptic bis(permethylpentalene)diiron, [{(CH3)6)C8}2Fe2] 
(Figure 1.17).[55]  Presence of two fused cyclopentadienyl rings, almost parallel with 
each other were found from the molecular structure of [{(CH3)6)C8}2Fe2] with a Fe-Fe 
bond distance of 2.3175 Å.   
Fe Fe
 
 
Figure 1.17. Bis(permethylpentalene)diiron metallocene 
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1.2.4. Bent metallocenes 
 
In bent metallocenes (Cp2MLx), the ring systems coordinated to the metal are not 
parallel, but are tilted at an angle where the L-M-L angle depends on the electron count 
of the complex and the substituents on the cyclopentadienyl ring avoiding the steric 
interference between the groups.  In a d
2
-complex, molybdocene dichloride (Cp2MoCl2), 
the Cl-Mo-Cl angle is 82° whereas, in d
1
 complex, niobocene dichloride, this angle is 
more open at 85.6°.  The d
0
-complex zirconocene dichloride has an angle which is even 
more open at 92.1°.[56]  In these compounds, the number of ligands (x) may vary from 
one to three.  A common example of a bent metallocene complex is titanocene dichloride 
(Cp2TiCl2) which has showed remarkable biological properties and is the first 
metallocene to undergo clinical trial.  A large number of titanium based bent 
metallocenes are known in the literature and shows a variety of properties related to 
catalysis, biological and material.  Recently, Semproni and coworkers have showed the 
reduction of the 1,3-disubstituted titanocene complexes to their corresponding titanocene 
dinitrogen compounds [(5-C5H3-1-iPr-3-R)2Ti]2(μ2,η
2,η2-N2)] where R = Me or 
isopropyl (Scheme 1.12).[57]  Single crystal study of the titanocene dinitrogen 
compounds showed the presence of an inversion centre at the center of the dinitrogen 
fragment and also the existence of meso isomer in [(5-C5H3-1-iPr-3-Me)2Ti]2(μ2,η
2,η2-
N2)] compound. 
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Scheme 1.12. Synthesis of titanocene based dinitrogen compounds 
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1.2.5. Bimetallic cyclopentadienyl complexes 
 
Cyclopentadienyl based bimetallic organometallic compounds having the general 
formula (Cp2MM’Lx) are compounds with two metals attached to each other by metal-
metal bonds and also linked to Cp and other ligands.  When the metals are identical then 
it is known as homobimetallic compounds and heterometallic when the metals are 
different.  In complexes with metal-metal bonds, each of the two metals has dz
2
, dxy, 
dxz, dyz and dx
2
-y
2
 orbitals involved in the interaction with its neighbor.  A coaxial (σ) 
interaction and eventually two lateral (π and δ) interactions result depending upon on the 
number of valence electrons available in these d-orbitals.  The dz
2
 orbital of each metal 
coaxially overlap to make the σbond whereas dxz and dyz orbitals of each metal can 
laterally overlap to give rise to πbonds.  The dxy and dx
2
-y
2
 orbitals can overlap according 
to lateral mode to form the bond (Figure 1.18).   
 
 
 
                  σ                                                       π                                                           
Figure 1.18. Metal- Metal bond interaction 
 
Reaction of nickelocene with pentacarbonyliron in benzene yielded 
tricarbonylcyclopenta- dienylnickel-cyclopentadienyliron.  Photolysis of [(5- 
C5H5)Co(CO)2] resulted in [(
5
- C5H5)Co(CO)] which reacted with the excess [(
5
- 
C5H5)Co(CO)2] to give [(
5
- C5H5)2Co2(CO)3] or dimerised to give [(
5
- 
C5H5)2Co2(CO)2].  Infrared spectroscopy of [Cp2Co2(CO)2(μ-CO)] has shown absorption 
at 1965 cm
-1
 and 1814 cm
-1
 for the presence of terminal and bridging metal carbonyls.  
The density functional theory of heterometallic binuclear cyclopentadienyl iron nickel 
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carbonyl compound [Cp2Fe(CO)Ni(μ-CO)2] has shown a coaxial structure with two 
bridging carbonyl compounds and one terminal carbonyl.  However, the isoelectronic 
[Cp2Co2(CO)3] compound has two different structures, namely [Cp2Co2(CO)2(μ-CO)] 
with a single bridging carbonyl and [Cp2Co2(μ-CO)3] with all three carbonyl groups in 
bridging positions.[58-60]   
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Figure 1.19. [Cp2Co2(CO)2(μ-CO)], [Cp2Fe(CO)Ni(μ-CO)2] and [Cp2Co2(μ-CO)3] 
 
Ito et al. have used density functional theory to optimize geometries of Zn2(5-
Cp*)2 (Cp* = C5Me5).  The calculated dissociation energies for the metal–metal and 
metal–ligand bonds predict that Zn2(5-Cp*)2 is a stable complex at room temperature. 
Ionic bond dominates the interaction between metal atom and ligand. The Zn–Zn bond is 
a single bond, which is further strengthened by a weak d–d interaction.[61] 
 
Zn Zn
 
Figure 1.20. Cyclopentadienyl complex with Zn-Zn bond 
 
Bulk electrolysis of [Re(η5- C5R5)(CO)3] ( R = H; Me) in [NBu4][TFAB] at Eappl 
= 1.4 V has formed the [Re2(η
5
- C5R5)2(CO)6][TFAB]2 as precipitate which was washed 
out with dichloromethane and was filtered out.  Absorption peaks in the range 1906-2062 
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cm
-1
 showed the presence of metal carbonyl peaks.[62]  Cyclic voltammetry of [Re(η5- 
C5R5)(CO)3] ( R = H; Me) in the anodic direction has given rise to a reversible one 
electron redox couple with E1/2  at 1.16 V and 0.91 V for the oxidation of [Re(η
5
- 
C5H5)(CO)3] / [Re(η
5
- C5H5)(CO)3]
+
 and [Re(η5- C5Me5)(CO)3] / [Re(η
5
- C5Me5)(CO)3]
+
 
respectively vs ferrocene / ferrocenium redox couple.  Oxidation of the [Re(η5- 
C5R5)(CO)3] complex at a lower scan rate or with a higher concentration of the complex 
has caused the formation of an irreversible of the peak at 1.16 V or 0.91 V for Re/Re
+
 
with a new peak at 0.55V and 0.15V [Re(η5- C5H5)(CO)3] / [Re(η
5
- C5H5)(CO)3]
+
 and 
[Re(η5- C5Me5)(CO)3] / [Re(η
5
- C5Me5)(CO)3]
+
 respectively.  The further analysis has 
been revealed that the extremely positive E° value at 1.16V or 0.91V corresponding to Re 
to Re
+
 in both the complexes made the system to behave as stronger oxidizing agent and 
forming the dimeric dication [Re2(C5R5)2(CO)6]
2+
 which was further produced the 
irreversible cathodic peaks at 0.55V or at 0.15V for the reduction of the 
[Re2(C5R5)2(CO)6]
2+
 / [Re(5- C5R5)(CO)3].  The weakly metal-metal (Re-Re) bonded 
dication [Re2Cp2(CO)6]
2+
 can be tuned to store and release the powerful one-electron 
oxidant [ReCp(CO)3]
+
.   
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Scheme 1.13. Synthesis of [Re2(C5R5)2(CO)6]
2+
 
 
The infrared and raman spectroscopy for the bimetallic [Cp2Ni2(CO)2], 
[Cp2Fe2(CO)4] (cis and trans forms), and [Cp2M2(CO)6] (M = Mo, W) complexes have 
been studied and compared to metallocene.[63]  Comparison of the spectra shows a 
common vibrational pattern of the infrared modes, with minor variations in frequency 
and intensity, which permits the establishment of a vibrational fingerprint of general 
validity.  The spectral patterns are apparently more complicated than the fingerprint 
scheme.  However, the basic features are easily interpreted on this basis.  
30 
 
NiNi
O
C
O
C
Fe Fe
O
C
C
O
OC CO
Fe Fe
C
O
CO
O
C
OC
M M
OC
CO
CO
OC
OC
CO
cis
trans M = Mo, W  
Figure 1.21. [Cp2Ni2(μ-CO)2], cis- ,trans-[Cp2Fe2 (μ-CO)2(CO)2]  
and [Cp2M2(CO)6] (M = Mo, W) 
 
1.2.6. Multimetallic cyclopentadienyl complexes 
 
In multimetallic organometallic compounds more than two metals are present 
with metal-metal bonds.  The metal present can be similar or different.  Triangular shaped 
heterotrimetallic polyhydrido complexes containing group 6 and group 8 metals 
[(Cp'Ru)2(CpM)(-H)5] (M= Mo, W) have been synthesized by the reaction of dimeric 
ruthenium methoxo complex (CpRuOMe)2 with dinuclear metal polyhydrido complexes 
[CpRu(-H)3MH3Cp'] as shown in Scheme 1.14.[64]  Molecular structure of these 
complexes have shown similar triangular metal cores having two short M-M bonds in the 
range 2.5-2.6 Å bridged by the two hydrido ligands and one long M-M bond of 3.0-3.1 Å 
bridged by a single hydride ligand.  The planes of the [C5(CH3)5] or [C5(C2H5)(CH3)4] 
have been found almost perpendicular to the triangular Ru-Ru-M plane. 
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Scheme 1.14. Synthesis of [(Cp'Ru)2(CpM)(-H)5] (M= Mo, W) 
 
1.2.7. Multidecker sandwich compounds  
 
Two or more than two metals are stacked through three or more than three Cp 
rings in multidecker sandwich compounds (CpxMy). The metal linkers can be same or 
different in these compounds.   In these multidecker complexes, the Cp rings may be 
parallel to each other or may be tilted.  [Ni2Cp3]
+
 was the first triple-decker sandwich 
having 34 valence electrons discovered by Werner and Salzer in 1972 (Figure 1.22).[65]  
A variety of triple decker and multi decker sandwich compounds were synthesized after 
that.   
Ni
Ni
+
 
 
Figure 1.22. [Ni2Cp3]
+
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Equimolar amount of ferrocene and GaCl3 in benzene has been yielded in the 
blue-green solution of [(C5H5)2Fe][GaCl4] which was further evaporated to give red 
coloured multidecker sandwich compound containing Ga(I) and Fe(II) ions in alternating 
array and stacked between cyclopentadienyl moieties, confirmed by XRD study.  The 
molecular structure also revealed the coordination of Ga(I) to two [GaCl4]
-
 and two 
cyclopentadienyl group and presence of 5-coordination in between each Ga(I) and the 
cyclopentadienyl moiety of two different ferrocene molecule.[66] 
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Scheme 1.15. Heterometallic multidecker compound 
 
[(5-C5H5)Tl(
5
-C5H5)Tl(
5
-C5H5)]- [Li(12-crown-4)2]
+
. thf has been synthesized 
from [(5-C5H5)Tl], [(C5H5)Li] and 12-crown-4 in 2:1:2 equivalent to obtain a triple 
decker sandwich compound in its anionic form (Figure 1.23).[67]  The molecular 
structure has been revealed the presence of two Tl atoms stacked in between three 
cyclopentadienyl rings and were placed symmetrically by a bridged (5-C5H5) group and 
each of the Tl atom has made a bond angle 133-135A
0
 with the adjacent two Cp rings. 
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Figure 1.23. [(5-C5H5)Tl(
5
-C5H5)Tl(
5
-C5H5)] 
 
1.3. Cymantrene based organometallic compounds 
 
Half sandwich cyclopentadienyl tricarbonylmanganese [(5-C5H5)Mn(CO)3] 
commonly known as cymantrene is a significant metal carbonyl compound in 
organometallic synthetic chemistry.  Cymantrene is an important precursor for the 
synthesis of various organometallic complexes by substitution of the protons at the Cp 
ring or by replacement of the carbonyl ligand attached to manganese.  The metal 
carbonyls of the cymantrenyl fragement are known to show very sharp and distinguish 
peaks in the mid infrared region between 1850 cm
-1
 to 2200 cm
-1
, a region where proteins 
and most organic molecules do not show any distinguishing peaks.  Therefore, it is likely 
that some of these compounds can be used as sensitive probes or labels by infrared 
spectroscopy for the detection of carbonyl ligands in biological environment.  
Cymantrene is a stable molecule with 18 electron system and can undergo one electron 
redox process at relatively higher potential (0.92 V) with respect to ferrocene.  Acylation 
and alkylation on the cyclopentadienyl ring of cymantrene via Friedel Craft method has 
been one of the versatile synthetic techniques to obtain large number cymantrenyl 
derivatives.[68]   
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Figure 1.24. Structure of cymantrenyl derivative (R = H, organic group) 
 
The chemistry of cymantrene and its derivatives have most recently been reported 
across a variety of chemical application.  Methylcyclopentadienyl manganese tricarbonyl 
[{5-(C5H4)CH3}Mn(CO)3] has been known as antiknock agent and used in gasoline to 
increase the efficiency of operation of engine by reducing the engine knocking and 
enhancing the octane number.[69]  Recently, Hamadi studied the octane enhancing 
properties with some of the organometallic reagents and solvents and concluded that 
selective blending agents can improve the octane number of the methyl substituted 
cymantrenyl derivative in various degrees. [70] 
Photochemistry of cymantrenyl derivatives have been known from earlier days in 
which irradiation of light in the wavelength range 300-500 nm resulted in loss of a 
carbonyl ligand with the dissociation of metal –carbon bond and formation of solvated 
system which can be further ligated to manganese with desired group.  Detail 
investigation revealed that irradiation of [(5 -C5H5)Mn(CO)3] results in the formation of 
excited molecule [(5-C5H5)Mn(CO)3]* which further forms an unstable 17 electron 
species [(5-C5H5)Mn(CO)2] by the removal of one molecule of CO from the excited 
molecule.  The electron deficient molecule [(5-C5H5)Mn(CO)2] behaves as an electron 
acceptor and can make stable complexes by the addition of electron donating species as 
shown in Scheme 1.16.[71] 
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Scheme 1.16. Proposed mechanism of photolysis in [(5 -C5H5)Mn(CO)3] 
 
In general, photolysis of [(5 -C5H5)Mn(CO)3] carried out in solvents such as 
hexane (C6H12), tetrahydrofuran (OC4H8), cyclo-octene (C8H14) etc lead to the formation 
of a solvated intermediate [(5-C5H5)Mn(CO)2D] where D= C6H12, OC4H8, C8H14 which 
further reacts with donating ligands like triethyl phosphine to give [(5-
C5H5)Mn(CO)2{P(C2H5)3}] (Scheme 1.17).[72]  The solvent intermediates and the 
ligated product can be identified by the help of infrared spectroscopy.  The infrared peaks 
for the tricarbonyl compound, [(5-C5H5)Mn(CO)3] comes at 2030 cm
-1
 and 1930 cm
-1
 
region which on photolysis in tetrahydrofuran (OC4H8) and cyclo-octene (C8H14) solvents 
gave new peaks at 1928 cm
-1
, 1852 cm
-1
 and 1963 cm
-1
, 1902 cm
-1
 region due to the 
formation of the solvated compounds [(5-C5H5)Mn(CO)2(OC4H8)] and [(
5
-
C5H5)Mn(CO)2(C8H14)] respectively.  Phosphine substitution also showed similar peaks 
at 1937 cm
-1
 and 1873 cm
-1
 for the compound [(5-C5H5)Mn(CO)2{P(C2H5)3 
The technique has been recently used in photolysis of [(5 -C5H5)Mn(CO)3] in a 
biphasic system to generate hydrogen from water.[73]  The method works the process of 
decarbonylation upon irradiation of UV light followed by coordination of a water 
molecule as shown in Scheme 1.25.  The shorter lived and unstable [CpMn(CO)2(H2O)] 
intermediate was detected by time-resolved IR spectroscopy which showed CO stretching 
absorption at 1862 and 1934 cm
-1
 region.  The lower stability of this intermediate can be 
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attributed to the weaker donor ability of the oxygen atom in water which further 
undergoes dissociation to give hydrogen and hydrogen peroxide in the two phase 
systems.   
 h+ 2
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H
O
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+Mn
OC CO
OC
 
 
Scheme 1.17 
 
1.3.1. Chelated Cymantrenyl complex 
Cymantrene based piano stool compound are interesting molecule to form a 
variety of derivatives where chelation plays a vital role in providing unique structural and 
photophysical properties.  This particular molecular system has the ability to form 
chelates involving the cp ring and the group ligated with the manganese centre by 
photochemical activation technique.   
In a typical example to prepare different chelated cymantrenyl molecules, photo-
irradiation of cyclopentadienyl manganese tricarbonyl [(5-C5H5)Mn(CO)3] derivatives 
with functional groups attached to the cyclopentadienyl ring led to intramolecular chelate 
formation followed by the dissociation of labile metal-CO bond.   
 Photochemical properties of cymantrene carbamates have been explored recently 
to understand their chelation properties and to investigate their potential in the use of 
photochromic system. UV irradiation of cymantrenyl carbamates, [(CO)2Mn{η
5
-
(C5H4)CH(R)N(R’)(CO)(OCMe3)}] synthesized by the reaction of 1- 
aminoethylcymantrene with di-tert-butyl- dicarbonate [74], produces a chelated 
compound in which the oxygen atom of the carbamate ligand is coordinated to the 
manganese atom.  The O-chelated manganese complex reversibly transformed to the 
parent cymantrenyl compound in dark at room temperature condition.  The O-chelated 
cymantrenyl compound was characterized by infrared spectroscopy with peaks in the 
region 1955 cm
-1
 -1855 cm
-1
 for the presence of metal carbonyls and in the range 1658 
cm
-1
 -1640 cm
-1
 for the carbamate carbonyl.   
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Scheme 1.18 
 
UV irradiation of a bifunctionalized cymantrenyl compounds containing both 
pyridine and ketone side chains led to the formation of two different types of chelates, O- 
and N chelate, involving simultaneous decarbonylation.[75]  However, interconversion 
has also been shown between the two chelated compounds using optimized reaction 
condition.  The molecular structure of the N- chelated cymantrenyl derivative confirmed 
by X-ray crystallography showed the formation of six membered chelate ring involving 
the Cp carbon and pyridine nitrogen atom.  However, irradiation of the N-chelated 
compound with visible light gave the O chelated cymantrenyl derivative, as shown in 
Scheme, which being thermally unstable isomerizes back to N- chelate isomer.  DFT 
calculations revealed that compound with tethered, coordinated functional group is labile 
enough to isomerize by a low-energy pathway involving several transient intermediates. 
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Scheme 1.19 
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Similar photolytic study of cymantrene based fragment with thioamide and 
pyridine side chain led to the formation of only S- chelated product.  Presence of pyridine 
group attached to the side chain does not lead to any isomerization of the S- chelated as 
observed in the earlier case. [75]  
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Scheme 1.20 
 
Heilweil et. al. has been described the photo-dissociation of [{η5-
C5H4(CH2COPh)}Mn(CO)3] with a side chain having a keto group to form a O-chelated 
species formed by UV irradiation of the cymantrenyl derivative followed by CO 
dissociation from the metal centre (Scheme 1.21).[76]  The unique half sandwich 
molecule was identified by various spectroscopic and computational techniques.  
Irradiation of this compound in non polar solvent changes the pale yellowish solution to a 
blue colored solution with the formation of a new UV-Vis. absorption peak at 635 nm.  
Infrared analysis showed that the peaks observed for [{η5-C5H4(CH2COPh)}Mn(CO)3] at 
2024 cm
-1
, 1946 cm
-1
 and 1938 cm
-1
 has changed to 1948 cm
-1
 and 1887 cm
-1
 due to the 
formation of O-chelated compound, [{η5-C5H4(CH2COPh)}Mn(CO)2].   
 
 
 
 
 
Scheme 1.21 
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1.3.2. Biological properties  
 
Combination of organometallic groups and peptides together can form a number 
of conjugates with fascinating and altered biological properties.  Particularly, when the 
organometallic moieties are tagged with cell-penetrating peptides that act as efficient cell 
delivery vehicles can serve as a new path in biological chemistry.  However, conjugations 
of biomolecules with metal moieties are not only synthetically difficult but pose hard 
challenges with the standard conjugate synthesis procedures.  Recently, Splith et al. have 
reported the preparation of some cymantrenyl-peptide bioconjugates by solid phase 
peptide synthetic technique and studied the influence of the linker group of the 
conjugates on cellular uptake and cell viability with MCF-7 breast cancer cells.[77]  The 
promising biological activity of the cymantrenyl bioconjugates on MCF-7 breast cancer 
cells was assigned to the combination of functionalized cymantrenyl group with the cell 
penetrating peptide. In comparison, the independent cymantrenyl derivative as well as the 
peptide concerned has been found to be inactive towards the anticancerous activity. 
 
 
 
 
 
 
Figure 1.25 
Generally, in the immunological methods biomolecules labelled by markers are 
used which can be detectable by some physical methods.  Several such probes based on 
transition metal fragments have been investigated where electrochemical processes are 
used for detection.  Recently, methyl imidate derivative of cymantrene bound to a protein 
bovine serum albumin (BSA) in aqueous solution has been reported by the research 
group of Jaouen which can able to detect the protein concentration by electrochemical 
reduction method.[78]  Cymantrenyl imidate compound has been synthesized from 
formylcymantrene through two step reaction process in which the first step consist of 
Mn
CO
COOC
O
Z
Y
X
X= CO-NH-Peptide, Y, Z= CH
Y= CO-NH-Peptide, X, Z= CH
Z= CO-NH-Peptide, X, Y= CH
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formation cymantrenylnitrile derivative which was transformed to the mthyl imidate 
compound using a base catalyzed addition of methanol.  Incubation of the mixture 
containing methanolic cymantrenyl imidate and BSA protein in phosphate buffer for 24 
hours and separation of the unbound cymantrenyl imidate from the mixture by size 
exclusion chromatography resulted in the formation of cymantrenyl imidate protein 
conjugate.  Electrochemical investigation of the conjugate showed reversible one electron 
redox process of the cymantrenyl fragment covalently bound to the protein.  The redox 
couple can be used to detect much lower concentration of BSA protein as compared to 
other traditional methods.   
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Figure 1.26 
  
The metal carbonyls attached to manganese in the cymantrenyl derivative can be 
used as IR probe in biological system by strategically labeling the molecule.  Fourier 
transform IR spectroscopy was used as a detection method, because metal carbonyl 
complexes display very intense and specific absorption bands in the spectral range 1800-
2200 cm
-1
 due to the stretching vibration modes of the carbonyl ligands bonded to metal.  
To understand the feasibility for the use of transition metal carbonyl complexes as labels 
to perform the immunoassay of biomolecules, functionalization of peptides has been 
carried out by cymantrene keto carboxylic acid by microwave-assisted solid phase 
peptide synthesis technique.[79]  The infrared bands of the cymantrenyl peptide 
bioconjugate showed stretching vibrational peaks at 1934 cm
-1
 and 2026 cm
-1
 region 
indicating the presence of metal carbonyl groups.  The negative influence of the 
cymantrenyl peptide bioconjugate on the cell viability of MCF-7 human breast cancer 
cell lines was then studied which showed its potency to use as infrared probe in 
bioimaging of peptides. 
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Figure 1.27. Cymantrene peptide conjugate 
 
Recent investigation on organometallic analogues of chloroquine showed 
significant antimalarial activity overcoming resistance to the parent drug chloroquine.  
Synthesis and characterization of some cymantrenyl and cyrhetrenyl 4-aminoquinoline 
conjugates with amine or amide linker such as (2-(7-Chloroquinolin-4-ylamino)ethyl)-4-
cymantrenylbutane amide, N-(2-(7-Chloroquinolin-4-ylamino)ethyl)-4-
cyrhetrenylbutaneamide and N-(7-Chloroquinolin-4-yl)-N′-(cymantrenylmethyl)ethane-
1,2- diamine have been carried out which showed promising antimalarial activity when 
evaluated against both chloroquine-sensitive and resistant strain of the malaria parasite 
Plasmodium falciparum.[80]  The cymantrenyl complex with an amine linker showed 
high activity against the chloroquine-sensitive strain and was inactive against the 
chloroquine-resistant strain, but showed promising result against Trypanosoma brucei at 
a much lower concentration.  Both cymantrenyl and cyrhetrenyl conjugates with amide 
linkage showed activity against both the chloroquine-sensitive and chloroquine resistant 
strain. 
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Figure 1.28. Cymantrenyl / Cyrhetrenyl-quinoline complex 
42 
 
1.3.3. Electrochemical properties 
Cyclopentadienylmanganese tricarbonyl came into focus for its unique and rich 
electrochemical properties which can be tuned by various substitution and coordination 
techniques.  However, very little has been explored on the electrochemistry of this half 
sandwich complex and its derivatives.  The study on the anodic one-electron oxidation 
property of [(5-C5H4R)Mn(CO)3], (R=H, NH2, CH3) revealed the formation of 17 
electron radical cation from the oxidation of the cymantrene, [MnCp(CO)3] at E1/2= 0.92 
V are persistent in solution and has been characterized spectroscopically.[81]  The cation 
mostly absorbs in the visible wavelength at 530 nm, near-IR region at 2066 cm
-1
 and at 
2118 cm
-1
 and 1934 cm
-1
 in IR regions.  Similarly, E1/2 of the radical cations for the Cp-
functionalized analogues, [Mn(η5-C5H4NH2)(CO)3] and [Mn(η
5
-C5Me5)(CO)3] were 
found to be 0.62 V and 0.64 V respectively by cyclic voltammetric analysis.  The 
formation of radical cations [Mn(η5-C5H4NH2)(CO)3]
+
 and [Mn(η5-C5Me5)(CO)3]
+
, was 
confirmed  by IR spectroelectrochemistry which showed higher wavelength shift of 98 
cm
-1 
and 107 cm
-1
 than that of the parent compound with colour change to green and 
turquoise for the formation of the respective radical cations.  Single crystal X-ray studies 
of [Mn(η5-C5H4NH2)(CO)3]
+
 and [Mn(η5-C5Me5)(CO)3]
+
 showed elongated Mn-C(O) 
and shortened C-O bonds displaying the effect of weaker metal-to-CO backbonding 
compared to that of neutral compounds. 
 
Mn
OC
CO
OC
R1
R1
R1
R1 R2
R2 = NH2, R1 =R2 = H, CH3
Mn
OC
CO
OC
R1
R1
R1
R1 R2
R2 = NH2, R1 =R2 = H, CH3
+.
 
 
Scheme 1.22 
 
Electrochemical property of cymantrenyl fragment was also studied with a 
cymantrenyl analog of tamoxifen, a well known anticancer drug, and recently known to 
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act via electron transfer mechanism.  The finely tuned redox potentials of the 
cymantrenyl-tamoxifen derivative, [Mn(CO)3(η
5
-C5H4(C2H5)C=C(C6H4R)2] impart 
significantly modified electronic and redox properties to the tamoxifen backbone which 
may play a effective role in cancer cell inhibition study.[82]  The derivative showed 
successive highly reversible redox processes at 0.78 V and 1.20 V due to the oxidation of 
the cymantrenyl fragment by cyclic voltammetry.  The half-sandwich tamoxifen 
derivative, gives a radical cation in which the charge is delocalized between the 
cymantrenyl and diphenylethene moieties and undergoes facile metal-carbonyl 
substitution reactions.  Most importantly, it is observed that the redox potentials of these 
systems can be readily controlled over a wide potential range by mere substitution of the 
metal carbonyls by donor groups.   
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Figure 1.29 
Three type of triazole linked cymantrenyl complexes, [1-{(η5–C5H4)Mn(CO)3}-4-
X-(N-N=N-CCH)], {R = C6H5, (2-NH2-C6H4), (3-NH2-C6H4)}, have been reported via 
“click” reaction from cupper catalyzed cycloaddition reaction of cymantrenyl azide with 
phenylacetelyne and ethynylanilines.[83]  The structural analysis of the cymantyrenyl 
compounds revealed the presence of a phenyl, m-aminophenyl or p-aminophenyl moiety 
at the 4-position of the triazole ring.  Electrochemical study by cyclic voltammetry 
showed two oxidation peaks in the positive potential due to Mn/Mn
+
 redox couple (1.2 V 
– 1.4 V) and triazole / triazolium redox couple (1.55 V – 1.775 V) for all the cymantrenyl 
triazole based compounds 
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Figure 1.30. Triazole based cymantrene 
 
1.4. Ferrocene based organometallic compounds 
 
Ferrocene and its derivatives are the most versatile organometallic compounds 
because of their unique structures, chemical and thermal stabilities, reversible redox 
properties etc.  The exclusive nature of their chemistry make them an excellent building 
block in several processes and their use in the field of material science, molecular wires, 
catalysis, molecular recognition, sensing, electronic communication, bio-conjugates and 
medicinal chemistry.  The recent focus of ferrocenyl derivatives in application related to 
biological properties has generated a new field of bioorganometallic chemistry.[84-92]   
The synthetic chemistry of ferrocene began in 1951 with the reaction of ferric 
chloride with a Grignard reagent of cyclopentadienyl magnesium bromide obtained from 
the synthesis of cyclopentadiene, magnesium and bromoethane in benzene.[93]  
However, several other methods for the preparation of ferrocene evolved in later years, 
the most efficient process being the use of freshly cracked cyclopentadiene reagent, 
deprotonated with potassium hydroxide and subsequent addition of ferric chloride 
solution.  Recent research has been focused on the synthesis of a variety of ferrocenyl 
derivatives for their potential use in different field.  Ferrocene and its derivatives are 
usually functionalized by electrophilic substitution, lithiation or via transition-metal-
catalyzed C−H activation of the Cp ring to give 1,1’-ferrocenyl derivatives.[86, 94-104]  
The most familiar methods used for the derivatization of ferrocene are Friedel−Crafts 
acylation, lithiation, borylation, mercuration etc.[105-107] 
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Tamm and coworkers have reported the synthesis of 1,1′-ferrocenedicarboxylic 
acid [Fc(COOH)2] in a large scale by a simple and convenient process from the reaction 
of sodium salts of cyclopentadienecarboxylic methyl and ethyl esters, Na(C5H4COOR) 
(R = Me, Et).  1,1′-ferrocenedicarboxylic acid has been further involved to get a series of 
1,1′-disubstituted ferrocenyl compounds of the type FcX2 (X = CH2OH, COCl, CON3, 
NCO, NHCOOMe, NHBoc, NH2) (Scheme 1.23).[108]  Some of the synthesized 1,1′-
disubstituted ferrocenyl compounds have been characterized by single crystal-XRD 
showing the presence of two functional groups separately attached at the two 
cyclopentadienyl rings in different orientation. 
 
Fe+ NaOC2H5 FeCl2O
C2H5O
C2H5O
++
X
X
X = CH2OH, COOH, COCl, 
CON3, NCO, NHBoc, NH2  
Scheme 1.23. 1,1′-disubstituted ferrocenyl compounds 
 
The ortho substitution containing a hetero atom or electron withdrawing group on 
ferrocene restrict the synthesis of 1,2- disubstitution of ferrocene having two hetero 
atoms or two electro withdrawing group.  Recently Lang et al. reported the synthesis of 
planar 1,2-disubstituted ferrocene derivatives anticipating their use in catalysis.[109-110]  
Lithiation of a series of alcohol derivatives and subsequent addition of POCl3 gave 
chlorophosphates which was converted to their ferrocenyl phosphates by the addition of 
lithiated ferrocenol.  The ferrocenyl phosphate was subjected to anionic phospho Fries-
rearrangement in presence of diisopropylamine, butyllithium, tetramethylethylenediamine 
and dimethylsulfate to give the 1,2-disubstituted ferrocenyl derivatives as shown in 
Scheme 1.24.[109] 
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Scheme 1.24 
 
Electrochemical and spectroscopic techniques have been frequently adopted to 
know the cation complexation properties of a variety of unsymmetrically disubstituted 
ferrocene compounds.  Recently, ferrocene-triazole based compounds are of interest due 
to their unique coordination ability, sensing properties and ectrochemical behaviour.[111] 
A unsymmetrical triazole based ferrocenyl system has been obtained by sequential 
functionalzsation of a bisazidoferrocene through click reaction with ethynylpyrene and 
Staudinger reaction with trimethylphosphine followed by hydrolysis and treatment with 
quinoline aldehyde (Figure 1.31).[112]  Molecular structure of the unsymmetrical 
ferrocenyl triazole derivative has shown that the quinoline and pyrene rings attached to 
the ferrocene fragment are exclusively coplanar and forms an eclipsed conformation 
across the ferrocenyl Cp rings.  The molecule showed hyperchromic shift in UV-Visible 
absorption spectroscopy by gradual addition of HP2O7 
3−
, Pb
2+
 and Hg
2+
 confirming their 
potential in sensor application.  The effect on fluroscence emission study also showed the 
capability of the ferrocenyl triazole derivative to behave as fluorescent probe for HP2O7 
3−
, Hg
2+
 and cobound Pb
2+
 cations in the presence of HP2O7 
3−
 anion. 
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Figure 1.31. Ferrocenyl triazole derivative 
 
1.4.1. C-H bond functionalization of ferrocene 
 
Among several methods to introduce substituents on the cyclopentadienyl rings of 
ferrocene, metal-catalyzed cross-coupling reactions have become a powerful tool to 
achieve highly efficient and selective transformations to create C-C and C-Heteroatom 
bonds directly on one or both the Cp rings of ferrocenyl unit. [113, 114]  A method for 
the direct functionalization of ferrocene compounds to prepare ferrocenyl vinyl derivative 
catalytically generated from vinyldiazo compounds and gold complexes has been 
reported recently by Lopez et. al (Scheme 1.25). [115]  The presence of different type of 
esters has been found to be inactive towards the regioselectivity forming E stereoisomer 
as the single product whereas the substitution at the vinyl group by alkyl and acetyl 
groups afforded both the isomers predominating E-stereoisomer over Z-stereoisomer.  
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Fe N
N
N
NH
C
N
O
48 
 
Palladium-catalyzed intramolecular C−H cyclization strategy has been adopted 
for the synthesis of planar chiral metallocenes with high enantioselectivities by the 
reaction of acyl ferrocenyl derivatives with Pd(OAc)2 in presence of 2,2'-
bis(diphenylphosphino)-1,1'-binaphthyl ligand (Scheme 1.26).  This synthetic method 
provided an efficient way to obtain structurally unique enantioselective ferrocenyl 
framework with a wide range of functional group such as aldehyde, ketones, carboxyl 
ester, and amides substituted at the other Cp ring of the ferrocene moiety.  The 
asymmetric 1,2- substitution formed on the same Cp ring by intramolecular cyclization 
has been offered the planar chirality to all the ferrocenyl derivatives making the reaction 
unique and distinct.[116] 
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Scheme 1.26 
 
A Rh (III)-catalyzed C-H bond functionalization of ferrocenecarboxamides 
derivative with alkynes has been reported for the facile synthetic route for planar chiral 
ferrocenylpyridones for their potential use as organocatalyst.  The reaction conditions 
have been optimized by the preliminary reaction of N-methoxy ferrocenecarboxamide 
and 1-phenyl-1-propyne in presence of different bases and with different temperature and 
optimizing the conditions at 60
0
C with sodium acetate and triethyl amine as bases and 
trifluro ethanol as solvent (Scheme 1.27).  The optimized reaction conditions have been 
applied for C-H bond functionalization of different type of substituted ferrocene 
carboxamide and alkynes to obtain various ferrocenyl pyridone derivatives from good to 
excellent yield.[117] 
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Scheme 1.27 
 
1.4.2. Ferrocenyl derivatives having biological properties 
The structural diversity and special properties like high stability, redox property 
and low toxicity of ferrocenyl compounds make them unique from the other metallocenes 
and are widely employed in drug designing with their improved biological activities and 
can be used as labelling tags in several biomolecules.  Conjugation of organometallic 
compounds with biomolecules such as DNA, amino acids and peptides can serve as a 
molecular scaffold with a redox active site and a biological marker.  The interest on 
bioconjugates has led to the design of several ferrocene –peptide architecture with unique 
properties like redox switching and sensor abilities.  The ability of ferrocenyl derivatives 
to act as molecular scaffold through hydrogen bonding interaction has been demonstrated 
recently by several research groups using peptide chains incorporation.  Synthesis of 1,1’-
disubstituted ferrocene –peptide bioconjugates and their structural evaluation reveals the 
formation of two identical intramolecular interchain hydrogen bonds between the 
carbonyl and NH units of the amino acid fragments to give a ten membered hydrogen 
bonded ring.  The structure resembles the hydrogen bonding pattern observed in an anti-
parallel -sheet.  In some cases, the molecules arrange in a helical fashion linked together 
via intramolecular hydrogen bonding where introduction of peptide chains into ferrocene 
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moiety induces some kind of conformational enantiomerization by the torsional twist 
generated by interchain hydrogen bonding interaction (Figure 1.32).[118-121] 
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Figure 1.32. Fc(-L-Ala-D-Pro-NHPy)2 and Fc(-D-Ala-D-Pro-NHPy)2 
 
Ferrocene substituted tamoxifen, also known as ferrocifen, and chloroquine 
derivatives are among the many examples where systematic functionalization of 
ferrocene has improved the cytotoxic activity of the standard drug itself.  Ferrocifen has 
been prepared from propionylferrocene by McMurry cross coupling reaction with 
dihydroxybenzophenone giving a halogenated compound which further reacts with 
dimethylamine chlorhydrate to yield ferrocifen (Figure 1.33).[122]  A mechanism have 
been proposed for the improved cytoxicity found in case of ferrocifen and its derivatives 
against both hormone dependent and hormone independent cancer cells through the 
radical formation of OH group attached to the phenyl ring present in the trans position of 
the ferrocenyl moiety forming quinone methide intermediate. [123, 124]  The ferrocenyl 
group has been predicted to give extra stabilty to the intermediate radical.  Inspired by the 
development of bioorganometallics, several researchers focused their investigation on 
ferrocenyl derivatives adopting different synthetic methods and studying facts related to 
biological chemistry, medicinal poperties, cytotoxicity behavior etc.  This unexpected 
boom in the field of bioorganometallic chemistry led to the synthesis of a ferroecnyl 
analog of chloroquine, a well known antimalarial drug.  However, there are several cases 
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found in medical investigation that the malaria parasite has developed resistant to the 
chloroquine drug, which posed a major global problem in treating the infection.  The 
ferrocenyl derivative of chloroquine, commonly known as Ferroquine, showed marked 
activity against both chloroquine susceptible and chloroquine resistant P. falciparum 
strains.[125]  Extensive study on the mechanistic aspects predicted that the higher 
activity of ferroquine is due to the presence of the ferrocene moiety in the lateral side 
chain of the aminoquinoline ring (Figure 1.33).   
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Figure 1.33. Structure of ferrocifen and ferroquine 
Multistep reaction of acetyl ferrocene with ethyl trifluoroacetate, hydrazine 
hydrate and ethyl bromoacetate afforded 5-ferrocenyl-3-(trifluoromethyl)-1H-pyrazole 
which further reacted with piperidine and sodium ascorbate in different reaction 
condition to give structurally different ferrocenyl pyrazole compounds (Figure 
1.34).[126]  Crystal structure analysis revealed the different substitution of the trifluoro 
and ferrocenyl groups in the pyrazolyl moiety.  All the derivatives have been reported to 
exhibit moderate to potent antitumor activities in vitro against A549 cell line compared to 
the standard drug 5-fluorouracil. 
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Some ferrocenyl compounds containing azines (-C=N-N=C-) have been 
synthesized by the reaction of 1,2-(dimethylamino) methyl ferrocenyl aldehyde with 
salicylaldehyde hydrazone derivatives which was further subjected to deprotonation by 
NaH followed by metallation using [RhCl(COD)]2 as depicted in Figure 1.35.[127]  A 
preliminary antiplasmodial investigation conducted against the chloroquine sensitive 
NF54 and chloroquine resistant K1 strains of P. falciparum showed that ferrocenyl azines 
exhibited weak to moderate activity across both parasitic strains.  However, upon 
complexation the activity gets enhanced compared to the ferrocenyl azines.[128]  The 
mechanism of the increased activity could not correleated with their -haematin 
inhibition.  Among all the synthesized ferrocenyl azine derivatives and its complex, the 
unsubstituted ferrocenyl azine compound and its complex have been found to exhibit the 
best activity against the chloroquine sensitive NF54 strain whereas the opposite behavior 
has been found against the chloroquine resistant K1 strains of P. falciparum.   
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The significant role of heterocyclic moieties in a variety of biological processes 
has prompted a large amount of studies in recent years to link different heterocycles to 
ferrocene based molecular system.  This interest led to the development of synthetic 
strategies for the design of a variety of ferrocene conjugated heterocyclic compounds and 
study their biological activity.  
Reaction of the precursor ferrocenylazide with 2-(prop-2-ynyloxy)-benzaldehyde 
through click reaction gave a ferrocenyl triazole aldehyde derivative which further 
reacted with rhodamine B hydrazide or rhodamine 6G hydrazide under reflux condition 
to furnish a triazole-rhodamine-ferrocene conjugates (Figure 1.36).[129]  Their 
electrochemical, optical, and metal cation sensing properties have been explored in 
aqueous medium.  The newly synthesized ferrocenyl receptors exhibited high turn-on 
fluorescence response for Hg
2+
 as well as I
−
 in an aqueous environment.  DFT 
calculations of the ferrocenyl derivative with Hg
2+
 showed the bonding of the ferrocenyl 
receptor through one nitrogen atom of the triazole ring, one nitrogen of the imine group, 
and two oxygen atoms of the carbonyl and ether groups to Hg
2+
, resulting in a nearly 
planar geometry around Hg
2+
.  Furthermore, both the ferrocenyl based receptors are less 
toxic toward MCF-7 cells and could able to detect intracellular Hg
2+
 by fluorescent 
imaging studies. 
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Figure 1.36. Ferrocenyl-triazole-rhodamine hybrid chemosensor 
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In order to improve the biological response of purely organic drugs, a few novel 
ferrocene derivatives within the isatin−ferrocene−triazole conjugate family have been 
synthesized by copper-mediated azide-alkyne cycloaddition method.[130]  In the first 
step, alkyl azido isatin was prepared by alkylation of substituted isatin with 
dibromoalkane and further substitution with sodium azide.  Copper mediated click 
reaction was then carried out with acetylenic ferrocene or ferrocenyl chalcones to afford 
the respective isatin-triazole-ferrocene conjugates (Figure 1.37).  The compounds with 
the ferrocenyl fragment showed enhanced antitubercular activity against M. tuberculosis 
in comparison to the isatin precursors.   
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Figure 1.37. Ferrocenyl isatin-triazole hybrid compounds 
 
The use of ferrocenyl derivatives as bioactive molecule has been established in 
current time and several reports show that a large number of ferrocene containing 
compounds display interesting cytotoxic and DNA cleaving activities. [131-141]  
Ferrocenyl aldehyde on reaction with 2,3- butanedione in presence of piperidine followed 
by reaction with salicylaldehyde under reflux condition afforded a ferrocenene based 
vinyl imidazole phenol derivatives which on further refluxation with [Ru(bpy)2Cl2]·2H2O 
gave the ruthenium complex of ferrocenyl imidazole derivatives as shown in Figure 
1.38.[142]  The differential pulse voltammetry of the complex [Ru(bpy)2-2-{4,5-bis[(E)-
2-ferrocenylvinyl]-1H-imidazol-2-yl}phenol](PF6) showed two redox peaks at +353 mV 
and +485 mV for Ru(II)/Ru(III) and Fe(II)/Fe(III) redox couples respectively whereas 
complex [Ru(bpy)2-2-{4,5-bis[(E)-2-ferrocenylvinyl]-1H-imidazol-2-yl)-4,6-
dichlorophenol](PF6)] showed only one peak shifted to more positive value due to the 
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presence of two electron-withdrawing chloride groups at +505 mV for both 
Ru(II)/Ru(III) and Fe(II)/Fe(III) redox couples.  All the complexes showed DNA 
cleavage activity which might be due to the presence of three redox active metal centers.  
The lower redox potential of the metal complex can be responsible for the generation of 
hydroxyl and peroxide radicals through fenton reaction under the experimental conditions 
for the DNA cleavage. 
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Figure 1.38 
 
1.4.3. Ferrocenyl compound as biosensor 
 
A biosensor is an analytical device which combines a biological component with 
a physicochemical detector and is used for the detection of an analyte.  Biosensors have 
potential environmental application and can be used in food industry, drug discovery, 
detecting gases like carbon dioxide and ammonia in blood samples.  
Ayranci et al have reported a novel ferrocenyldithiophosphonate functional 
conducting polymer and its use as an immobilization matrix in amperometric biosensor 
applications.[143]  Reaction of 1,4-bis-2-thienylbutane-1,4-dione with p-
phenylenediamine gave 4-(2,5-di(thiophen-2-yl)-1H-pyrrol-1-yl)aniline which was 
further reacted with ferrocenyldithiophosphonate to afford 4-(2,5-di(thiophen-2-yl)-1H-
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pyrrol-1-yl)amidoferrocenyldithiophosphonate.  Both the 4-(2,5-di(thiophen-2-yl)-1H-
pyrrol-1-yl)aniline and 4-(2,5-di(thiophen-2-yl)-1H-pyrrol-1-yl)amidoferrocenyldithio 
phosphonate was then electrochemically polymerized using the potential between -0.5 V 
to +1.5 V on graphite electrode forming a redox mediated ferrocenyl copolymer surface 
(Figure 1.39). The ferrocenyl copolymer was immobilized with glucose oxidase by 
means of glutaraldehyde for their application as a redox mediated ferrocenyl biosensor.  
The ferrocenyl biosensor can be used for glucose analysis in real samples with better 
detection limit for glucose by means of the current signal observed at+0.45 V.  The 
changes in current signals at +0.45 V has been observed to be proportional to glucose 
concentration in the range 0.5 to 5.0 mM.  Moreover, the method overcomes the 
problems such as the oxygen deficiency during the enzymatic reaction and interference of 
other substances during electrochemical measurements which are of critical points for the 
biosensor fabrication.   
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Figure 1.39. A ferrocenyl- polymer conjugate biosensor  
 
Yang et al. has reported the synthetic procedure for a ferrocenyl based derivative 
used as an intercalator to double stranded DNA (dsDNA) obtained from the reaction of 
ferrocenecarboxylic acid with oxalyl chloride followed by addition of 2,2’-
(ethylenedioxy)bis(ethylamine) and naphthalenetetracarboxylic dianhydride (Figure 
1.40).[144]  The binding of the ferrocenyl intercalator to dsDNA was measured by 
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differential pulse voltammetry and was optimized for the recognition of single base pair 
mismatched sequences.  The results reveal the feasibility of detecting human DNA 
biomarkers in wastewater using the synthesized ferrocenyl based biosensor, which may 
allow further development of DNA population biomarkers for evaluation of public health. 
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Figure 1.40. Ferrocenyl based intercalator to dsDNA/ ferrocenyl dsDNA intercalator 
 
1.4.4. Ferrocenyl compounds as chemosensor 
 
The design of molecular receptors having the ability of selective binding and 
recognition of neutral molecules, cations or anions by means of various different physical 
tools is an interesting area of research.  In this context, ferrocene has largely proved to be 
a simple and remarkably robust building block for the preparation of such ferrocenyl 
receptors displaying electrochemical sensing properties exploiting the redox activity of 
ferrocene moiety.[145, 146]  Additionally, binding of targets at specific binding site of 
ferrocenyl unit can affect the UV-visible and fluorescence spectra of the ferrocenyl 
58 
 
derivative and can be applied for the designing of dual sensing and multisensing 
ferrocenyl based chemosensor.[129, 147] 
Karagollua et al. have reported the selective sensing properties of ferrocene-
functionalized triazole compounds, [{Ar(CH2)2(C2HN3)
5
-C5H4)}Fe
5
-C5H5)], (Ar = 
C4H3S or styrene) for phosphate, H2PO4
−
and HP2O7
3−
 using electrochemical process 
(Figure 1.41).[148]  The ferrocene-appended thiophene compound was prepared by a 
three-step process starting from 3-(2-hydroxyethyl)thiophene and subsquent reaction with 
phosphorus tribromide, azidification and azide-alkyne cycloaddition reaction to give 
thiophene based ferrocenyl-triazole compound.  Ferrocenyl styrenic polymer was 
prepared using the cycloaddition reaction of azide-functional styrene polymer with 
ethynylferrocene.  The presence of extra populated ferrocenyl groups around the styrenic 
backbone in ferrocene-styrene copolymer has resulted in more effective interaction 
improving the chemical recognition ability toward H2PO4
−
 and HP2O7
3− 
anions.  
However, the study showed that both the thiophene and styrene functionalized ferrocenyl 
compounds have shown better recognition ability for H2PO4
− 
 than HP2O7
3−
 anion. 
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Figure 1.41. Ferrocene functionalized thiophene and styrene copolymer 
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Kumar and coworker have proposed multichannel ferrocenylpyrazolines, [{(1-(2-
C5NH4)3-(Ar)-C3N2H)(
5
-C5H4)}Fe(
5
-C5H5)], (Ar = 1-naphthyl, 9-anthryl, 1-pyrenyl) 
containing ferrocene as a redox unit, an aromatic ring fluorophore and a binding system 
containing two nitrogen atoms on the pyridylpyrazoline moiety.  Aldol condensation of 
acetyl ferrocene with different aldehyde in basic condition gave the corresponding 
ketoenones which was further reacted with 2-hydrazinopyridine to afford the ferrocenyl 
pyrazoline compounds (Scheme 1.28).[149]  The binding assay and recognition ability of 
these compounds was studied towards the metal ions by using electrochemical and 
optical method.  Systematic study showed the ability of the ferrocene compounds to 
behave as selective multichannel chemosensors in the presence of Co
2+
, Cu
2+
, and Zn
2+
 
ions.  The cathodic shift in the redox potential (E=71-156mv) of the ferrocenyl 
pyrazoline receptors observed in cyclic voltammetry as well as the decrease of the high 
energy band at 330 nm- 335 nm with the red shift in UV visible spectra (= 7-13nm) 
confirms complexation of the ferrocenyl derivatives with the cations.  Furthermore, the 
downfield shift in proton NMR spectra and the increase in emission accompanied by a 
red shift at 430 nm in fluorescence spectroscopy during the gradual addition of various 
cations to the ferrocenyl pyrazoline compound containing naphthyl moiety showed it to 
be the most significant receptor compared to the other ferrocenyl pyrazolines. 
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Scheme 1.28. Synthesis of ferrocenyl pyrazolin derivatives 
 
A ferrocenyl imidazoquinoxaline ion pair receptor has been synthesized from the 
reaction of 1,2-diamino-4-nitrobenzene, furyl and ferrocenecarboxaldehyde by Molina et 
al. and has been studied for the sensing ability for HSO4
-
 anions in the presence of a 
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cobound divalent Pb
2+
 or Zn
2+
 cation as guest species (Figure 1.42).[150]  The cathodic 
shift observed during the electrochemical analysis on addition of Pb
+2
 and Zn
+2
 to 
ferrocenyl imidazoquinoxaline receptor and HSO4
-
 has been found to increase by 120mv 
and 220mv than the complexation of the mixture of Pb
+2
 and Zn
+2
 with the ferrocenyl 
imidazoquinoxaline receptor alone.  Addition of Pb
+2
 and Zn
+2
 to the solution mixture of 
ferrocenyl imidazoquinoxaline receptor and HSO4
-
 has also dramatically enhanced the 
fluorescence emission by 237-fold and 85-fold respectively than that of the ferrocenyl 
imidazoquinoxaline receptor and HSO4
-
 mixture itself.   
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Figure 1.42. Ferrocenyl imidazoquinoxaline 
 
Two step reaction process of pentakis(phenylthio)benzaldehyde with diethyl 
aminomethylphosphonate followed by the treatment of n-BuLi and formylferrocene gave 
[4-(5-C5H5)Fe(
5
-C5H4)-1-{(C6H6S)5C6H6}-1-(C=N-CH=CH)] while the treatment of  
pentakis(phenylthio)benzaldehyde with diethyl [(ferrocenylmethylidene)aminomethyl] 
phosphonate afforded the compound [1-(5-C5H5)Fe(
5
-C5H4)-4-{(C6H6S)5C6H6}-1-
(C=N-CH=CH)] (Figure 1.43).[151]  Electrochemical and spectroscopic techniques have 
been carried out to understand the complexation behavior of these compounds with 
different cations showing their complex formation with Pb
+2
, Hg
+2
 and Cu
+2
.  Anodic 
shift (ΔE1/2 = 125 mV) in square wave voltammetry and red shift of the low-energy band 
in the absorption spectrum (Δλ = 119 nm) revealed selective dual molecular recognition 
of the receptor [4-(5-C5H5)Fe(
5
-C5H4){(C6H6S)5C6H6}(C=N-CH=CH)] with Pb
+2
 
cation.   
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Figure 1.43 
 
1.4.5. Electronic communication in ferrocene based molecules 
 
A large part of the organometallic chemistry has been focused on the studies of 
electron transfer processes in ferrocenyl conjugated compounds based upon the tunable 
redox activity of the ferrocene moiety.  Stepnicka et al. have reported a series of 
heterobimetallic cyclopentadienyl complexes connected through different linker groups.  
Reaction of (2-phenylethyl)ferrocene, (E)-(2-phenylethenyl)ferrocene or 
(phenylethynyl)ferrocene with [Ru(5-C5R5)(MeCN)3][PF6] (R= H, Me) showed the 
formation of the heterobimetallic complexes [(5-C5H5)Fe(
5
-C5H4)-X-(η
6
-C6H5)Ru(η
5
-
C5R5)][PF6], (X = CH2CH2, CH=CH, C≡C; R = H, Me) as shown in Figure 1.44.[152]  
Investigation of the redox chemistry of the bimetallic compounds showed their push−pull 
behavior involving electron-rich ferrocenyl moiety and the cationic Ru(η6-arene) 
fragment as the electron donor and acceptor components.  Cyclic voltammetric and 
spectroelectrochemical studies revealed electronic communication between the metal 
centers in compounds possessing the conjugated linking groups.  An anodic shift 
(100−150 mV) of the ferrocene/ ferrocenium couple was observed in the Fe-Ru 
heterobimetallic complexes as compared to that of the ferrocenyl-benzene analog due to 
the presence of cationic ruthenium metal center in conjugation with the ferrocene unit 
resulting in the decrease in electron density at the ferrocenyl centre making the electron 
removal more difficult. 
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A ferrocene based boryl-functionalized bithiophene compound has been obtained 
from [2,2’-bis(BBr2)2-5,5’-(C4H2S)2] by a systematic synthetic procedure involving 
addition of boron tribromide and trimethylstannylferrocene and subsequent reaction with 
pentafluorophenyl copper to give a diferroceneyl compound, [2,2’- bis{B(C6F5)(
5
-C5H4) 
Fe (5-C5H5)}-5,5’-(C4H2S)2] (Figure 1.45).[153]  The molecule revealed electronic 
communication in between the ferrocenyl moieties.  The cyclic voltammetric study 
showed one reversible one electron oxidation at -11 mV and a quasi-reversible second 
oxidation wave at +207 mV relative to the Fe(II) / Fe(III) couple with the peak separation 
of E = 218 mV due to the moderate degree of metal-metal interaction through the 
diborylated bithiophene linker.  Addition of pyridine to the compound resulted in 
lowering of the redox potentials with the peak separation of 108 mV indicating decrease 
in electronic communication between the ferrocene moieties because of the interaction or 
complexation of the boron center with pyridine.  
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Figure 1.45 
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Nemykin and group recently reported the synthesis of diferrocenyl 
azadipyrromethene compound and its borylated derivatives to understand the role of 
heterocyclic chromophore on electronic coupling behavior through the bridging group.  
Ferrocene based azadipyrromethene compounds have been prepared by a stepwise 
reaction process involving aldol condensation of ferrocenecarbaldehyde with 
acetophenone to give the corresponding ferrocenyl chalcone followed by Michael 
addition and reaction with ammonium acetate under refluxing condition to obtain 
diferrocenylazadipyrromethene compound.  Further treatment with BF3·Et2O in presence 
of a base afforded the fluoroboryl analog of diferrocenylazadipyrromethene (Scheme 
1.29).[154]  The X-ray crystal structure of both the diferrocenyl derivatives has 
confirmed the presence of  the syn-conformation of the ferrocene groups in the 
molecules.  Cyclic voltammetry study showed two reversible redox couple for the two 
ferrocenyl units while the potential difference between the first and the second oxidation 
peaks are 340 mV and 640 mV for the diferrocenylazadipyrromethene and its fluoroboryl 
derivative respectively.  Spectroelectrochemical experiment for the diferrocenyl 
derivative containing fluoroboryl moiety has shown the disappearance of the bands in 
visible region with the appearance of a new band in NIR region during the first oxidation 
 
and disappearance of the NIR band with a new peak in visible region during the second 
oxidation.  The spectroelectrochemical data along with DFT study confirmed marked 
electronic coupling between the two ferrocenyl units in these types of molecules. 
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Scheme 1.29 
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1.4.6. Diferrocenyl organometallic compounds 
 
 Compounds containing diferrocenyl system with various bridging units and 
multiple redox processes have been widely studied because of their potential application 
in molecular photonics, optoelectronics, redox-driven fluorescence markers and sensors.  
Such systems have been intensely studied in recent decades for some interesting features 
related to multiredox and electronic communication properties.  A range of different 
multiferrocenyl compounds with a series of conjugated or non-conjugated bridging 
moieties have been synthesized and studied their electrochemical properties.  
In recent times, molecules having two metal centers linked with bridging ligand are of 
interest due to their electronic interaction across the ligand which may enhance biological 
processes, catalytic reactions and show their potency for molecular wires and 
switches.[155]  The bridging ligand should provide electronic coupling pathway in 
between the metal centres to promote electronic communication by means of their 
properties like flexibility, degree of delocalization and length of bridging unit.  A recent 
report described the formation of ferrocene conjugated ethynylethenes, [(5-
C5H5)Fe{(
5
-C5H4)CC(COOMe)C=C(COOMe)CC(
5
-C5H4)}Fe(
5
-C5H5)], by a 
sonogashira coupling reaction of ferrocenylacetylene with a dibromoester derivative 
(Scheme 1.30).[156]  Upon irradiation of light, the E-isomer of the ferrocene-conjugated 
ethynylethene showed decrease in spectral bands at 355-365 nm and 520-530 nm due to 
its transformation to the Z-isomer accompanied by reduction of electronic 
communication between the ferrocenes. 
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Nonclassical hydrogen bonds such as XH···M and XH···HM with the electron 
rich metal centres play a significant role in some ferrocenyl chemistry developing the 
area of organometallic crystal engineering.[157]  A strong and thermally stable 
nonclassical NH···Fe intramolecular hydrogen bond has been observed by Heinz et al 
recently during the synthesis of a diferrocenyl tosyl hydrazone compound obtained by the 
reaction of diferrocenyl ketone, p-toluenesulfonyl hydrazide, and p-toluenesulfonic acid 
(Figure 1.46).[158]  Similar type of NH···Ru intramolecular hydrogen bond in 
diruthenocenyl tosyl hydrazone has also been explored by them.  The intramolecular 
hydrogen bonding interaction, NH···Fe and NH···Ru, in both Z and E isomers have been 
confirmed by single crystal X-ray Diffraction study.[159]  The NH···Ru intramolecular 
hydrogen bond was found to be stronger than that of NH···Fe.  Two redox couple have 
been found for the diferrocenyl tosyl hydrazones with the lower oxidation potential for 
the metal without intramolecular hydrogen bonding and the higher oxidation potential for 
the metal with intramolecular hydrogen bonding.   
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Figure 1.46 
 
A diferrocenyl derivative bis(methylidenamino)[2.2]ferrocenophane containing 
CH=N linkage has been synthesized from the Staudinger reaction of bis(azido)-ferrocene 
with triphenylphosphine followed by aza-Wittig type reaction with ferrocenyl dialdehyde 
in good yield (Figure 1.47) [160].  The structure shows two ferrocenyl fragments attached 
together by two diaza bridging chains forming a cyclic framework.  The two different 
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cyclopentadienyl rings of the ferrocene groups and the imine protons were identified by 
the 
1
H NMR spectroscopy at δ 4.07-5.44 ppm and δ 9.39 ppm respectively.  The 
electrochemical behavior of the diazaferrocenophane derivative has been carried out by 
the cyclic voltammetry showing two reversible one electron redox processes with E1/2 
value at -0.06 V and 0.45 V corresponding to two different ferrocenyl units. 
 
Fe Fe
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Figure 1.47. Bis(methylidenamino)[2.2]ferrocenophane 
 
A diferrocenyl carbohydrazide Schiff base type derivative, [(5-C5H5)}Fe{(
5
-
C5H4)CH=NNHC(S)NHN=CH(
5
-C5H4)}Fe{(
5
-C5H5)] bearing a methylene 
thiocarbohydrazide linkage, synthesized from the reaction of formyl ferrocene and 
thiocarbohydrazide, has been reported as precursor for different heterocyclic diferrocenyl 
derivatives for their use in pharmaceutical application.  Cyclization of the diferrocenyl 
carbohydrazide with dimethyl-but-2-ynedioate or with methyl iodide and sodium 
methoxide afforded two diferrocenyl species with different bridging spacers (Scheme 
1.31).[161]  The compounds contain triazole and thiazolone heterocyclic moiety as 
bridge across the two ferrocenyl fragments.  
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Scheme 1.31. Cyclization of diferrocenyl methylene carbohydrazide 
 
Photochemical reaction of ferrocenylacetylene with sulfur in presence of metal 
carbonyl (M(CO)6; M = Cr, Mo, W) afforded two deferrocenyl compounds, 2,4-
diferrocenylthiophene and 2,6-diferrocenyldithiine involving thiophene and dithiine 
heterocyclic bridging units respectively as depicted in Scheme 1.32.  The molecular 
structure of 2,6-diferrocenyldithiine revealed the existence of unique puckered 1,4-
dithiine ring with ferrocenyl groups attached at 2 and 6 positions forming a syn 
conformation of the diferrocenyl compound. [162] 
Fe Fe Fe
S
Fe Fe
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+
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Scheme 1.32 
 
Sohar and coworkers have reported the synthesis of diferrocenyl derivatives with 
pyrimidine type linkers obtained by the reaction of formyl ferrocene, urea and acetyl 
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ferrocene in presence of ferric chloride or from the reaction of formyl ferrocene, urea and 
benzyl-3-oxobutanoate in presence of boric acid as catalyst (Figure 1.48).[163]    
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Figure 1.48 
 
Similar type of diferrocenyl systems having a heteroaromatic pyridine group as 
bridge, namely 2,5- diferrocenyl pyridine and the 2,6- diferrocenyl pyridine have been 
reported by Lang and coworkers by Negishi C,C cross-coupling reactions of 2,5- dibromo 
pyridine or 2,6-dibromo pyridine with ferrocenyl zinc chloride in presence of palladium 
catalyst (Figure 1.49).[164]  The presence of the ferrocenyl units and the heterocyclic 
groups were identified by spectroscopic techniques.  Cyclic voltammetry of both the 
compounds has shown two reversible one electron redox couples for the presence of two 
ferrocenyl units.  Inter valence charge transfer transitions have been observed for both the 
pyridine bridged diferrocenyl compounds using spectroelectrochemistry.  The IVCT 
analysis revealed improved electronic interaction between the para-substituted 
metallocenyl redox groups than that of in 2,6- pyridine bridged diferrocenyl compound.   
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Figure 1.49 
69 
 
Yin et al. have reported the synthesis of a thermally stable differocenyl system 
linked through a photochromic ligand dithienylethenes by a witting reaction of 1,2-
Bis(5'-formyl-2'-methylthien-3'-yl)perflurocyclopentene using ferrocenyl phosphonium 
bromide as shown in Scheme 1.33.[165]  The molecular structure of the diferrocenyl 
complex revealed the presence of ring opening isomer of the dithienylethene unit in 
conjufgation with two ferrocenyl groups across the two ends.  Irradiation of suitable 
wavelength of light afforded reversible ring closing and ring opening process observed by 
the shifting of the absorption peaks in UV-Visible spectroscopy.   
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Scheme 1.33 
 
1.5. Half sandwich and Ferrocenyl conjugate system 
Heterobimetallic complexes containing both ferrocenyl and iridium or rhodium based 
half sandwich fragments have been synthesized by a Schiff base condensation reaction of 
ferrocenyl salicylaldimine derivative with [M(C5Me5)Cl2]2 (M= Ir, Rh) in presence of 
triethylamine as base (Scheme 1.34).[127]  The structural analysis showed the presence 
of a metal coordinated interaction involving the half sandwich metal bonded to imine 
nitrogen and phenyl oxo group of the ferrocene based ligand. 
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Scheme 1.34 
 
A heterotrimetallic compound containing both ferrocenyl and half sandwich 
fragments, 1-cymantrenyl-3,5-diferrocenylbenzene, has been formed by the 
cyclocondensation of acetylferrocene and acetylcymantrene catalyzed by SiCl4 (Figure 
1.50).[166]  The X-ray crystal structure of the compound revealed the presence of a 
cymantrenyl and two ferrocenyl fragments linked to each other by a benzene ring.   
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Figure 1.50. 1-cymantrenyl-3,5-diferrocenylbenzene 
  
Lohan et al. have reported a palladium-copper-catalyzed Sonogashira cross-
coupling reaction of 2-methyl-3-butyn-2-ol with diiodobiferrocene in refluxing 
diisopropylamine followed by addition of MLnX (M=Ru, Os; L=PPh3; dppf; X=Cl, Br) to 
form a series of heterometallic complexes of the type [LnM{(
5
-C5H4)(CC)(
5
-
C5H4)}Fe{(
5
-C5H4)(
5
-C5H4)}Fe{(
5
-C5H4)(CC)R}] (R=H, (
5
-C5H4)LnM).[167]  In 
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both the compounds, the biferrocene fragment is linked either by one or two piano stool 
units via C≡C group (Scheme 1.35). 
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Scheme 1.35 
 
The monolithiation of bromo ferrocene with subsequent addition of 2,3,4,5-
tetramethylcyclopent-2-enone in presence of para-toluenesulfonic acid followed by 
addition of n-BuLi and TiCl4 afforded a fulvalenediyl-bridged heterobimetallic 
compound [(5-C5H5)Fe{(
5
-C5H4)(C5Me4)TiCl3}] (Scheme 1.36).[168]  Single crystal 
X-ray diffraction study has shown the presence of sandwich ferrocene and three legged 
piano stool [(C5Me4)TiCl3] fragments involving an exo arrangement of iron and titanium 
atoms with respect to the fulvalenediyl-bridge.  UV-Visible spectral analysis for the 
heterometallic compound showed a low energy band at 660 nm due to the energy transfer 
from the electron rich ferrocenyl moiety to the electron deficient half sandwich, 
[(C5Me4)TiCl3].  The lower energy band disappeared either by oxidation of ferrocene or 
by the reduction of [(C5Me4)TiCl3] during the spectroelctrochemical experiment.  Two 
reversible redox couple have been observed at 0.14 V corresponding to Fe (II)/Fe (III) 
and at -1.11 V due to Ti (IV) / Ti (III) during electrochemical analysis of the 
heterobimetallic derivative.   
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In summary, chapter 1 describes the immense potential of cylopentadienyl based 
metal complexes and their recent application based upon electrochemistry, bioactivity, 
catalysis and sensor.  In view of their significant contribution, we became interested to 
design and synthesize different ferrocene and cymantrene based molecular compounds 
involving functional moieties like hydrazones, enones etc and explore their 
electrochemical and biological properties.  Efforts have also been made to establish the 
structural characterization of sandwich and half sandwich organometallic compounds by 
single crystal X-ray diffraction technique and understand their potential as metal sensing 
and biological agents. 
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Chapter 2 
Synthesis, characterization and 
structural evaluation of 
cymantrenyl hydrazone derivatives 
 
 
 
 
 
 
83 
 
2.1. Introduction  
 Studies of Schiff-base compounds with organometallic tags are increasingly 
drawing much interest due to their distinctive properties and features concerning both 
organometallic and coordination chemistry [1-9].  Molecular compounds containing 
organometallic tags have been found to be potential therapeutics against major diseases 
and can play a vital role as tracers in immunological analysis based on several analytical 
methods like FTIR, electrochemical, atomic absorption techniques etc [10-13, 24-26].  
The use of ferrocenyl derivatives as bioactive molecule has been established recently and 
several reports show that a large number of ferrocene containing compounds display 
interesting cytotoxic and DNA cleaving activities [14-20].  Recently, some Cp based half 
sandwich organometallic fragments have been studied for their various biological 
properties ranging from antimalarial, antimicrobial, anticancer, enzyme inhibitors and 
phototoxicity [21-28].   
 Cyclopentadienyl based metal complexes with functionalized side-chains are 
presently being explored by several research groups anticipating some unique properties 
that may be different from {CpM} systems without the functional side chain.  In this 
regard, a large number of half sandwich metal complex with functionalized side chains 
have been studied for biological, photophysical and electronic properties.  Recently, 
synthesis of cyrhetrenyl, [CpRe(CO)3], system with Schiff base type funtionalization 
carried out by the condensation reaction of 5-nitro-2-furanaldehyde with different 
cyrhetrenyl amines showed higher trypanocidal activity as compared to their organic and 
ferrocenyl analogs (Figure 2.1).[8]  The efficient antichagasic properties has been 
attributed to the enhanced lipophilic character of the metal fragment and a possible 
synergy between the cyrhetrenyl and 5-nitrofuran groups. 
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Figure 2.1. Cyrhetrenylimine derivatives 
 A number of biologically active compounds of technicium, [(CpR)
99m
Tc(CO)3] 
have been synthesized for their probable therapeutic and radionuclide based diagnostic 
applications [24, 25].  Alberto’s group demonstrated the formation of {CpTc} based 
compounds with different side chains at the cyclopentadienyl moiety by using Diels-
Alder dimerized precursor bearing biologically active substituents with [
99m
TcO4]
-
 or  
[
99m
Tc(OH2)3(CO)3]
+
 in aquous medium (Scheme 2.1).  This interesting synthetic strategy 
provided an access to use labeled biomolcules with 
99m
Tc in water phase and could able 
to play a vital role in the development of radiopharmaceuticals. 
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Scheme 2.1 
85 
 
 Meggers et al. reported protein inhibitor property of a organoruthenium analogue 
of staurosporine, which contains a half sandwich, [CpRu(CO)], fragment attached to 
indolocarbazole heterocycle [27].  The half sandwich based staurosporine derivative was 
synthesized from aryl hydrazine precursor using multistep reaction processes involving 
Fischer indole synthesis to prepare a pyridoindole derivative which was subsequently 
coupled with dibromomaleimide using anaerobic photocyclization to give the 
indolocarbazole heterocyclic ligand.  The heterocycle was then treated with 
[CpRu(CO)(CH3CN)2]PF6 to give the half sandwich ruthenium-staurosporine complex 
(Figure 2.2). 
Ru
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Figure 2.2. Ruthenium staurosporine derivative 
 
Some of these half sandwich complexes have been very interestingly used as 
labelling agents in the field of metalloimmunoassay.  In most cases for the study related 
to metalloimmunoassay using organometallic system, the metal based tracers are 
molecules derived from the analyte to be assayed to which an organometallic moiety has 
been attached.  This gives rise to some type of competition between the analyte and the 
tracer to bind to a limited amount of antibody.  In this regard it is highly required that the 
metal fragments to be used as tracer must be stable in air and biological media and can be 
structurally fine tuned, if required, for optimum sensitivity of the assay.  Different 
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labelling studies in recent times showed that half sandwich complexes are well suited for 
metallic agents and can be used with a variety of biomolecular entities.  Among them, 
cymantrenyl derivative based tracers are significant molecule which are stable, can be 
easily tuned by different substitution at the Cp ring and at the metal carbonyl part and 
show specific IR signals with intense absorption in the range1900-2200 cm
-1
 for their use 
as IR probes in various biological samples.  Cymantrenyl fragment has been succesfully 
labelled with biotine molecule by the coupling reaction of cymantrenyl carboxaldehyde 
with biotine hydrazide.  Metallo-biotins have been suitable for a wide range of antigens 
and provide several possibilities for immunoassays of antibodies.  Biotinylated 
cymantrene complex a biotine fragment attached to the Cp ring of the cymantrene via a 
Schiff base type C=N bond.  The Cp ring remains pi –bonded with the manganese metal 
atom by a pentahapto mode of bonding.  Three metal carbonyls are also attached with the 
metal center to make the system stable with 18 valence electrons (Scheme2.2).[28] 
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Scheme 2.2 
  
Cymantrene based labeling of phenobarbital was carried out by using simple 
acylation reaction of p-aminophenobarbital by cymantrenyl acylchloride (Figure 2.3).  
The labelled phenobarbital was used for a non-radioisotopic immunoassay, also termed as 
cabonylmetalloimmunoassay (CMIA), using FTIR spectroscopy to detect the CO 
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stretching modes of the organometallic label.  The method was of comparable sensitivity 
to a [
14
C] radio-immunoassay for the detection of Phenobarbital at femtomole level.[29]  
Similarly nortriptyline, a tricyclic antidepressant drug, was labelled by acylation of the 
secondary amino group with cymantrenyl acylchloride (Figure 2.3).[30]  
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Figure 2.3 
 
Other than the carbonyl immunoassay, cymantrenyl fragments have also been 
used conjugated with cell-penetrating peptide, hCT(18-32)-k7, which transformed the 
intracellular distribution of the peptide inducing cytotoxic properties against MCF-7 
cancer cells.[31]  Recently, some sandwich and half sandwich metal fragments were 
coupled with a platencimycin to investigate structure- property relationship of their 
biological properties and the influence of the organometallic fragments on the bioactive 
part of the molecule.  Synthesis of cymantrene based platencimycin derivative was 
carried out by a multistep reaction process involving derivatization of the cymantrenyl 
side chain linked to the Cp ring to obtain first a fused cyclohexenone ring system and 
then a series of reaction step to get the desired platensimycin linked cymantrenyl 
compounds (Figure 2.4).[32]  The antibacterial, antitumor activity and molecular 
modeling for platencimycine derivatives have been studied and a comparative 
investigation was carried out to understand the involvement of a specific fragment or 
group in the biological activity.   
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Figure 2.4 
  
In view of their enormous opportunity, we became interested to synthesize some 
Schiff base compounds containing [(5-C5H4R)Mn] organometallic tags and investigate 
their structural and biological properties.  We selected cymantrenyl moieties as because 
these compounds contain metal carbonyls which show specific IR signals with intense 
absorption in the range1900-2200 cm
-1
 and can be used as IR probes in various biological 
samples.  Moreover, to our knowledge cymantrenyl Schiff base compounds have been 
rarely studied and one of the reports show the synthesis of cymantrenyl-biotine 
compounds for their use as tracer molecule [28], whereas cymantrenyl - hydrazone 
compounds have been largely unexplored and are yet to be investigated for their possible 
antibacterial activities.  In this chapter, we describe the synthesis and characterization of 
four cymantrenyl hydrazone Schiff base compounds (1 - 4).  Compound 1 -3 have been 
characterized structurally by single crystal X-ray diffraction techniques.  Antibacterial 
activity and electrochemical properties have been studied for some of the cymantrenyl 
compounds.  
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2.2. Experimental Sections 
2.2.1. General Procedures 
 All reactions and manipulations were carried out under an inert atmosphere of 
dry, pre-purified argon using standard schlenk line techniques.  Solvents were purified, 
dried and distilled under argon atmosphere prior to use.  Infrared spectra were recorded 
on a Perkin Elmer Spectrum RX-I spectrometer as KBr pellet or CH2Cl2 solution and 
NMR spectra on a 400 MHz Bruker spectrometer in CDCl3 or DMSO-d6 solvent.  
Elemental analyses were performed on a Vario El Cube analyser.  Mass spectra were 
obtained on a SQ-300 MS instrument operating in ESI mode.  TLC plates (20x20 cm, 
Silica gel 60 F254) were purchased from Merck.  [(CO)3Mn(
5
-C5H4COCH3)], 
[H2NN(H)C(O)R], (R = -C6H4OH-o, C6H4N-p, C6H5, C6H4N-o) were prepared following 
reported procedures [33, 34]. 
 
2.2.2. Synthesis of [(CO)3Mn{(
5
-C5H4)C(CH3)═NN(H)C(O)R}] (1-4) 
 In a typical synthetic procedure, respective hydrazide (0.1 mmol) was taken in a 
two-neck round bottomed flask and ethanol (10 ml) solvent was added.  The solution was 
stirred under nitrogen atmosphere to obtain a clear solution.  To the reaction mixture 0.1 
mmol of monoacetyl cymantrene (25 mg, 0.1 mmol) and 2 drops of acetic acid was added 
at room temperature and under stirring condition and the reaction was continued for 3-4 
hrs.  After the reaction, the solution was filtered and the pale yellow precipitate was 
washed with cold ethanol and vacuum dried.  The product was purified by preparative 
TLC in 5% ethanol: n-hexane solvent mixture.  (Yield = 35 mg (92 %) (1); 32 mg (88 %) 
(2), 29 mg (81 %) (3); 31 mg (86 %) (4)) 
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1: Anal. calcd. (found): C, 53.68 (53.45); H, 3.42 (3.37); N, 7.36 (7.45).  IR(, cm-1, 
CH2Cl2): 3278.7 (br), 3057.4 (br), 2010 (s), 1923.7 (vs), 1630.4 (s), 1601.5 (m).  
1
H 
NMR (, CDCl3): 2.15 (s, 3H, CH3), 4.84 (s, 2H, 
5
-C5H4), 5.38 (s, 2H, 
5
-C5H4), 6.92 (t, 
J = 7 Hz, 1H, C6H4), 7.05 (d, J = 7 Hz, 1H, C6H4), 7.45-7.49 (m, 1H, C6H4), 9.01 (br, 1H, 
NH), 11.66 (br, 1H, OH).  MS (ESI): m/z 381 (M)
+
.   
 
2: Anal. calcd. (found): C, 52.60 (52.78); H, 3.28 (3.21); N, 11.50 (11.62).  IR(, cm-1, 
CH2Cl2): 3210 (br), 2019 (vs), 1929.8 (vs, br), 1669 (s), 1603 (w).  
1
H NMR (, CDCl3): 
2.09 (s, 3H, CH3), 4.79 (s, 2H, 
5
-C5H4), 5.11-5.40 (m, 2H, 
5
-C5H4), 7.67 (s, 2H, 
C6H4N), 8.78 (s, 2H, C6H4N), 8.95 (br, 1H, NH). 
 
3: IR(, cm-1,CH2Cl2): 3213 (br), 2018 (vs), 1926 (vs, br), 1658 (br), 1604 (w).  
1
H NMR 
(, CDCl3): 2.09 (s, 3H, CH3), 4.79 (s, 2H, 
5
-C5H4), 5.17-5.34 (m, 2H, 
5
-C5H4), 7.49-
7.84 (m, 5H, C6H5), 8.83 (br, 1H, NH). MS (ESI): m/z 365 (M+1)
+
.   
 
4: IR(, cm-1,CH2Cl2): 3195 (br), 2017 (vs), 1925.5 (vs, br), 1654 (br), 1590 (w).  
1
H 
NMR (, CDCl3): 2.1 (s, 3H, CH3), 4.78 (s, 2H, 
5
-C5H4), 5.15-5.36 (m, 2H, 
5
-C5H4), 
7.47 (s, 1H, C6H4N), 8.17 (s, 1H, C6H4N), 8.89 (br, 2H, C6H4N), 9.16 (br, 1H, NH).  MS 
(ESI): m/z 366 (M+1)
+
. 
 
 
2.2.3. Crystal structure determination for 1 - 3. 
 Single crystal X-ray structural studies of 1 - 3 were performed on a CCD Oxford 
Diffraction XCALIBUR-S diffractometer equipped with an Oxford Instruments low-
temperature attachment.  Data were collected at 150(2) K using graphite-monochromated 
Mo Kα radiation (λα = 0.71073 Å).  The strategy for the data collection was evaluated by 
using the CrysAlisPro CCD software.  The data were collected by the standard phi-omega 
scan techniques, and were scaled and reduced using CrysAlisPro RED software.  The 
structures were solved by direct methods using SHELXS-97 and refined by full matrix 
least-squares with SHELXL-97, refining on F
2
 [35].  The positions of all the atoms were 
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obtained by direct methods.  All non-hydrogen atoms were refined anisotropically.  The 
remaining hydrogen atoms were placed in geometrically constrained positions and 
refined with isotropic temperature factors, generally 1.2Ueq of their parent atoms.  The 
crystallographic details are summarized in Table 2.1. 
 
2.2.4. Antibacterial activity 
 Compounds 1, 2 and 3 were screened for their antibacterial activity in vitro 
following the protocol described elsewhere [36].  The antibacterial effect was assayed 
against both Gram positive bacteria viz., Staphylococcus aureus, Bacillus subtilis and 
Gram negative bacteria viz., Escherichia coli, Pseudomonas aeruginosa and Klebsiella 
pneumoniae by the agar well diffusion method [36].  The compounds were dissolved in 
DMSO at different concentrations ranging from 500 to 15.625 g/ml.  Mueller Hinton-
agar (containing 1% peptone, 0.6% yeast extract, 0.5% beef extract and 0.5% NaCl, at pH 
6.9–7.1) plates were prepared and 0.5 – McFarland culture (1.5 X 108 cells/ml) of the test 
organisms were swabbed onto the agar plate.  9mm wells were made in the LB agar petri 
dishes.  100µl of each of the compound with decreasing concentrations was added to 
separate wells.  DMSO was used as the negative control and Ampicillin was used as 
positive control.  The plates were incubated at 37°C and observed for zones of inhibition 
around each well after 24 hours.  The results were compared with the activity of 
Ampicillin at identical concentrations.  The MIC, defined as the lowest concentration of 
the test compound, which inhibits the visible growth, was determined visually after 
incubation for 24 h at 37ºC. 
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2.3. Results and Discussion 
 Cymantrenyl based hydrazone compounds, [(CO)3Mn{(
5
-C5H4)C(CH3)═N-
N(H)C(O)-C6H4-OH}] (1), [(CO)3Mn{(
5
-C5H4)C(CH3)═N-N(H)C(O)-C6H4N-p}] (2), 
[(CO)3Mn{(
5
-C5H4)C(CH3)═N-N(H)C(O)-C6H5}] (3) and [(CO)3Mn{(
5
-
C5H4)C(CH3)═N-N(H)C(O)-C6H4N-o}] (4) were synthesized by the room temperature 
reaction of [Mn(CO)3{(
5
-C5H4)COCH3}] with the appropriate hydrazide compounds 
(salicyloyl hydrazide, isonitinyl hydrazide, benzoyl hydrazide and nicotinyl hydrazide) 
(Scheme 2.3).  All the compounds have been isolated and purified by preparative 
chromatography and characterized by spectroscopic techniques. 
 
 
EtOH
O
NHNH2
RT
CH3
N N
H
O
+
1 : X = C-OH, Y = Z = CH
2 : X = Y = CH, Z = N
3 : X = Y = Z = CH
4 : X = Z = CH, Y = N
Mn
OC
OC CO
MnOC
OC CO
X
Y
Z
Z
Y
X
O
CH3
 
 
Scheme 2.3 
  
Infrared spectral analysis for compounds 1 - 4 reveals the presence of terminal 
metal carbonyl groups in the region 1923 – 2019 cm-1 and peaks corresponding to C═O 
and C═N in the range 1601.5 cm
-1
 - 1669 cm
-1
.  
1
H NMR spectra shows the presence of 
protons corresponding to substituted cyclopentadienyl unit, methyl group, NH and 
aromatic ring protons for each of the four cymantrenyl hydrazone compounds.  
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Compound 1 also shows a broad peak at  11.66 corresponding to -OH proton.  Mass 
spectral analysis for 1 shows the characteristic molecular ion peak (M
+
) at m/z 381 
whereas for compounds 3 and 4, ESI-MS peaks are observed at m/z 365 [(M+1)
+
] and 
366 [(M+1)
+
] respectively. 
 
2.3.1. Molecular structure of 1 - 3 
 Single crystal X-ray diffraction studies have been successfully carried out for 1- 3 
with the respective single crystals, grown from dichloromethane/n-hexane solvent 
mixture at -10 ºC.  The molecular structure of compound 1, 2 and 3 confirms the presence 
of a cymantrenyl unit linked to the hydrazone chain, [C═NN(H)C(O)-R] involving a 
C═N bond (Figure 2.5, Figure 2.6 and Figure 2.7).  In molecules 1 and 3, the 
cyclopentadienyl and phenyl rings are almost coplanar, whereas in compound 2 the 
cyclopentadienyl ring and the pyridyl rings are perpendicular to each other forming a 
dihedral angle of around 72º between the cyclopentadienyl and pyridyl plane.  The C═N 
bond distances for 1, 2 and 3 are 1.279(2) Å, 1.280(3) Å and 1.285(3) Å respectively, 
which are comparable to that in ferrocenyl Schiff base compounds, [(5-C5H5)Fe{(
5
-
C5H4)C(H) ═NN(H)C(O)C6H5}] (1.277(4) Å) [4] and [Fe{(
5
-C5H4)C(CH3) 
═NN═C(C5H4N)}2] (1.241 (7) – 1.300(7) Å) [37].  The N1-N2 single bond distance in 1 
(1.372(2) Å) is shorter than that in 2 (1.391(3) Å), 3 (1.377(2) Å) and in [(5-
C5H5)Fe{(
5
-C5H4)C(H)═NN(H)C(O)C6H5}] [4].  In the structures of 1 - 3, the C═O and 
N-H bonds have been found to be trans to each other.  (CCDC Numbers, 1: 882043, 2: 
882044). 
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Figure 2.5. ORTEP diagram of 1.  Selected bond lengths (Å) and bond angles (º): N(1)-
C(9) = 1.273(3), N(1)-N(2) =1.372(2), N(2)-C(11)=1.338(3), O(4)-C(11) =1.227(2), 
C(9)-N(1)-N(2) =116.39(16), C(11)-N(2)-N(1) =120.80(16).  
 
 
Figure 2.6. ORTEP diagram of 2.  Selected bond lengths (Å) and bond angles (º): N(2)-
C(5) =1.280(3), N(1)-N(2) =1.391(3), N(1)-C(4) =1.340(3), O(4)-C(4) =1.221(3), O(1)-
C(1) =1.144(4), C(5)-N(2)-N(1) =116.3(2), C(4)-N(1)-N(2) =118.3(2). 
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Figure 2.7. ORTEP diagram of 3.  Selected bond lengths (Å) and bond angles (º): N(1)-
C(9) = 1.285(3), N(1)-N(2) =1.377(2), N(2)-C(11)= 1.368(3), O(4)-C(11) =1.227(2), 
C(9)-N(1)-N(2) =117.98(17), C(11)-N(2)-N(1) =117.13(17).  
 
 
The crystal packing of 1 shows two types of H-bonding interactions involving N2-H…O5 
(2.646 Å) and O5-H…O4 (2.680 Å) as shown in Figure 2.8.  On the other hand, 
compound 2 has intermolecular hydrogen bonding involving O4…H1-N1 atoms, thus 
forming a chain with alternately aligned parallel units (Figure 2.9).   
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Figure 2.8. Packing diagram for compound 1  
(Hydrogen atoms have been omitted for clarity). 
 
 
  
Figure 2.9. Packing diagram for compound 2 along ac plane  
(Hydrogen atoms have been omitted for clarity). 
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Table 2.1. Crystal data and structure refinement parameters for compounds 1 - 3. 
 1 2 3 
Empirical 
formula 
C17 H13 Mn N2 O5 C16 H12 Mn N3 O4 C17 H13 Mn N2 O4 
Formula weight 380.23 365.23 364.23 
Crystal system Monoclinic Orthorhombic  Monoclinic 
Space group P 21/c P b c a P 21/c 
a, Å 12.2632(6) 7.9517(3) 18.6221(9) 
b, Å 10.5915(6) 18.8279(6) 8.6924(4) 
c, Å  12.7224(7) 21.5734(7) 29.4752(13) 
 deg 90 90 90 
 deg 99.307(5) 90 99.770(2) 
 deg 90 90 90 
V, Å
3
 1630.70(15) 3229.84(19) 4702.0(4) 
Z 4 8 12 
Dcalcd, Mg m
-3
 1.549 1.502  
abs coeff, mm
-1
 0.840 0.842 0.866 
F(000) 776 1488 2232 
Cryst size, mm 0.33 x 0.28 x 0.23 0.32 x 0.26 x 0.23 0.189 x 0.134 x 0.051 
 range, deg 3.17 to 25.00 2.94 to 24.99 2.22 to 30.26 
index ranges -14≤ h ≤ 14,  
-12≤ k ≤ 12,  
           -15≤ l ≤ 15 
-9≤ h ≤ 9,  
-20≤ k ≤ 22, 
             -25≤ l ≤ 25 
      -26≤ h ≤26, 
      -12≤ k ≤ 12,  
      -37 ≤ l ≤ 41 
reflections 
collected/ unique 
12573 / 2869 [R(int) 
= 0.0305]  
19145 / 2820 [R(int) = 
0.0496] 
100674/ 13160 [(Rint 
= 0.0376)] 
data/ restraints / 
parameters 
2869 / 0 / 231 2820 / 0 / 218 13160 / 0 / 664 
goodness-of-fit 
on F
2
 
1.063 1.051 1.070 
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Final R indices 
[I>2(I)] 
R1 = 0.0304,  
wR2 = 0.0832 
R1 = 0.0387,  
wR2 = 0.0939 
R1 = 0.0451,  
wR2 = 0.1081 
R indices (all 
data) 
R1 = 0.0346, 
 wR2 = 0.0867 
R1 = 0.0478,  
wR2 = 0.1011 
      R1 = 0.0730,  
      wR2 = 0.1218 
largest diff peak  0.236  0.319  2.297  
and hole, eÅ
-3
 -0.179 -0.381 -0.640 
 
2.3.2. Antibacterial activity of 1 - 3 
 Antibacterial study was carried out for three of the synthesized compounds, 1, 2 
and 3.  All of them showed potential inhibition activity against the bacterial strains as 
shown in Table 2.1.  Among the cymantrenyl hydrazones, compound 3 has better MIC 
against E.coli and P. aeruginosa bacterial strain whereas cymantrenyl isonicotinyl 
hydrazone (2) showed better result when tested with K. pneumoniae.  Comparison of the 
inhibition activity for these cymantrenyl compounds with the reported antimicrobial 
properties of their organic analogue reveals increased inhibitory activity for the 
compounds containing organometallic fragments [38].  For example, the MIC for the 
hydroxyphenyl benzoylhydrazone, [(OH)C6H4CH=NNHC(O)Ph] has been found in the 
range 125-500, much higher than that for the cymantrenyl analogs.[22]  Isonicotinic 
hydrazide and their hydrazone derivative, [C6H4N(CH3)C(O)C═NNHC(O)C5H4N] shows 
MIC greater than 200 g/ml against E.coli, S.aureus and B. subtilis [39].  Antibacterial 
study on similar types of ferrocenyl compounds reported recently by other groups against 
some bacterial strains also showed promising results [20], whereas inhibition activity 
with cymantrenyl compound has been rarely studied.  Significant antibacterial activity for 
the reported organometallic compounds could possibly be due to the presence of 
cymantrenyl groups that are playing a vital role to increase the cell permeability and 
lipophilicity of the compounds.  Factors like better -electron delocalization and blocking 
of metal binding sites of the enzyme of microorganism may also result in better inhibition 
activity in metal containing compounds.  The MIC data reported in Table 2.2 for 
cymantrenyl hydrazones will eventually help us in understanding the properties of these 
types of compounds.   
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Table 2.2. Minimum inhibitory concentration (MIC) value in g/ml 
Compounds B. subtilis E. coli S. aureus K. pneumoniae P. aeruginosa 
 
1 125 250 125 -- 125 
 
2 250 125 -- 62.5 250 
 
3 -- 62.5 -- 125 31.25 
 
Ampicillin 15.62 31.25 15.62 31.25 62.5 
 
 
 In summary, chapter 2 describe the synthesis of four new cymantrenyl hydrazone 
Schiff base compounds [(CO)3Mn{(
5
-C5H4)C(CH3)═NN(H)C(O)-C6H4-OH}] (R = 
C6H5, C6H4-OH, C6H4N-p, C6H4N-m) (1-4).  Three of the cymantrenyl hydrazones have 
been structurally characterized by single crystal X-ray diffraction study.  Some of the 
compounds have shown moderate antibacterial activities in vitro against different 
bacterial strains compared to ampicillin as standard drug.  We are presently trying to 
understand the scope of hydrazone type compounds having the cymantrenyl scaffold in 
biological imaging studies and as tracer molecules. 
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Chapter 3 
Synthesis, characterization and 
redox properties of 
unsymmetrically substituted 1,1’-
Ferrocenyl dihydrazone compound 
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3.1. Introduction 
The use of ferrocenyl derivatives as bioactive molecule has been established 
recently and several reports show that a large number of ferrocene containing compounds 
display interesting cytotoxic and DNA cleaving activities [1-7].  A large part of the 
research is also concentrated on the synthesis of conjugates of peptides and peptide 
nucleic acids with organometallic fragments, in particular having ferrocene moiety.  Very 
recent studies on Schiff base compounds containing organometallic fragments reveal that 
ferrocenyl Schiff base compounds have exciting biological properties and are potential 
compounds for antitumor, antibacterial, antimalarial and antifungal activities [6-9].  
Carbohydrazones are a special class of azomethine type Schiff base compounds that act 
as ionic or neutral moieties and their derivatives shows a range of biological activity like 
anticonvulsant, antidepressant, analgesic, antimicrobial, antitumor, anti-platelet, 
vasodilator, antiviral etc.[10–17]  Reactivity of hydrazones with transition metal salts 
give rise to some interesting coordination features and has been well investigated for the 
last two decades.  The β-nitrogen and carbonyl oxygen atom present in these compounds 
coordinates to the metal atom with unique stereochemical features, whereas the α-
nitrogen remains uncoordinated.  Metal complexes of acyl-hydrazones are known for 
wide spectrum of biological and pharmaceutical activities, such as inhibition of tumor 
growth, antioxidative effect, antimicrobial and antiviral properties.[18-23]  However, a 
very few literatures are known on the synthesis of ferrocene based hydrazones and study 
related to reactivity and biological activity.  Some early studies on ferrocenyl hydrazones 
show the preliminary investigation of ferrocenylidene derivatives of N-aroyl hydrazone 
and their metal chelate complexes.[24-26]  Synthesis of ferrocene containing bis-
bidentate Schiff-base ligands, [Fe{(5-C5H4)C(Me)NN(H)C(S)NH2}2] have been 
synthesized by the condensation reaction of diacetylferrocene with thiosemicarbazide 
which further reacted with [Zn(MeCO2)2·2H2O] to generate a double-helical zinc 
complex via self-assemble process (Figure 3.1).[27] 
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Figure 3.1 
 
 Another set of ferrocenyl Schiff base compounds containing disubstituted 
hydrazone groups have been prepared by the reaction of 1,1’-diacetylferrocene with 
salicylaldehyde and pyridine carboxyaldehyde in a 1:2 ratio in refluxing ethanol solution.  
Structural analysis of the disubstituted ferrocenyl hydrazones reveals the presence of two 
hydrazone chains attached to the Cp rings of the ferrocenyl fragment which are projected 
in the same direction to obtain an eclipsed geometry as shown in Figure 3.2.  The 
ferrocenyl hydrazone subsequently forms metal complexes by reaction with the 
respective metal salts by self assembled type of reaction process.[28] 
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 Vazquez-Lopez and group reported recently the reaction of 2-hydroxybenzoic 
hydrazide and ferrocenyl carbaldehyde to give the respective hydrazones which act as 
tetra or tridentate planar chelating ligand that co-ordinate through the phenolic 
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hydroxylamide oxygen and one or two imine nitrogen atoms.  Complexes of the type 
[ReX(CO)3{(
5
-C5H5)Fe(
5
-C5H4)C(H)NN(H)C(O)(C6H4OH)}], (X = Cl, Br) have thus 
been formed by the reaction of rhenium carbonyl with the ferrocenyl hydrazone in reflux 
condition (Scheme 3.1).[29] 
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 Biologicaly active ferrocenyl amino hydrazones were prepared by the reaction of 
7-chloroquinolinylhydrazine and chloro hydrazinyl-2-methoxyacridine with ferrocenyl 
aminoaldehyde derivatives to give a range of substituted ferrocenyl hydrazone linked to 
heterocyclic moieties.  Ferrocenylamino aldehyde precursors was synthesized from N,N-
dimethylaminomethylferrocene by a two step reactions involving substitution of the 
amino alkyl by the desired amines like pyrroline and morpholine and subsequent 
ortholithiation followed by dimethylformamide addition to form the aldehyde.  The 
quinoline and acridine based ferrocenyl hydrazones showed high anti-mycobacterial 
activity for tuberculosis inhibition against M. tuberculosis H37Rv strain. [30] 
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Figure 3.3 
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 Reaction of Schiff bases derived from ferrocenylmethylamine with Li2PdCl4 led 
to the formation of a unique heteroannular palladium complexes obtained from a 
cyclometalation type of reaction with the unsubstituted cyclopentadienyl ring (Scheme 
3.2).  Single-crystal X-ray analysis confirmed that the carbon−palladium bond formed by 
using a carbon atom in the unsubstituted Cp ring.  The palladacyclic ferrocenyl 
hydrazone exhibits high catalytic activity for the Suzuki−Miyaura coupling reaction of 
aryl bromides with phenylboronic acid giving high yields of the biaryl products.[31]   
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 In view of the importance of ferrocenyl hydrazone in coordination and biological 
chemistry, efforts were made to prepare different types of hydrazone linked to ferrocene 
fragment.  However, literature search revealed that a good number of mono ferrocenyl 
hydrazone compounds have been reported [7, 24-26], but the synthesis of 1,1’-
unsymmetrically substituted ferrocenyl hydrazone compounds have been rarely carried 
out.  In this chapter, we describe the synthesis of hydrazone derivatives containing 
unsymmetrically 1,1’ disubstituted ferrocenyl fragment by using unsymmetrical 
acetylferrocene precursor.  Electrochemical investigations have also been carried out to 
understand their redox processes for some of the ferrocenyl hydrazone compounds.   
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3.2. Experimental Sections 
3.2.1. General Procedures 
 All reactions and manipulations were carried out under an inert atmosphere of 
dry, pre-purified argon using standard Schlenk line techniques.  Solvents were purified, 
dried and distilled under argon atmosphere prior to use.  Infrared spectra were recorded 
on a Perkin Elmer Spectrum RX-I spectrometer as KBr pellet or CH2Cl2 solution and 
NMR spectra on a 400 MHz Bruker spectrometer in CDCl3 or d6-DMSO solvent.  
Elemental analyses were performed on a Vario El Cube analyser.  Mass spectra were 
obtained on a SQ-300 MS instrument operating in ESI mode.  Cyclic voltammetric and 
differential pulse voltammetric measurements were carried out using a CH Instruments 
model 600D electrochemistry system.  A platinum working electrode, a platinum wire 
auxiliary electrode and a silver / silver chloride reference electrode were used in a 
threeelectrode configuration.  The supporting electrolyte was 0.1 M [NEt4]ClO4 and the 
solute concentration was 103 M.  The scan rate used was 50 mV s1.  All 
electrochemical experiments were carried out under a nitrogen atmosphere and are 
uncorrected for junction potentials.  TLC plates (20x20 cm, Silica gel 60 F254) were 
purchased from Merck.  [Fe(5-C5H4COCH3)2], [H2NN(H)C(O)R], (R = -C6H4-OH, 
C6H4N-p, C6H5, C6H4N-o) were prepared following reported procedures [32, 33]. 
 
3.2.2. Synthesis of 1,1’-[CH3C(O)(
5
-C5H4)Fe{(
5
-C5H4)C(CH3)═NN(H) 
C(O)R}] (5 - 8) 
 In a two-necked round bottomed flask ethanol solution (10 ml) of the respective 
hydrazide (0.5 mmol) was taken and 1,1’-diacetyl ferrocene (135 mg ;0.5 mmol) was 
added.  The reaction mixture was stirred under inert atmosphere and two drops of acetic 
acid was added and the stirring was continued for 6-12 hours at room temperature.  The 
reaction was monitored using TLC.  After the reaction, the solution was vacuum dried 
and the mixture was subjected to chromatographic work up using preparative TLC.  
Elution with 70% Ethyl acetate : n-hexane solvent mixture afforded 1,1’-diacetyl 
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ferrocene and an orange colored compound 1,1’-[CH3C(O)(
5
-C5H4)Fe{(
5
-
C5H4)C(CH3)═N-N(H)C(O)-R}] {R = C6H5 (5), C6H4-OH (6), C6H4N-p (7), C6H4N-m 
(8)}, in the order of elution.  Trace amount of other orange bands and unreacted 
hydrazides were also obtained during chromatographic workup. {Yields: 5, 90 mg (46 
%); 6: 87 mg (43%); 7: 103 mg (53 %); 8: 94 mg (44 %)} 
 
5: Anal. calcd. (found): C, 64.97 (65.12); H, 5.19 (5.05); N, 7.22 (7.34).  IR(, cm-1, 
CH2Cl2): 1666 (vs), 1650 (vs, br), 1603 (m), 1581 (m). 
1
H NMR (, CDCl3): 2.09 (s, 3H, 
CH3), 2.29 (s, 3H, CH3), 4.33 (t, 2H, 
5
-C5H4), 4.44 (t, 2H, 
5
-C5H4), 4.75 (t, 2H, 
5
-
C5H4), 4.80 (t, 2H, 
5
-C5H4), 7.42 – 7.86 (m, 5H, -C6H4).  MS (ESI): m/z 389 [M+H]. 
 
6: Anal. calcd. (found): C, 62.40 (62.58); H, 4.99 (4.86); N, 6.93 (6.84).  IR(, cm-1, 
CH2Cl2): 3086 (br), 1665 (vs), 1643 (s), 1605 (m), 1552 (s, br).  
1
H NMR (, CDCl3): 
2.21 (s, 3H, CH3), 2.38 (s, 3H, CH3), 4.45 (t, 2H, 
5
-C5H4), 4.54 (t, 2H, 
5
-C5H4), 4.84 (t, 
2H, 5-C5H4), 4.87 (t, 2H, 
5
-C5H4), 6.93 – 7.56 (m, 4H, -C6H4), 11.89 (s, 1H, OH).  MS 
(ESI): m/z 405 [M+H]. 
 
7: Anal. calcd. (found): C, 61.72 (61.90); H, 4.92 (4.83); N, 10.80 (10.68).  IR(, cm-1, 
CH2Cl2):, 1665 (vs), 1649 (s), 1600 (m), 1552 (s), 1536(s).  
1
H NMR (, d6-DMSO): 2.20 
(s, 3H, CH3), 2.32 (s, 3H, CH3), 4.49 (t, 2H, 
5
-C5H4), 4.61 (t, 2H, 
5
-C5H4), 4.78 (t, 2H, 
5-C5H4), 4.81 (t, 2H, 
5
-C5H4), 7.8 (s, 2H, C5H4N), 8.77 (s, 2H, C5H4N), 10.91 (s, 1H, 
NH).  MS (ESI): m/z 390 [M+H]. 
 
8: IR(, cm-1,CH2Cl2): 1667 (vs), 1652 (s, br), 1592 (m), 1537 (m, br).  
1
H NMR (, d6-
DMSO): 2.12 (s, 3H, CH3), 2.23 (s, 3H, CH3), 4.30 (t, 2H, 
5
-C5H4), 4.39 (t, 2H, 
5
-
C5H4), 4.69 (t, 2H, 
5
-C5H4), 4.72 (t, 2H, 
5
-C5H4), 7.46 (t, J = 7.2 Hz, 1H, C5H4N), 8.13 
(d, J = 7.2 Hz, 1H, C5H4N), 8.67 (s, 1H, C5H4N), 8.94 (s, 1H, C5H4N), 10.75 (s, 1H, NH).  
MS (ESI): m/z 390 [M+H]. 
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3.2.3. Reaction of 7 with hydrazide 
 
Ethanol solution (10 ml) of compound 7 (39 mg, 0.1 mmol) was taken in a two -
necked round bottomed flask and an equivalent amount of the respective hydrazide (0.1 
mmol) (isonicotinyl hydrazide or salicyloyl hydrazide) and acetic acid (2 drops) was 
added under stirring and inert atmospheric condition.  The solution was stirred at room 
temperature and under nitrogen atmosphere for 2 hrs.  The reaction was continuously 
monitored using TLC.  After the completion of the reaction, the solution was filtered and 
the volume was reduced to minimum amount.  Preparative TLC was carried out with the 
reaction mixture using n-hexane:ethanol (80:20v/v) solvent mixture to separate an orange 
colored compound [Fe{(5-C5H4)C(CH3)═N-N(H)C(O)(C5H4N)}2] (9) (Yield = 32 mg, 
62 %)) or [{(5-C5H4)C(CH3)═N-N(H)C(O)-C6H4-OH}Fe{(
5
-C5H4)C(CH3)═N-
N(H)C(O)(C5H4N)}] (10) (Yield= 40 mg, 78 %).  Some amounts of unreacted compound 
and decomposition have also been observed after the reaction.   
 
9: Anal. calcd. (found): C, 61.41 (61.75); H, 4.70 (4.59); N, 16.53 (16.64).  IR(, cm-1, 
KBr): 3420 (vs), 1642 (vs), 1617, 1595.  
1
H NMR (, d6-DMSO): 2.29 (s, 6H, CH3), 4.61 
(s, 4H, 5-C5H4), 4.81 (s, 4H, 
5
-C5H4), 7.84 (m, 4H, C5H4N), 8.81 (m, 4H, C5H4N). MS 
(ESI): m/z 509 [M+H]. 
 
10: Anal. calcd. (found): C, 61.95 (62.27); H, 4.78 (4.70); N, 13.38 (13.46).  IR(, cm-1, 
CH2Cl2): 3418 (m), 3274.5 (m), 1658.7 (s), 1642.4 (s), 1599.5 (s), 1564.7 (s), 1549.6 
(vs).  
1
H NMR (, d6-DMSO): 2.15 (s, 3H, CH3), 2.28 (s, 3H, CH3), 4.43 (s, 2H, 
5
-
C5H4), 4.57 (s, 2H, 
5
-C5H4), 4.74 (s, 2H, 
5
-C5H4), 4.79 (s, 2H, 
5
-C5H4), 6.52-7.82 (m, 
8H, C5H4N, C6H4).  MS (ESI): m/z 523 [M]. 
 
3.2.4. Crystal structure determination for 7  
 A single crystal X-ray structural study of 7 was performed on a CCD Oxford 
Diffraction XCALIBUR-S diffractometer equipped with an Oxford Instruments low-
temperature attachment.  Data were collected at 150(2) K using graphite-monochromated 
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Mo Kα radiation (λα = 0.71073 Å).  The strategy for the data collection was evaluated by 
using the CrysAlisPro CCD software.  The data were collected by the standard phi-omega 
scan techniques, and were scaled and reduced using CrysAlisPro RED software.  The 
structure was solved by direct methods using SHELXS-97 and refined by full matrix 
least-squares with SHELXL-97, refining on F
2
 [34].  The positions of all the atoms were 
obtained by direct methods.  All non-hydrogen atoms were refined anisotropically.  The 
remaining hydrogen atoms were placed in geometrically constrained positions and 
refined with isotropic temperature factors, generally 1.2Ueq of their parent atoms.  The 
crystallographic details are summarized in Table 3.1.  (CCDC Number, 7: 1476351) 
 
Table 3.1. Crystal data and structure refinement parameters for compound 7 
 7 
Empirical formula C20 H21 Fe N3 O4 
Formula weight 423.25 
Crystal system Monoclinic 
Space group P 21/c 
a, Å 24.209(4) 
b, Å 9.6025(18) 
c, Å  8.4544(17) 
 deg 90 
 deg 94.706(8) 
 deg 90 
V, Å
3
 1958.8(6) 
Z 4 
Dcalcd, Mg m
-3
 1.435 
abs coeff, mm
-1
 0.801 
F(000) 880 
Cryst size, mm 0.260x0.190 x 0.160 
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 range, deg 2.711 to 24.993 
index ranges -19 ≤ h ≤ 28, -10 ≤ k ≤ 10, -9 ≤ l ≤ 10 
reflections collected/ unique 5810 / 2893 [R(int) = 0.0650] 
data/ restraints / parameters 2893 / 0 / 263 
goodness-of-fit on F
2
 1.022 
Final R indices [I>2(I)] R1 = 0.0479, wR2 = 0.0798 
R indices (all data) R1 = 0.1135, wR2 = 0.0993 
largest diff peak  0.266 
and hole, eÅ
-3
 -0.287 
 
3.3. Results and Discussion 
 Unsymmetrically 1,1’-disubstituted ferrocenyl compounds have been of interest 
due to their multifunctional properties with unique structural features and tunable 
electrochemical responses.  In the current study, we have been able to synthesize 
unsymmetrically 1,1’-disubstituted ferrocenyl compounds containing two different 
hydrazone units by using simple synthetic methodology involving selective 
transformation of one of the Cp substituent.  Reaction of 1,1’-diacetylferrocene (135 mg, 
0.5 mmol) with equivalent amount of benzoyl, salicyloyl, isonicotinyl and nicotinyl 
hydrazide (0.5 mmol) results in the formation of 1,1’-[CH3C(O)(
5
-C5H4)Fe{(
5
-
C5H4)C(CH3)═N-N(H)C(O)-R}] {R = C6H5 (5), C6H4-OH (6), C6H4N-p (7), C6H4N-m 
(8)} respectively.  The reaction also gave some amount of side products, one of them has 
been identified by comparison of the literature spectroscopic data as the disubstituted 
ferrocenyl hydrazones, 1,1’-[Fe{(5-C5H4)C(CH3)═N-N(H)C(O)-R}2], {R = C6H5, C6H4-
OH, C6H4N-p, C6H4N-m}.[11]  Compounds 5 - 8 were isolated and purified by 
chromatography using 70% ethylacetate-hexane solvent mixture and characterized by IR, 
NMR, Mass spectral analysis and single crystal X-ray Crystallography.   
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Scheme 3.3 
 
Infrared spectra for compounds 5-8 show peaks corresponding to C=O and C=N 
stretching frequency in the range 1667–1600 cm-1 region.  1H NMR spectra of 5 and 6 
reveals the presence of singlet peaks at  2.09-2.21 and  2.29-2.38 region respectively 
corresponding to two different methyl protons.  Four triplet (broad) peaks at  4.33-4.87 
region corresponding to eight substituted ferrocenyl Cp protons, while a multiplet at 
6.93–7.86 region for phenyl protons have been observed for each of the two 
compounds.  A singlet peak at downfield region ( 11.89) shows the presence of OH 
proton in compound 6.  
1
H NMR spectra of 7 and 8 show two peaks at  2.20 -  2.32 
region corresponding to the methyl protons,  4.3-4.81 (four peaks each) for disubstituted 
ferrocenyl Cp protons and at  7.46 -  8.94 due to the pyridyl protons.  NH protons have 
also been observed at 10.91 and 10.75 for compounds 7 and 8 respectively.  Mass 
spectral analysis of compounds 5-8 shows the presence of [M+H] peak at m/z 389, 405 
and 390 respectively. 
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Figure 3.4. Molecular structure of 7. Selected bond lengths (Å) and bond angles (º): N(2)-
C(15) = 1.338(11), N(1)-N(2) = 1.381(9), O(2)-C(15) = 1.187 (10), N(1)-C(09) = 
1.284(10), C(09)-N(1)-N(2) = 116.0(7), O(2)-C(15)-N(2) = 123.7(8).  
 
 Single crystal, grown from dichloromethane/n-hexane solvent mixture at -10 ºC 
has been used for single crystal X-ray diffraction study.  Molecular structure of 7 
confirms the presence of a –COCH3 group attached to one of the Cp ring, while the other 
Cp ring is linked to a hydrazone unit via a C═N bond.  The structural analysis confirms a 
double bond character of C(9)-N(1) bond with a bond length of 1.289 (3) Å, while N(1)-
N(2) corresponds to single bond character (1.394(2) Å).  The two ferrocenyl Cp rings are 
at eclipsed position and the plane of the pyridyl ring is almost perpendicular to the Cp 
ring with a torsional angle of 153º.  The C-O bond length corresponding to keto group 
attached to pyridine ring is slightly shorter (C(15)-O(2)= 1.203(2) Å) than the keto group 
linked to Cp ring (C(6)-O(1) = 1.220(2) Å).  Packing diagram reveals inter-molecular 
hydrogen bonding interaction between O2…H-N2 (2.124 Å) with the formation of linear 
polymeric chain with alternate molecular units as shown in Figure 3.5. 
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Figure 3.5. Packing diagram showing H-bonding interaction. 
 
 
 To understand its reactivity, we added equivalent amount of isonicotinyl 
hydrazide to an ethanol solution of 7 under inert atmosphere to isolate the symmetrically 
disubstituted derivative [Fe{(5-C5H4)C(CH3)═N-N(H)C(O)(C5H4N)}2] (9).  This reveals 
that the pendant acetyl group attached to one of the Cp ring in compound 7 is taking part 
in the reaction to form Schiff base type hydrazone linkage.  Therefore, we carried out 
similar reaction technique to prepare 1,1’ unsymmetrically disubstituted ferrocenyl 
compounds containing two different hydrazone units.  Thus, compound 7 was reacted 
with equivalent amount of salicyloyl hydrazide to obtain a new ferrocene containing 
mixed hydrazone compound [Fe{(5-C5H4)C(CH3)═N-N(H)C(O)(C5H4N)}{(
5
-
C5H4)C(CH3)═N-N(H)C(O)-C6H4-OH}] (10) (Scheme 3.4).   
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Scheme 3.4 
 
Compounds 9 and 10 have been characterized by IR and 
1
H NMR spectroscopy.  Infrared 
spectra for compounds 9 and 10 show peaks corresponding to C=O and C=N stretching 
frequency in the range 1595-1642 cm
-1
 and 1600-1659 cm
-1
 respectively.  Presence of 
CH3, disubstituted ferrocenyl and pyridyl protons for compound 9 have been confirmed 
from their corresponding peaks in 
1
H NMR spectra at  2.29,  4.61-4.81 and  7.84-8.81 
respectively.  Proton NMR spectra for compound 10 shows two methyl peaks at  2.28 
and  2.15 region, four peaks in the range  4.43-4.79 corresponding to eight ferrocenyl 
protons and phenyl and pyridyl protons are observed in the range  6.52-7.82 as 
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multiplet.  ESI mass spectral analysis for 10 reveals the presence of [M] fragment at 523 
m/z region.  To our knowledge 1,1’-unsymmetrically substituted ferrocenyl mixed 
hydrazone compounds are novel and the synthetic method described here can be used to 
prepare a varied range of ferrocenyl hydrazone compounds containing unsymmetrically 
Cp substituted side chains.   
 The electrochemical properties of compounds 5-8 have been examined in 
acetonitrile solution (0.1M TBAP) by cyclic voltammetry and differential pulse 
voltammetry (Table 3.2).  Compounds 5-8, involving a ferrocenyl moiety linked to an 
acetyl and a hydrazone group exhibited a reversible redox process in between + 0.66 and 
+0.69 V due to the Fe(II)/Fe(III) redox couple.  Among the four compounds, the redox 
couple of 6 have been observed in slightly lower potential region due to the presence of 
o-hydroxy substituent making the oxidation more easier.  When redox couple was 
compared with the oxidation potential of 1,1’-diacetyl ferrocene, it has been observed 
that the presence of acetyl group exerts a quite strong electron withdrawing effect than 
that of the hydrazone moiety.  For instance, the oxidation of 5-8 is 140 mV – 110 mV less 
positive than that of diacetylferrocene which reveals that the presence of one hydrazone 
group in 5-8 makes the oxidation more easier than diacetyl ferrocene. 
 
Table 3.2. Cyclic voltammetric data for 5-8  
Compounds Epa Epc dpv (V) E1/2 (V) (ΔEp (mV)) 
5 0.717 0.657 0.66 0.69 (60) 
6 0.69 0.633 0.634 0.66 (57) 
7 0.708 0.643 0.653 0.676 (65) 
8 0.70 0.638 0.645 0.67 (62) 
 
 In summary, methodology has been designed to obtain unsymmetrically 
substituted ferrocenyl dihydrazone compound from 1-acetyl-1’-
isonicotinylferrocenylhydrazone precursor.  Study of their electrochemical properties by 
cyclic voltammetric techniques showed responses corresponding to ferrocene-
ferrocenium couple.  These ferrocenyl Schiff base compounds are further suited for 
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complexation reaction to obtain multimetallic compounds and various modification for 
their application in the field of bioorganometallic chemistry.  We are currently engaged in 
the synthesis and reactivity of a variety of Cp based organometallic compounds and 
exploring their possibility for effective medicinal properties. 
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Chapter 4 
Ferrocenyl-cymantrenyl hetero-
bimetallic chalcones: Synthesis, 
reactivity and biological properties. 
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4.1. Introduction 
Ferrocenyl chalcone compounds belong to a chalcone family in which one or both 
the aromatic groups are substituted by ferrocenyl units and are connected by an enone 
bridge.  Recently, a bunch of different ferrocenyl chalcones and their derivatives have 
been synthesized which show marked electrochemical and biological properties [1].  
These systems have been investigated as precursors for a variety of ferrocene containing 
heterocycles like pyrazoles, pyrimidines etc [2].  It has now been well established that 
chalcone moieties constitute an important class of naturally occurring flavonoids and 
exhibit a wide spectrum of biological activities such as anti-cancer, anti-microbial, anti-
malarial and anti-inflammatory activities [3].  In recent years, a number of synthetic 
studies have been carried out on monosubstituted ferrocenyl chalcone of types A and B 
(Figure 4.1) [2, 4], while the structural types C and D containing 1,1’-disubstituted 
ferrocenyl chalcone moiety have been studied to a lesser extent [5].  Literature survey 
also reveals that there are only three reports for the synthesis of hetero-bimetallic 
chalcones of types E and F [6,20], whereas the disubstituted analogs of hetero-bimetallic 
chalcone (types G and H) have not been studied so far.  In this chapter, we have focused 
our study on ferrocenyl chalcones of types F and H containing polynuclear bimetallic 
moieties with multiple redox centers.   
 
 
 
 
 
 
 
 
 
Figure 4.1. Ferrocenyl chalcones, types A-H. 
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Recently, multimetallic redox active systems have attracted interest due to their 
various application related to electronic communication, bioactivity, sensors, molecular 
electronic devices, optical properties etc [7-11].  To understand the significance of 
multimetallic compounds, a series of fluorinated bimetallic complexes containing both 
sandwich and half sandwich moieties have been synthesized by Roemer et al. using [2+2] 
cycloaddition reaction to give cymantrene and ferrocene based complexes with 
perfluorinated bridging moieties.  Introduction of fluorinated chains into Cp rings of 
metal organic framework and presence of bimetallic arrangement remarkably altered the 
reactivity and electrochemical behavior of the complexes (Figure 4.2).[19] 
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Figure 4.2 
 
In the area of biological chemistry, ferrocene based organometallic compounds 
constitute an interesting class of molecules with potential application in the field of 
anticancer, antimalarial and other therapeutical activities [12, 13].  Some of these recent 
investigations led to the immergence of a relatively new field of bioorganometallic 
chemistry [14], where a large number of ferrocene and half sandwich based compounds 
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have been found to display interesting cytotoxic, DNA cleaving and other biological 
activities [12,13, 15-18].  Ferrocene substituted tamoxifen and ferrocenyl chloroquine 
derivatives are among the many examples in which ferrocene incorporation have 
improved the activity of the drug [17].  Recently, we have also reported some 
biologically active ferrocenyl and cymantrenyl hydrazone compounds and synthesized 
half-sandwich based dithiocarboxylato-alkyne complexes by sunlight driven reaction 
which also showed remarkable antibacterial activity [18].  Arancibia and coworkers have 
synthesized a new series of hybrid organometallic-organic and dinuclear organometallic 
chalcones containing the cyrhetrenyl fragment as shown in Figure 4.3.[20]  
1
H and 
13
C 
NMR spectral data signify an E-stereochemistry at the C=C bond, as well as predicts a -
cis conformation of the enone moiety in solution.  In the solid state a similar structural 
identity was established for 1-ferrocenyl-3-cyrhetrenyl-2-propen-1-one by single crystal 
X-ray crystallography.  The cyrhetrenyl group exerts electron withdrawing effect on the 
ketonic carbonyl and olefinic carbons and correlate exactly with the shift in
 13
C NMR of 
the compound.  The antimalarial activity of the compounds against the chloroquine-
susceptible strain 3D7 and the chloroquine-resistant strain W2 of Plasmodium falciparum 
were evaluated in vitro which indicates that these cyrhetrene conjugates are more active 
compared to their ferrocenic analogues. 
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 Two hetero tri-metallic compounds with potent activity against Gram-positive 
bacteria including multi-resistant Staphylococcus aureus were synthesized.  The 
compound consist of two different functionality, one having a peptide nucleic acid 
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backbone and an alkyne side chain, substituted with cymantrenyl, (dipicolyl)Re(CO)3 and 
ferrocenyl moieties (Figure 4.4).[21]  The unique nature of trimetallic compound with the 
presence of a pseudopeptide backbone, a positive charge, and three lipophilic 
organometallic residues, namely, ferrocene, cymantrene, and a (dipicolyl)Re(CO)3 
moiety, are considered to be responsible for the potent antibacterial activity against 
Gram-positive bacteria.   
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Figure 4.4 
  
In view of the interesting properties of sandwich –half sandwich conjugate 
molecular system and their emerging potential in biological and electrochemical 
activities, we focused our studies on the synthesis of ferrocene and half-sandwich based 
multimetallic compounds, in particular, types F and H (Figure 4.1) and use them for 
electrochemical studies and biological evaluation.  To the best of our knowledge, 
synthesis and bioactivity of trinuclear ferrocenyl chalcone of type H has so far remain 
unreported.  However, only a few studies on chalcones of type F have been reported but a 
large part of the synthetic, structural and biological chemistry of type F compounds have 
remain unexplored.  In this chapter, we describe the synthesis of novel hetero-metallic 
chalcones containing both ferrocenyl and cymantrenyl fragments and studied their 
reactivity towards mono- and diphosphine substitution.  Antimalarial and antibacterial 
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properties were studied for two bimetallic chalcones and electrochemical analysis was 
carried out to understand their redox properties.  TD-DFT study was also conducted for 
ferrocenyl-cymantrenyl hetero-metallic chalcone (10) to predict the molecular orbitals 
involved for various electronic transitions.  Molecular structural characterizations for two 
new ferrocenyl-cymantrenyl chalcones have been carried out which revealed the 
conformational identity of the compounds. 
 
4.2. Experimental Sections 
4.2.1. General Procedures 
 All reactions and manipulations were carried out under an inert atmosphere of 
dry, pre-purified argon using standard Schlenk line techniques.  Solvents were purified, 
dried and distilled under inert atmosphere prior to use.  Infrared spectra were recorded on 
a Perkin Elmer Spectrum RX-I spectrometer as CH2Cl2 solution and NMR spectra on a 
400 MHz Bruker spectrometer in CDCl3 solvent.  Elemental analyses were performed on 
a Vario El Cube analyzer.  Mass spectra were obtained on a SQ-300 MS instrument 
operating in ESI mode.  Cyclic voltammetric and differential pulse voltammetric 
measurements were carried out using a CH Instruments model 600D electrochemistry 
system.  A platinum working electrode, a platinum wire auxiliary electrode and a silver / 
silver chloride reference electrode were used in a threeelectrode configuration.  The 
supporting electrolyte was 0.1 M [NEt4]ClO4 and the solute concentration was 10
3 
M.  
The scan rate used was 50-200 mV s
1
.  All electrochemical experiments were carried out 
under nitrogen atmosphere and are uncorrected for junction potentials.  TLC plates 
(20x20 cm, Silica gel 60 F254) were purchased from Merck.  [(CO)3Mn(
5
-
C5H4COCH3)] [22], [(
5
-C5H5)Fe(
5
-C5H4CHO)] and [Fe(
5
-C5H4CHO)2] [23] were 
prepared following reported procedures.  
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4.2.2. Synthesis of [(CO)3Mn(
5
-C5H4)COCH=CH(
5
-C5H4)Fe(
5
-C5H5)] 
(11). 
 An ethanolic solution (10 ml) of ferrocenyl carboxyaldehyde (21mg, 0.1 mmol) 
was taken in a round bottom flask and acetyl cymantrene (28 mg, 0.1 mmol) was added 
under stirring condition.  Two equivalents of sodium hydroxide in ethanol solution was 
then added to the reaction mixture and stirring was continued at room temperature under 
inert atmosphere for 3 hours.  The reaction was continuously monitored by TLC and on 
completion of the reaction the solution was dried under vacuum and the residue was 
dissolved in dichloromethane solvent and subjected to chromatographic work-up using 
column chromatography.  Elution with dichloromethane/hexane (30:70 v/v) solvent 
mixture separated the following compounds in the order of elution: [(CO)3Mn(
5
-
C5H4)COCH3], [(
5
-C5H5)Fe(
5
-C5H4CHO)] and violet colored compound [(
5
-
C5H4)Mn(CO)3COCH=CH(
5
-C5H4)Fe(
5
-C5H5)] (11). {Yield: 32 mg (73 %)}  
 
11: Anal. calcd. (found): C, 57.01 (57.23); H, 3.39 (3.34).  IR (CO, cm
-1
,CH2Cl2) 2022.8 
(vs), 1937 (vs, br), 1653 (s), 1586 (s).  
1
H NMR (, CDCl3): 4.2 (s, η
5
-C5H5, 5H), 4.52 (t, 
J = 2 Hz, η5-C5H4, 2H), 4.6 (t, J = 2 Hz, η
5
-C5H4, 2H), 4.9 (t, J = 2 Hz, η
5
-C5H4, 2H), 5.55 
(t, J = 2 Hz, η5-C5H4, 2H), 6.58 (d, J = 15 Hz, CH=, 1H), 7.78 (d, J = 15 Hz, =CH, 1H ).  
13
C NMR (, CDCl3): 69.16 (η
5
-C5H5), 69.95 (η
5
-C5H4), 71.66 (η
5
-C5H4), 78.47 (η
5
-
C5H4), 83.61 (η
5
-C5H4), 86.59 (η
5
-C5H4), 93.78 (η
5
-C5H4), 117.41 (=CH), 146.38 (=CH), 
185.29 (-C=O).  UV –Vis. (λ (nm), CH2Cl2) =321, 384, 502.  MS (ESI): m/z 443 [M+H].  
 
4.2.3. Synthesis of 1,1’-[{(CO)3Mn(
5
-C5H4)COCH=CH(
5
-C5H4)}2Fe] 
(12). 
 A solution of 1,1’-ferrocenyl dialdehyde (24 mg, 0.1 mmol) in ethanol (10 ml) 
was taken in a round bottomed flask and acetyl cymantrene (56 mg ,0.2 mmol) was added 
under stirring condition.  Ethanolic solution of sodium hydroxide was then added to the 
reaction mixture dropwise and stirred for 3-4 hours at room temperature under inert 
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atmosphere.  The reaction was continuously monitored by TLC and on disappearance of 
the reactants the solution was dried under vacuum and the residue was dissolved in 
dichloromethane solvent and subjected to chromatographic work-up using column 
chromatography.  Elution with dichloromethane/hexane (40:60 v/v) solvent mixture 
separated the violet colored compound [{(5-C5H4)Mn(CO)3COCH=CH (
5
-C5H4)}2Fe] 
(12) along with trace amount of the reactants. {Yield: 46 mg (65 %)} 
 
12: Anal. calcd. (found): C, 55.01 (55.18); H, 2.87 (2.81).  IR (CO, cm
-1
,CH2Cl2): 2021 
(vs), 1925 (vs, br), 1648 (s), 1591 (s).  
1
H NMR (, CDCl3): 4.44 (t, J = 2 Hz η
5
-C5H4, 
4H), 4.47 (t, J = 1.8 Hz, η5-C5H4, 4H), 4.82 (t, J = 2 Hz, η
5
-C5H4, 4H), 5.45 (t, J = 1.8 Hz 
η5-C5H4, 4H), 6.43 (d, J= 15Hz, CH=, 2H), 7.57 (d, J=15Hz, =CH, 2H).  
13
C NMR (, 
CDCl3): 70.76 (η
5
-C5H4), 73.42 (η
5
-C5H4), 79.86 (η
5
-C5H4), 83.77 (η
5
-C5H4), 86.67 (η
5
-
C5H4), 93.42 (η
5
-C5H4), 118.60 (=CH), 144.43 (CH=), 185.31 (-C=O).  UV – Visible (λ 
(nm), CH2Cl2) = 304, 334, 374 (sh), 505. MS (ESI): m/z 699 [M+H]. 
 
4.2.4. Synthesis of [(CO)2(PPh3)Mn(
5
-C5H4)COCH=CH(
5
-C5H4)Fe 
(5-C5H5)] (13). 
 In a two necked round bottomed flask, compound 11 (22 mg, 0.05 mmol) was 
taken in THF/ toluene solvent and was stirred at room temperature under inert 
atmosphere to get a clear violet solution.  To the stirring solution, triphenylphosphine (13 
mg, 0.05 mmol) was added and the whole reaction mixture was irradiated with UV light 
for 10 minutes.  After the irradiation the stirring was continued at room temperature 
under inert atmosphere for 17 hours and the solution was dried under vacuum and the 
residue was dissolved in minimum amount of dichloromethane solvent and subjected to 
chromatographic work-up using preparative TLC.  Elution with dichloromethane/hexane 
(60:40 v/v) solvent mixture separated the reactant, 11 and an orange colored compound 
[(CO)2(PPh3)Mn(
5
-C5H4)COCH=CH(
5
-C5H4)Fe(
5
-C5H5)] (13) along with trace 
amount of decomposition.  {Yield: 23 mg (68 %)} 
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13: IR(CO, cm
-1
,CH2Cl2): 1936 (s), 1874 (s), 1645 (s).  
1
H NMR (, CDCl3): 4.18 (s, η
5
-
C5H5, 5H), 4.47 (t, η
5
-C5H4, 2H), 4.59 (t, η
5
-C5H4, 2H), 5.24 (t, η
5
-C5H4, 2H), 5.32 (t, η
5
-
C5H4, 2H), 6.63 (d, J= 15Hz, CH=, 1H), 7.40 – 7.45 (m, C6H5, 15H), 7.7 (d, J= 
15Hz,=CH, 1H ). 
31
P NMR (, CDCl3): 89.77 (MnPPh2-).  MS (ESI): m/z 677 [M]. 
 
4.2.5. Reaction of 11 with Bis-diphenylphosphino ferrocene (dppf) 
In a two neck round bottomed flask, toluene solution (5 ml) of compound 11 (22 
mg, 0.05 mmol) and bis-diphenylphosphino ferrocene (dppf) (26 mg, 0.05 mmol) was 
taken and stirred at room temperature under inert atmospheric condition.  The whole 
reaction mixture was irradiated with UV light for 7 minutes and stirred for 16 hours.  The 
reaction was continuously monitored using TLC.  After the completion of the reaction the 
solution was dried under vacuum and the residue was dissolved in minimum amount of 
dichloromethane solvent and subjected to chromatographic work-up using preparative 
TLC.  Elution with dichloromethane/hexane (80:20 v/v) solvent mixture separated the 
reactants, [{(5-C5H4)PPh2}2Fe] and [{(
5
-C5H5)Fe(
5
-C5H4)CH=CHCO(
5
-
C5H4)Mn(CO)3] (11) and orange colored compounds, [{(
5
-C5H5)Fe(
5
-
C5H4)CH=CHCO(
5
-C5H4)Mn(CO)2PPh2(
5
-C5H4)Fe(
5
-C5H4)PPh2] (14) in major 
amount and [{(5-C5H5)Fe(
5
-C5H4)CH=CHCO(
5
-C5H4)Mn(CO)2PPh2(
5
-C5H4)}2Fe] 
(15) in minor amount.  Trace amount of decomposition and other indistinguishable 
products was also obtained during TLC separation. {Yields: 14, 23 mg (47 %); 15, 8 mg 
(12 %)} 
 
14: IR (CO, cm
-1
, CH2Cl2): 1934 (vs), 1874 (vs), 1646 (s), 1588 (s).  
1
H NMR (, 
CDCl3): 3.69 (t, η
5
-C5H4, 2H), 3.97 (t, η
5
-C5H4, 2H), 4.05 (t, η
5
-C5H4, 2H), 4.13 (t, η
5
-
C5H4, 2H), 4.22 (s, η
5
-C5H5, 5H), 4.37 (t, η
5
-C5H4, 2H), 4.47 (t, η
5
-C5H4, 2H), 4.60 (t, η
5
-
C5H4, 2H), 5.20 (t, η
5
-C5H4, 2H), 6.62 (d, J = 15 Hz, CH=, 1H), 7.22-7.37 (m, C6H5, 
20H), 7.72 (d, J = 15 Hz, =CH, 1H).  
31
P NMR (, CDCl3): -17.62 (PPh2-), 82.66 
(MnPPh2-).  MS (ESI): m/z 969 [M+H], 940 [M-CO].   
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15: IR (CO, cm
-1
, CH2Cl2) 1934 (vs), 1873 (vs), 1648 (s), 1587 (s).  
1
H NMR (, CDCl3): 
3.88 (t, η5-C5H4, 4H), 3.9 (t, η
5
-C5H4, 4H), 4.06 (t, η
5
-C5H4, 4H), 4.23 (s, η
5
-C5H5, 10H), 
4.48 (t, J = 2 Hz , η5-C5H4, 4H), 4.61 (t, J = 2 Hz, η
5
-C5H4, 4H), 5.18 (t, J = 2 Hz, η
5
-
C5H4, 4H), 6.60 (d, J = 15.6 Hz, CH=, 2H), 7.30-7.38 (m, C6H5, 20H), 7.73 (d, J = 15.6 
Hz, =CH, 2H ).  
31
P NMR (, CDCl3): 82.84 (MnPPh2-).  MS (ESI): m/z 1326 [M-2CO]. 
 
4.2.6. Synthesis of [{(CO)2(PPh3)Mn(
5
-C5H4)COCH=CH(
5
-C5H4)}2Fe] 
(16). 
 In a two neck round bottom flask, THF solution of compound 12 (35 mg, 0.05 
mmol) was taken and stirred at room temperature under inert atmosphere.  
Triphenylphosphine (26 mg, 0.1 mmol) was then added to the reaction mixture and 
irradiated with UV light for 10 minutes in continuous stirring condition.  After the UV-
irradiation, stirring was continued at room temperature for 20 hours and the solution was 
dried under vacuum.  The residue was dissolved in minimum amount of dichloromethane 
solvent and subjected to chromatographic work-up using preparative TLC.  Elution with 
dichloromethane/hexane (60:40 v/v) solvent mixture separated the reactant, 
[{(CO)3Mn(
5
-C5H4)COCH=CH(
5
-C5H4)}2Fe] (12) and an orange colored compound, 
[{(CO)2(PPh3)Mn(
5
-C5H4)COCH=CH(
5
-C5H4)}2Fe] (16) during the elution.  Trace 
amount of decomposition and some minor products was also observed during the 
workup.  {Yields: 32 mg (54 %)} 
 
16: IR(CO, cm
-1
,CH2Cl2): 1948 (s), 1880 (s), 1648 (m), 1591 (m).  
1
H NMR (, CDCl3): 
4.12 (t, η5-C5H5, 4H), 4.46 (t, η
5
-C5H4, 4H), 4.55 (t, η
5
-C5H4, 4H), 5.22 (t, η
5
-C5H4, 4H), 
6.55 (d, J= 15Hz, CH=, 2H), 7.39-7.46 (m, C6H5, 30H), 7.62 (d, J= 15Hz,=CH, 2H ).  
31
P 
NMR (, CDCl3): 89.76 (MnPPh2-).  MS (ESI): m/z 1167 [M]. 
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4.2.7. Crystal structure determination for 11 and 13 
Single crystal X-ray structural studies of 11 and 13 were performed on a CCD 
Oxford Diffraction XCALIBUR-S diffractometer equipped with an Oxford Instruments 
low-temperature attachment.  Data were collected at 150(2) K using graphite-
monochromated Mo Kα radiation (λα = 0.71073 Å).  The strategy for the data collection 
was evaluated by using the CrysAlisPro CCD software.  The data were collected by the 
standard 'phi-omega scan techniques, and were scaled and reduced using CrysAlisPro 
RED software.  The structures were solved by direct methods using SHELXS-97 and 
refined by full matrix least-squares with SHELXL-97, refining on F
2
 [24].  The positions 
of all the atoms were obtained by direct methods.  All non-hydrogen atoms were refined 
anisotropically.  The remaining hydrogen atoms were placed in geometrically constrained 
positions and refined with isotropic temperature factors, generally 1.2Ueq of their parent 
atoms.  The crystallographic details are summarized in Table 4.1. (CCDC Numbers, 11: 
1025035, 13: 1025036). 
 
Table 4.1. Crystal data and structure refinement parameters for compounds 11 and 13. 
      11      13 
Empirical 
formula 
C21 H15 Fe Mn O4 C39 H30 Cl3 Fe Mn O3 P 
Formula weight 442.12 794.74 
Crystal system Orthorhombic Triclinic 
Space group P n a 21 P -1 
a, Å 6.9502(4) 10.2716(5) 
b, Å 24.3206(14) 10.3919(5) 
c, Å  10.9894(8) 18.6183(9) 
 deg 90 92.670(1) 
 deg 90 98.100(1) 
 deg 90 116.641(1) 
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V, Å
3
 1857.6(2) 1745.1(2) 
Z 4 2 
Dcalcd, Mg m
-3
 1.581 1.513 
abs coeff, mm
-1
 1.484 1.091 
F(000) 896 810 
Cryst size, mm 0.33 x 0.26 x 0.21 0.33 x 0.26 x 0.21 
 range, deg 3.05 to 24.99 2.21 to 27.40 
index ranges -8 ≤ h ≤ 8, -28 ≤k ≤ 28,  
-11 ≤ l ≤ 13 
-13 ≤ h ≤ 13, -13 ≤ k ≤ 13, 
 -24 ≤ l ≤ 24 
reflections 
collected/ unique 
13965 / 3140 [R(int) = 0.0468] 60130 / 7887 [R(int) = 
0.0364] 
data/ restraints / 
parameters 
3140 / 1 / 245 7887 / 0 / 484 
goodness-of-fit 
on F
2
 
1.029 0.996 
Final R indices 
[I>2(I)] 
R1 = 0.0360, wR2 = 0.0948 R1 = 0.0373, wR2 = 
0.0910 
 
R indices (all 
data) 
R1 = 0.0388, wR2 = 0.0976 R1 = 0.0446, wR2 = 
0.0959 
largest diff peak  0.485 0.661 
and hole, eÅ
-3
 -0.298 -0.643 
133 
 
4.2.8. Computational details 
The Gaussian 03 program was used for the Density Functional Theory (DFT) 
calculation of compound 11.  The basis set already implemented in the program was used 
for the different types of calculations.  The geometry of the compound was optimized at 
the Becke’s three parameter hybrid method with LYP correlation (B3LYP) level [25, 26] 
and using LanL2DZ basis set.  In addition to optimization, frequency calculation, Time-
Dependent Density functional Theory (TD-DFT) calculations were done at same level of 
calculation and using the same basis sets.  The absence of imaginary vibrational 
frequencies in calculated vibrational spectrum ensures the presence of a true minimum in 
the potential energy surface.  The spectroscopic and electronic property of this complex 
has been computed by time dependent DFT (TD-DFT) calculation [27] at the same 
B3LYP level in gaseous phase.  The nature and the role of the electronic excitation 
contributions are rationalized in terms of frontier molecular orbitals (FMO). 
 
4.2.9. Antibacterial activity 
 Compounds 11 and 12 were screened for their antibacterial activity in vitro 
following the protocol described elsewhere [28].  The antibacterial effect was assayed 
against both gram positive bacteria Bacillus subtilis and gram negative bacteria viz., 
Escherichia coli, Pseudomonas aeruginosa and Klebsiella pneumoniae by the agar well 
diffusion method [28].  The compounds were dissolved in DMSO at different 
concentrations ranging from 500 to 15.625 g/ml.  Mueller Hinton-agar (containing 1% 
peptone, 0.6% yeast extract, 0.5% beef extract and 0.5% NaCl, at pH 6.9–7.1) plates were 
prepared and 0.5 – McFarland culture (1.5 X 108 cells/ml) of the test organisms were 
swabbed onto the agar plate.  9mm wells were made in the LB agar petri dishes.  100µl of 
each of the compound with decreasing concentrations was added to separate wells.  
DMSO was used as the negative control and Chloramphenicol was used as positive 
control.  The plates were incubated at 37°C and observed for zones of inhibition around 
each well after 24 hours.  The MIC, defined as the lowest concentration of the test 
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compound, which inhibits the visible growth, was determined visually after incubation 
for 24 h at 37ºC. 
 
4.2.10. Antimalarial activity  
Compounds 11 and 12 were studied for antimalarial activity against 3D7 as well 
as K1 strains of P. falciparum.  The in vitro cultures of both Chloroquine - sensitive 
(3D7) and - resistant (K1) strains of Plasmodium falciparum are routinely maintained in 
medium RPNI supplemented with 25mM HEPES, 0.2% D-glucose, 0.21% sodium 
bicarbonate and 0.5% ALBUMAX-II [29].  The stock (10mM) solution of compounds 
was prepared in DMSO and required dilutions were made in test culture medium (RPMI-
1640 with 10% FBS). For evaluation of 50% inhibitory concentration (IC50) of the 
compounds, Malaria SYBR Green I-based fluorescence (MSF) assay [30] was carried 
out.  Two-fold serial dilutions of test samples were made in 96 well plates and incubated 
with 1.0% parasitized cell suspension containing 0.8% parasitaemia (Asynchronous 
culture with more than 80% ring stages).  The highest concentration used was 100µM.  
The plates were incubated at 37
o
C in CO2 incubator in an atmosphere of 5% CO2 and air 
mixture.  72 hours later 100 µl of lysis buffer containing 2x concentration of SYBR 
Green-I (Invitrogen) was added to each well and incubated for one hour at 37
o
C.  The 
plates were examined at 485±20nm of excitation and 530±20nm of emission for relative 
fluorescence units (RFUs) per well using the fluorescence plate reader (FLX800, 
BIOTEK).  Data was transferred into a graphic programme (EXCEL) and IC50 values 
were obtained by Logit regression analysis of dose-response
 
curves.  Chloroquine 
diphosphate (SIGMA) was used as the reference drug.  
 
4.3. Results and Discussion 
 Room temperature reaction of 1-ferrocenyl carboxyaldehyde and 1,1’-ferrocenyl 
dicarboxyaldehyde with acetylcymantrene in presence of ethanolic sodium hydroxide 
under inert atmospheric condition led to the formation of the corresponding di- and tri-
metallic chalcone compounds, [(CO)3Mn(
5
-C5H4)C(O)CH=CH(
5
-C5H4)Fe(
5
-C5H5)] 
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(11) and [{(CO)3Mn(
5
-C5H4)C(O)CH=CH(
5
-C5H4)}2Fe] (12) respectively (Scheme 
4.1).  The compounds were isolated and purified using column chromatography and 
subjected to spectroscopic characterization.   
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Scheme 4.1 
 
 Both the compounds 11 and 12 have been characterized by IR, 
1
H, 
13
C, 
31
P NMR 
and mass spectroscopy.  Infrared spectra of 11 and 12 show peaks corresponding to 
ketonic group at 1653 cm
-1
 and 1648 cm
-1
 respectively and terminal metal carbonyls in 
the region 2023-1925 cm
-1
.  
1
H NMR spectrum for 11 reveals the presence of 
unsubstituted ferrocenyl Cp protons at  4.2 (singlet) and substituted ferrocenyl protons 
at  4.52 (triplet) and  4.6 (triplet) region.  Peaks corresponding to cymantrenyl Cp 
protons have been obtained at slightly downfield region at  4.9 (triplet) and  5.55 
(triplet) positions.  The two olefinic CH protons have been obtained as a doublet at  6.58 
and  7.78 regions.  The more downfield peak represents the -olefinic proton close to 
the ketonic group.  
13
C NMR of 11 also reveals the presence of unsubstituted Cp at 
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69.16 position and six peaks for susbstituted Cp in the range 69.95 - 93.78.  Olefinic 
carbon has been obtained at 117.41 and 146.38 region and the ketonic group has been 
identified by a peak at 185.29 position.  Proton NMR spectrum for 12 is very similar to 
that of compound 11, but the unsubstituted Cp peak at  4.2 position is absent in the 
spectrum of compound 12.  
1
H NMR spectra shows the presence of peaks at  4.44(t) and 
4.47 (t) for substituted ferrocenyl proton, peaks at  4.82 (t) and  5.45 (t) corresponds 
to substituted cymantrenyl protons and at  6.43 and  7.57 for the four olefinic protons.  
13
C NMR spectrum of 12 shows the presence of six peaks in the range 70.76 - 93.42 
corresponding to the susbstituted Cp’s attached to iron and manganese centers.  Peaks at 
118.6 and 144.43 revealed the presence of olefinic carbon while, peak at 185.31 is 
due to the ketonic groups.  UV–visible absorption spectrum for 11 was studied in 
dichloromethane solvent and shows absorption peaks at 321 nm, a shoulder near 384 nm 
and a broad band with max in the region 502 and UV-Visible spectrum for 12 shows 
absorption peaks at 304 nm, 334 nm, 374 nm and a broad band at 505 nm region (Figure 
4.5).   
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Figure 4.5. UV-Visible spectra of 11 and 12 
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4.3.1. Molecular structure of 11 
Single crystal X-ray diffraction study has been carried out for [(CO)3Mn(
5
-
C5H4)C(O)CH=CH(
5
-C5H4)Fe(
5
-C5H5)] (11) with single crystal, grown from 
dichloromethane/n-hexane solvent mixture at -10 ºC.  Compound 11 crystallizes in 
orthogonal space group P n a 21 with one formula unit in the unit cell.  Molecular 
structure of 11 shows a ferrocenyl Cp ring bridged to the cymantrenyl Cp ring via three 
carbon , -unsaturated chain unit (Figure 4.6).  Three terminal metal carbonyl groups 
with Mn-C-O bond angles in the range 178.9º -177.5º are attached to the manganese 
center satisfying the 18 - electron count.  The C(6)-C(5) bond distance is 1.331(5) Å 
revealing a double bond character and the ketonic C═O bond distance was found to be 
1.220(5) Å.  The torsional angle for H-C5-C4-O4 and H-C6-C5-H are 171.3º and 178º 
respectively which confirm an E-isomer.  The two Cp rings in the ferrocenyl fragment are 
at a torsional angle of 7º and the average bond distance for the ferrocenyl metal – carbon 
bond is 2.045 Å.  The structural analysis also reveals that the iron and the manganese 
fragments are oriented trans- to each other with respect to the enone chain representing an 
anti-conformation.  This conformation is unlike to that of recently reported ferrocenyl-
cyrhetrenyl chalcone having a syn conformation of the two metal based fragments [6a].  
In the solid structure, the assembly of the molecule shows an interesting alternate 
arrangement because of CO(4)∙∙∙∙H(Cp) interactions in the range 2.386 – 2.646 Å as 
shown in Figure 4.7. 
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Figure 4.6. Molecular structure of 11.  Selected bond lengths (Å) and bond angles (º): 
C(5)-C(6) = 1.331(5), O(4)-C(4) = 1.220(5), O(1)-C(1) = 1.143(5), C(4)-C(7) = 1.492(5), 
C(5)-C(4)-C(7) = 117.2(4), C(6)-C(5)-C(4) = 121.7(4).  
 
 
Figure 4.7. Molecular assembly of 11. 
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The presence of three terminal carbonyl groups attached to manganese atom prompted us 
to study the reactivity features of 11 and 12 by phosphine substitution.  We anticipated 
that the presence of enone chain linked to the cp ring may be able to stabilize the THF 
solvated adduct, [(thf)(CO)2Mn(
5
-C5H4)R] which can then react with phosphine to get 
the desired product.  Therefore, we carried out photochemical reaction, under UV light, 
of compound 11 with triphenylphosphine in THF solvent.  After the UV irradiation the 
reaction was continued at room temperature to obtain the phosphine substituted 
compound, [(CO)2(PPh3)Mn(
5
-C5H4)COCH=CH(
5
-C5H4)Fe(
5
-C5H5)] (13) (Scheme 
4.2).  Compound 13 was characterized by IR, NMR and mass spectroscopy.  Infrared 
spectrum shows bands at 1936 cm
-1
 and 1874 cm
-1
 corresponding to terminal metal 
carbonyls and the peak pattern exactly matches with that of cymantrenyl compounds with 
mono carbonyl substitution [31].  A band corresponding to ketonic C=O group for enone 
moiety has also been detected.  Proton NMR of 13 revealed the presence of substituted 
and unsubstituted cyclopentadienyl ring for ferrocenyl and cymantrenyl fragments.  Two 
doublets due to olefinic protons (6.63 and 7.7) and a multiplet equivalent to 15 
protons at 7.40 – 7.45 region have been obtained for the presence of 
triphenylphosphine group attached to manganese.  
31
P NMR showed one peak at 89.77 
for the only phosphorus present in the molecule.  A molecular ion peak at m/z 677 has 
also been obtained by mass spectral analysis of compound 13. 
 
4.3.2. Molecular structure of 13 
Single crystal X-ray diffraction study has been carried out for [PPh3(CO)2Mn(
5
-
C5H4)C(O)CH=CH(
5
-C5H4)Fe(
5
-C5H5)] (13) with the single crystal, grown from 
chloroform/n-hexane solvent mixture at -10 ºC.  Compound 13 crystallizes in triclinic 
space group P-1 with one formula unit in the unit cell.  The asymmetric unit consists of 
one molecule of 3 and a chloroform solvent molecule.  The molecular structure of 13 
reveals the presence of a ferrocenyl fragment and a cymantrenyl moiety bridged by an 
enone unit and the manganese atom is attached to one cp ring by 5 type of linkage, two 
terminal carbonyl groups and one triphenylphosphine ligand (Figure 4.8).  The bond 
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distance between manganese and phosphorus atom is 2.24 Å while the two Mn-CO bond 
distances are 1.78 Å.  The Mn-C-O bond angles are in the range of 178.32º -179.83º 
representing the presence of terminally bonded metal carbonyls.  The torsional angle 
between the two Cp rings of the ferrocenyl fragment is at an angle of 11º, slightly greater 
than that in 11.  The metal carbonyl bond distance, C(1)-O(1) = 1.153(1) Å has also been 
found to be longer than that in the parent compound 11 (1.143(5) Å) as expected for a 
phosphine substituted derivative.  The structural analysis of 13 reveals that the two 
metallic fragments are oriented in syn-conformation with respect to the 
{CpC(O)CH=CHCp} moiety.  The syn-conformation observed in 13 is exactly opposite 
to that observed for compound 11.   
Figure 4.8. Molecular structure of 13 (Solvent molecules have been deleted for clarity).  
Selected bond lengths (Å) and bond angles (º): C(9)-C(10) = 1.332(1), O(1)-C(1) = 
1.153(1), Mn(1)-P(1) = 2.243(1), O(3)-C(8) = 1.228(0); C(8)-C(9)-C(10) = 122.08(0), 
O(3)-C(8)-C(9) = 122.28(0), Mn(1)-C(1)-O(1) = 178.32(0). 
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 To understand the reactivity of 11 with diphosphines, we chose bis-
(diphenylphosphino ferrocene), due to its better coordinating ability and expecting 
formation of some new multiferrocenyl derivative.  Photochemical reaction under UV 
light of compound 11 with bis-(diphenylphosphino ferrocene) in toluene/THF solution 
led to the formation of a major orange compound, [{(5-C5H5)Fe(
5
-
C5H4)CH=CHCO(
5
-C5H4)Mn(CO)2PPh2(
5
-C5H4)Fe(
5
-C5H4)PPh2] (14) and a minor 
product, [{(5-C5H5)Fe(
5
-C5H4)CH=CHCO(
5
-C5H4)Mn(CO)2PPh2(
5
-C5H4)}2Fe] (15) 
(Scheme 4.2).  The poor yield of compound 15 could not be improved after several 
attempts by changing various reaction conditions.  Both the compounds have been 
characterized by IR, 
1
H NMR, 
31
P NMR and mass spectroscopy.  Infrared spectra of 14 
and 15 show peaks corresponding to ketonic group at 1648-1649 cm
-1
 and terminal metal 
carbonyls at 1934-1935 cm
-1
 and 1872-1876 cm
-1
 region respectively.  The pattern of the 
metal carbonyl peaks in the infrared spectra for both 14 and 15 are similar to that 
obtained for mono-substituted cymantrenyl derivatives [28] and that of compound 13.  
The strong peak at 2024 cm
-1
 observed in 11 is absent in the IR spectra of compounds 14 
and 15, while a new peak at around 1872 cm
-1
 arises due to the substitution of one 
carbonyl group from the cymantrenyl fragment.   
Proton NMR of 14 reveals the presence of unsubstituted ferrocenyl Cp ring at 
4.22 (singlet) and another eight peaks, each equivalent to two protons, have been 
obtained corresponding to substituted Cp protons.  Olefinic protons are obtained as 
doublets at 6.62 and 7.72 region and twenty phenylic protons showed multiplet at 
7.22-7.37 region.  31P NMR of 14 confirms the presence of two types of phosphorus in 
the molecule: a metal coordinated phosphine showed a peak at 82.66 and uncoordinated 
phosphorus was obtained at -17.62 region.  Mass spectral analysis reveals the presence 
of peak at m/z 969 corresponding to [M+H]
+
 ion of the compound.   
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Scheme 4.2 
In spite of low yield of compound 15, we have been able to characterize by IR, 
NMR and mass spectroscopy.  
1
H NMR spectra showed unsubstituted ferrocenyl Cp ring 
at 4.23 (singlet) equivalent to ten protons and six peaks was observed for substituted Cp 
protons, with each peak equivalent to four protons.  The spectrum also exhibits two 
doublets and one multiplet corresponding to four olefinic and twenty phenylic protons 
respectively.  Phosphorus NMR with a peak at 82.84 revealed the presence of only one 
type of metal coordinated phosphorus.  Mass spectral analysis of 15 showed the presence 
of peak at m/z 1326 due to [M-2CO]
 
 ion. 
 Reaction under UV light condition with compound 12 and triphenylphosphine in 
presence of thf solvent gave an orange product, [{(CO)2(PPh3)Mn(
5
-
C5H4)COCH=CH(
5
-C5H4)}2Fe] (16) (Scheme 4.3).  Compound 16 was characterized by 
IR, NMR and mass spectral analysis.  Infrared spectrum of 16 showed peaks 
corresponding to terminal metal carbonyls at 1948 and 1880 cm
-1
 region and ketonic 
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C=O at 1648 cm
-1
.  Proton NMR spectrum revealed the presence of substituted ferrocenyl 
Cp and substituted cymantrenyl cp protons at 4.12, 4.46, 4.55 and 5.22 region.  Two 
doublets at 6.55 and 7.62 with a coupling constant value of 15 Hz revealed the 
presence of olefinic protons in the molecule, while 30 phenylic protons have been 
confirmed from a multiplet at 7.39-7.46 region.  One phosphorus peak at 89.76 has 
been observed in 
31
P NMR spectrum.  This shows that the two phosphorus groups present 
in the molecule are equivalent.  The ESI mass spectral data shows ion peak at m/z 1167 
corresponding to the molecular ion of compound 16. 
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Scheme 4.3 
 
4.3.3. Redox properties of 11 - 14 
The electrochemical properties of compounds 11-14 have been examined in 
acetonitrile solution (0.1M TEAP) by cyclic-voltammetry.  Compounds 11 and 12 
showed one reversible response in the potential range 0.47-0.50 V involving single 
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electron Fe(II) / Fe(III) couple of the ferrocenyl fragment and an irreversible response at 
1.35 V for 11 and 1.15 V for 12 corresponding to the oxidation of Mn(I) to Mn (II) when 
scanned in the positive potential side (Figure 4.9).  The one-electron nature of 
Fe(II)/Fe(III) couple have been tentatively established by comparing its current height 
with that of the standard ferrocene/ferrocenium couple under the same experimental 
conditions.  The much higher potential range at which the oxidative response has been 
observed for Mn(I)/Mn(II) couple is consistent with the E1/2 values in the literature for 
[MnCp(CO)3]
0/+
 (0.92 V) [32], [(Cp-triazolyl)Mn(CO)3]
0/+
 (+1.4 V) [33] and [Mn(5-
C5H4)CHO(CO)3]
0/+
 (1.10 V) couple [34].  The oxidation at the higher potential range is 
presumed to decrease the Mn-C(O) bond strength due to the weakening of the metal to 
CO back bonding which eventually makes the oxidized species unstable and give rise to 
an irreversible response.  The reversibility of the Mn center may be restored by CO-
substitution, which will stabilize the oxidized species while lowering the oxidation 
potential.  Compound 13, triphenylphosphine substituted analogue of 11, showed 
accordingly one reversible response at +0.52 V corresponding to ferrocene/ferrocenium 
couple and one quasi-reversible response at +0.70 V due to Mn(I)/Mn(II) couple (Figure 
4.9 & Table 4.2).  The oxidative response at higher potential corresponding to 
Mn(I)/Mn(II) has been shifted to lower potential value on phosphine substitution and 
showed quasi-reversible behavior as compared to that observed for compounds 11 and 
12.  The presence of one phosphine ligand attached to the manganese center in 13 eases 
the oxidation process and increases the stability of the oxidized species resulting in 
observation of a quasi-reversible couple under the same experimental condition.   
The cyclic voltammogram of 14 showed three responses (one reversible and two 
irreversible couple) corresponding to two ferrocenyl and one cymantrenyl fragments.  
The ferrocenyl fragment attached to phosphorus atom showed a reversible couple at 
+0.28V while the oxidative response of the ferrocenyl attached to enone moiety was 
observed at +0.57 V having slightly irreversible character.  This is unlikely to that 
observed in compounds 11-13 in which all the three compounds showed reversible 
response in the range +0.52 - +0.47 V for the ferrocenyl part of the compounds.  The 
Mn(I)/Mn(II) couple has been observed as irreversible response with the presence of only 
anodic peak at +0.86 V (Table 4.2).  
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Table 4.2. Cyclic voltammetric data for 11-14. 
Compounds              Epa               Epc         E1/2 (ΔEp (mV)) 
11 +0.54 V, +1.37 V +0.46 V, +1.32 V +0.5 V (80), +1.35 V (50) 
12 +0.52 V, +1.25 V +0.43 V, +1.04 V +0.475 V (90), +1.145 V (210) 
13 +0.55 V, +0.74 V +0.49 V, +0.66 V +0.52 V (60), +0.7 V (80) 
14 +0.32 V, +0.59 V, +0.86 V +0.23 V, +0.55 V +0.28 V (90), +0.57 V (40) 
*
In acetonitrile at a scan rate of 50-200 mv s.   E1/2 (V) = (Epa+Epc)/2, where Epa and 
Epc are the anodic and cathodic peak potentials Vs. Ag/AgCl respectively.  ΔEp (mV) = 
Epa-Epc 
 
 
           
        11            12 
          13            14 
Figure 4.9. Cyclic voltammograms () and differential pulse voltammograms (…) of 
compound 11-14 in Acetonitrile / 0.1 M TEAP at 298 K vs Ferrocene / Ferrocenium 
couple. 
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4.3.4. Anti-malarial activity of 11 and 12 
In order to understand the biological properties of bimetallic chalcones 11 and 12, 
in vitro antimalarial activity was studied against chloroquine-susceptible 3D7 as well as 
chloroquine-resistant K1 strains of P. falciparum.  IC50 values for the compounds are 
depicted in (Table 4.3).  Both the compounds 11 and 12 studied exhibited moderate 
antimalarial activity against 3D7 as well as K1 strains of P. falciparum.  The inhibition 
activities observed for compounds 11 and 12 (IC50 = 2.35 & 2.78 (3D7); 9.47 & 8.14 
(K1)) are higher than that reported recently for different ferrocenyl chalcones, 
[FcC2H2C(O)(
5
-C5H4)Re(CO)3] (IC50 = 18.9 against 3D7), [FcC(O)C2H2(
5
-
C5H4)Re(CO)3] (IC50 = 26.9 (3D7)) [6(a)], [FcC(O)C2H2Ph] (IC50 = 19 (K1)), 
[FcC(O)C2H2Ph-OH] (IC50 = 20.6 (K1)), [FcC(O)C2H2Ph-OMe] (IC50 = 17 (K1)), 
[FcC(O)C2H2(C5H4N)] (IC50 = 14 (K1)) and [FcC2H2C(O)Ph-OH] (IC50 = 36 (K1)) 
[1(e)], whereas the IC50 value for 11 and 12 are comparable to [FcC(O)C2H2Ph-NO2] 
(IC50 = 5.1 (K1)) and [FcC2H2C(O) (3-C5H4N)] (IC50 = 4.6 (K1)) [1(e)].  The higher 
activity of 11 and 12 reveals some influence of bimetallic ferrocenyl-cymantrenyl 
moieties on the antiplasmodial activity of the compounds.  The presence of an extra 
cymantrenyl unit attached to ferrocenyl Cp ring via enone chain in compound 12 may not 
have much effect on the antiplasmodial activity, although a slight decrease in IC50 value 
was observed when tested against K1 strain.  A plausible explanation for the moderate 
antimalarial activity of 11 and 13 is the presence of ferrocenyl and cymantrenyl moieties 
which may have influenced the redox properties, lipophilicity and structural orientation 
of the compounds. 
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Table 4.3. Antimalarial activity against 3D7 strain and K1 strain of P. falciparum  
Compounds IC50 (µM) 
3D7 strain K1 strain 
11 2.35 9.47 
12 2.78 8.14 
Chloroquine 0.005 0.22 
 
4.3.5. Anti-bacterial activity of 11and 12 
Antibacterial study was carried out for compounds 11 and 12 against Gram 
positive B. subtilis and Gram negative E. coli, K. pneumoniae, P. aeruginosa bacterial 
strains.  Both the compounds showed moderate inhibition activity against the bacterial 
strains as shown in Table 4.4.  Compound 12 containing two enone units showed higher 
activity as compared to compound 11 against B. subtilis and E. coli, while compound 11 
showed lower MIC value against K. pneumoniae strain.  Our recent reports also showed 
high antibacterial activity of ferrocenyl hydrazone compounds and some Cp based half 
sandwich cymantrenyl hydrazone compounds revealing their potential as medicinal agent 
[18].  Other half sandwich organometallic compounds showing potential antibacterial 
properties include [(η6-C6Me5)Cr(CO)3] incorporated platensimycin derivative and [(η
6
-
p-cymene)RuCl(ofloxacin)] [35-37].  Significant antibacterial activity for the reported 
organometallic compounds could possibly be due to the presence of both ferrocenyl and 
[(5-C5H5)Mn] fragments which are supposed to play a vital role in increasing the cell 
permeability and lipophilicity of the compounds.  Different other factors like electron 
delocalization and blocking of metal binding sites of the enzyme of microorganism may 
also result in better inhibition activity in metal containing compounds.  The MIC data 
reported in Table 4.4 for multimetallic Cp based compounds will be important to 
understand the biological potential of these types of compounds.   
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Table 4.4. Minimum inhibitory concentration (MIC) value in g/ml 
Compounds B. subtilis E. coli K. pneumoniae P. aeruginosa 
11 125 N 62.5 250 
12 62.5 62.5 N N 
Chloramphenicol 4 4 31.25 31.25 
 
N – Inhibitory activity not observed 
 
4.3.6. DFT calculation of 11 
Molecular Geometry Optimization 
 DFT calculation was carried out for compound 11 using single crystal x-ray 
diffraction data coordinates for the geometry optimization without any constrain.  The 
DFT optimized molecular structure at B3LYP level and using LanL2DZ basis set has 
been shown in Figure 4.10.  The data reveals that the average bond length for Fe-C(cp) 
(2.077Å), C=C (1.348 Å) and Mn-C(cp) (2.184 Å) are found to be well correlated with 
that of experimentally (XRD) obtained data.  Calculated C=O and C≡O bond lengths 
were also found to be matching excellently; 1.225 (exp. 1.219 Å) and 1.148 (exp. 1.147 
Å).  In general all the optimized bond angles agree well within 1˚ when compared with 
crystal structure data. 
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Figure 4.10. DFT optimized molecular structure of 11 
 
4.3.7. TD-DFT calculation and Correlation with electronic transitions 
 Absorption spectrum of 11 consists of mainly three bands.  The 
strongest band for the complex in absorption spectrum appears in the region 270-350 nm.  
A small hump appears at 370-420 nm regions and a broad peak appears at 450-600 nm 
region.  In order to get deeper understandings of transitions occurring in the compound, 
TD-DFT calculation has been performed.  The calculated oscillator strengths, energies 
and transitions between moleculera orbitals are tabulated in Table 4.4.  The assignment of 
the calculated electronic transitions to the experimental absorption bands was based on an 
overview of the contour plots and relative energy of highest occupied (HOMO) and 
lowest unoccupied (LUMO) molecular orbital involved in the electronic transitions 
(Figure 4.11).  Electronic transition at 546 nm corresponds to HOMO-1 to LUMO+ 4 
molecular orbital (MO), which may be assigned to a charge transfer transition from iron-
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centered orbital to π* (Cp of Fe and dx
2
-y
2
 of Fe atom).  Transition at 346 nm corresponds 
to HOMO to LUMO transition, which may be assigned to charge transfer from π (Cp of 
Fe and CH-C=O) to π*(Cp of Mn and dz
2
 of Mn atom).  Transition occurring at 332 nm is 
due to HOMO-2 to LUMO i.e π (Cp of Fe and CH-C=O) to π*(Cp of Mn and C=O).  The 
corresponding calculated oscillator strength represented very well the experimental 
absorption intensities of various bands.  Highest energy band (304nm) corresponds to 
HOMO to LUMO+2, representing transition from π (Cp of Fe) to π* (Cp of Mn and 
C≡O) i.e ligand to ligand charge transfer transition (LLCT).  The molecular orbitals also 
show the electronic communication as a result of conjugation between the two metallic 
fragments linked via an enone moiety.  The complete transition phenomenon in UV-Vis 
region has been represented pictorially with calculated frontier molecular orbital diagram 
in Figure 4.11. 
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Figure 4.11. Selected molecular orbitals of 11 
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Table 4.5. Calculated oscillator strength and their corresponding energies for selected 
transition of compound 11 using TD-DFT method.  
Wavelength (nm) Oscillator strength Energy (eV) Transitions between 
MOs 
546 0.0049 2.2272 HOMO-1 →LUMO+4  
423 0.0210 2.9254 HOMO-1 → LUMO  
387 0.0279 3.2009 HOMO-1 → LUMO         
376 0.0762 3.2946 HOMO  → LUMO          
332 0.3413 3.7267 HOMO-2 → LUMO      
304 0.0790 4.0732 HOMO→ LUMO+2 
288 0.0113 4.2914 HOMO-4 → LUMO+3          
276 0.0223 4.4762 HOMO-10 → LUMO   
267 0.0559 4.6310 HOMO-2 → LUMO+2          
264 0.0050 4.6844 HOMO-4 → LUMO+6         
256 0.0295 4.8383 HOMO-2 → LUMO+5         
253 0.0157 4.8999 HOMO-11 → LUMO         
251 0.0051 4.9218 HOMO→ LUMO+6          
 
In summary, synthesis of new ferrocenyl-cymantrenyl bimetallic chalcones have 
been carried out and their reactivity study with triphenylphosphine and 1,1’-ferrocenyl 
diphosphine results in the formation of respective phosphine derivatives of the bimetallic 
chalcones.  Structural characterizations of two bimetallic chalcones, 11 and 13 have been 
carried out.  Compound 11 shows anti conformation of the metallic fragments while, the 
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PPh3 substituted bimetallic chalcone (13) confirms syn conformation, in which the two 
metallic moieties are on the same side with respect to the enone chain.  Antimalarial and 
antibacterial evaluation on compounds 11 and 12 reveal their moderate inhibition 
activity.  Efforts may be focused to increase the bioactivity by incorporating heterocyclic 
moieties and understanding the structure –activity relationship on these types of 
compounds.   
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Chapter 5 
Synthesis of diferrocenyl 
hydrazone-enone receptor 
molecule: Biological evaluation, 
electronic communication and 
metal binding study 
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5.1. Introduction 
Efficient energy transfer between redox active centers is one of the interesting 
aspects for organometallic compounds due to their potential in the development of 
molecular electronic devices.[1]  Among a range of redox active species, ferrocenyl 
system plays a vital role as a remarkable redox signaling unit in various organometallic 
molecules or scaffold.  In recent times, a large number of ferrocene based organometallic 
molecular entities have been synthesized for their application as chemosensors, energy 
storage devices, multichannel receptor, biosensor molecules etc.[2-5]  Compounds 
containing multiple redox centers have also been highly focused due to their various 
application related to electronic communication, sensors and molecular wires.[6]  
Therefore, design of novel ferrocenyl assemblies with substituent at the cyclopentadienyl 
ring have attracted considerable interest and led to the development of variety of such 
derivatives.  Molecular system containing more than one ferrocene units shows 
interesting electron transfer processes when the metal centers are no longer independent 
of each other and are said to be electronically coupled through suitable bridging chains.  
The interesting part associated with the design is in the fact that the 
ferrocene/ferrocenium redox couple can be tuned significantly by the judicious choice of 
substituents on the rings of the ferrocene moiety and led to the emergence of a large 
variety of ferrocene based functional compounds using concise synthetic routes.  
Recently, functionalization of ferrocene has attracted the synthetic community to obtain a 
range of ferrocene based molecular systems with unique electronic properties and 
structural variety.[7]  Functionalization in the form of mono-substituted and 1,1’ 
symmetrically disubstituted ferrocenyl derivatives are well known and has been 
extensively studied, while, unsymmetrical 1,1’-disubstituted ferrocenyl derivatives are 
comparatively less known.  The later systems have the ability to show improved 
multifunctional behavior and redox properties.[8,11]   
A disubstituted ferrocene-derived triazoles, 1,1′-Bis[(4-ferrocenyl)-1H-1,2,3-
triazol-1-yl]ferrocene and 1,1′-Bis{[4-(phenanthren-9-yl)]-1H-1,3,4-triazol-1-
yl}ferrocene, have been prepared from diazidoferrocene using the copper-catalyzed click 
reaction and have been characterized by spectroscopic analysis (Figure 5.1).[9]  
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Investigation of the electrochemical behavior of the triferrocenyl triazole compound by 
cyclic voltammetry with two reversible one electron couple at 544 mV and 953 mV 
revealed the dependency of ferrocene based oxidation potential on the position of triazole 
group.  Both the triazol based ferrocenyl compounds have been found to act as receptor 
molecules and showed selective binding interaction with anions as well as cations.  A 
cathodic shift of the receptors by the addition of F
−
, AcO
−
, H2PO4 
−
 and HP2O7 
3− 
anions 
and an anodic shift of 1,1′-Bis[(4-ferrocenyl)-1H-1,2,3-triazol-1-yl]ferrocene by the 
addition of Zn
2+
, Hg
2+ 
and Pb
+2
 with ΔE1/2 = +22mV to +76 mV and that of 1,1′-Bis{[4-
(phenanthren-9-yl)]-1H-1,3,4-triazol-1-yl}ferrocene by Hg
2+ 
cation have been 
investigated by cyclic voltammetry.   
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Figure 5.1. Ferrocen-triazole derivatives 
 
Recently, a novel synthetic strategy has been applied for the synthesis of 
ferrocenyliminophosphorane compound starting from ferrocene through lithiation, click 
reaction and Staudinger reaction which further undergoes aza-Witting type of coupling 
reaction with various aldehydes to give the corresponding unsymmetrical diferrocenyl 
triazole derivative, 1,1’-[Ar-CH=N(5-C5H4)Fe{(
5
-C5H4)(NN=NC=CH)(
5
-
C5H4)Fe(
5
-C5H5)], {Ar = pyrene, quinoline, fluorene} (Figure 5.2).[10]  Cyclic 
voltammetry of the diferrocenyl triazole compound showed two redox couple due to the 
presence of two ferrocene units positioned in different environment.  The lower oxidation 
potential (E1/2 =0.03-0.05V) was for the mono substituted ferrocene and the higher 
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oxidation potential (E1/2 =0.24-0.31V) has been attributed to the di-substituted ferrocenyl 
fragment.  The compound also act as receptor molecule showing distinct shift of the 
potentials due to the gradual addition of Pb
+2
 and Zn
+2 
metal cations.  The metal 
recognition properties of the ferrocenyl receptors with Ni
2+
, Cd
2+
, Zn
2+
 and Pb
2+
 cations 
have also been confirmed by the blue-shift, red shift or change in intensities of the energy 
bands in the UV-Visible spectroscopy.  DFT calculations revealed that the binding of the 
receptor with the metal ions take place through imine group of the receptor and the N 
atom of the quinoline ring with feeble interaction of the triazole unit. 
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Figure 5.2. Unsymmetrical diferrocenyl triazole 
 
An unsymmetrically substituted ferrocenyl ditopic receptor containing a urea and 
a benzo crown ether unit has been synthesized by the reaction of ferrocenyl 
monoaldehyde with N-methyl piperazine, n-BuLi and tri-n-butylborate followed by a 
Suzuki coupling reaction with 4-bromobenzo-18-crown-6 and subsequent addition of 
ammonium acetate and 4-nitrophenylisocyanate (Scheme 5.1).[11]  The absorption 
maxima in UV-Visible spectroscopy associated with the free receptor at 304 nm and 332 
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nm has been shifted to 288 nm and 356 nm along with the appearance of a new 
absorption peak at 472 nm by the addition of F
-
 anion.  The addition of anoin also shows 
naked eye colour change of the solution in visible region from colourless to yellow.  This 
chromogenic process was reversed by the addition of K
+
 cation with the disappearance of 
the peak in the visible region at 472 nm and colour change of the solution from yellow to 
colourless.  The ferrocenyl ditopic receptor acts as a chromogenic molecular sensor due 
to its switching on and off function induced by the addition of anion and cation.  
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Scheme 5.1 
 
Diferrocenyl molecular systems have been well known to participate in electronic 
coupling between the ferrocene fragments and play a vital role in the development of 
intervalence properties in several organometallic compounds.  A multistep reaction 
involving iodo ferrocene, 2,6-dichlorobenzoyl chloride, N-hydroxybenztriazole and 
amino ferrocene produced a diferrocenyl amide derivative, [(5-C5H5)Fe{(
5
-
C5H4)NHC(O)}(
5
-C5H5)Fe{(
5
-C5H4)NHC(O)CH3}].  Thionation of the diferrocenyl 
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amide with Lawesson’s reagent gave a diferrocenyl thioamide derivative, [(5-
C5H5)Fe{(
5
-C5H4)NHC(S)}(
5
-C5H5)Fe{(
5
-C5H4)NHC(O)CH3}] (Scheme 5.2).  The 
structure of the compound, revealed by spectroscopic analysis, shows the presence of 
unsymmetrically substituted diferrocenyl system, in which the two ferrocenyl moieties 
are linked together by thioamide bridge.  The shifting of absoption band in UV-Visible 
spectrum of the diferrocenyl thioamide compound to lower energy (λmax= 480 nm) than 
that of the corresponding diferrocenyl amide (λmax=446 nm) confirms some intervalence 
charge-transfer character of the compound.  In addition, the potential shift in diferrocenyl 
thioamide towards higher potential region of the first oxidation potential due to Fe (II)/ 
Fe(III) couple in comparison to the corresponding amides indicates the influence of O to 
S substitution on the electronic properties of the compound.  DFT analysis showed 
intramolecular hydrogen bonding of diferrocenyl thioamide derivative and both inter and 
intramolecular hydrogen bonding for the oxidized species.  
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Scheme 5.2 
 
 Reaction of 1-bromo-1′-formylferrocene with trimethoxymethane, 
methylbenzene-sulfonic acid followed by palladium catalysed Negishi cross-coupling 
with 2,5-dibromothiophene or 2,5-dibromo-3,4-ethylenedioxy thiophene gave the 
corresponding diformyldiferrocenyl thiophene derivatives [CHO(5-C5H4)}Fe{(
5
-
C5H4)(C4H2S)(
5
-C5H4)}Fe{(
5
-C5H4)CHO}] and [CHO(
5
-C5H4)}Fe{(
5
-C5H4)(3,4-
(OCH2)2C4H2S)(
5
-C5H4)}Fe{(
5
-C5H4)CHO}] (Figure 5.3).  One of the 
diformyldiferrocenyl thiophene has been characterized by single crystal X-ray diffraction 
study showing parallel orientation of ferrocenyl units with respect to the thiophene core.  
Electrochemical analysis by cyclic voltammetry showed two reversible one electron 
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redox couple for both the diformyl diferrocenyl thiophene derivatives.  The introduction 
of electron donating ethylenedioxy unit at the thiophene ring of diformyldiferrocenyl 
thiophene derivative has been found to increase the electronic coupling between the 
ferrocenyl groups. 
FeFe
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OHC CHO
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Figure 5.3. Formyl ferrocenyl thiophene derivatives 
 
 Recently, functionalization of ferrocene with biologically active groups and their 
study on different biological properties have led to the immergence of a new field of bio-
organometallic chemistry.[14-15]  We have been focusing our study on a variety of 
ferrocene based molecular systems ranging from ferrocenyl hydrazones, hetero-bimetallic 
ferrocenyl chalcones, ferrocene based cluster compounds, ferrocenyl dithiocarboxylates 
and multiferrocenyl compounds and reported their synthesis and biological 
properties.[16]  In view of the emerging potential of unsymmetrically functionalized 
ferrocenyl moieties, we selected to introduce both hydrazone and enone functionality on 
the same ferrocenyl fragment, anticipating a change in property and unique structural 
behavior in contrast to either ferrocenyl hydrazone or ferrocenyl chalcone compounds.  It 
has been well understood that hydrazones and chalcones independently constitute a large 
class of important molecules which show a number of interesting features related to 
coordination behavior and biological properties and are significant molecules as 
precursors to several heterocyclic compounds.[17, 18]   
 In this chapter, we describe the synthesis of a novel diferrocenyl bifunctional 
molecular system containing hydrazone and enone units using simple and systematic 
synthetic route.  To the best of our knowledge, unsymmetrical difunctionalization of 
ferrocenyl moiety with hydrazone and enone groups are not known in the literature.  
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Further to our notice, diferrocenyl systems with two different functional chains are less 
known and rarely attempted for study.  We have been able to synthesize four analogs of 
the diferrocenyl hydrazone-enone derivatives with different aromatic end groups and 
describe their unique structural identity and selective metal ion sensing properties.  We 
also report here the antibacterial and BSA binding properties of some of the compounds 
and carried out cyclic-voltammetric studies to understand electronic communication 
inside the molecule.  DFT calculation was also performed to establish some of the 
interesting features related to structural stability, metal ion interaction and molecular 
orbital energies. 
 
5.2. Experimental Sections 
5.2.1. General Procedures 
 All reactions and manipulations were carried out under an inert atmosphere of 
dry, pre-purified argon using standard Schlenk line techniques.  Solvents were purified, 
dried and distilled under argon atmosphere prior to use.  Infrared spectra were recorded 
on a Perkin Elmer Spectrum Two FTIR spectrometer as CH2Cl2 solution and NMR 
spectra on a 400 MHz Bruker spectrometer in CDCl3 or d6-DMSO solvent.  Elemental 
analyses were performed on a Vario El Cube analyzer.  Mass spectra were obtained on a 
SQ-300 MS instrument operating in ESI mode.  Cyclic voltammetric and differential 
pulse voltammetric measurements were carried out using a CH Instruments model 600D 
electrochemistry system.  A platinum working electrode, a platinum wire auxiliary 
electrode and a calomel reference electrode were used in a threeelectrode configuration.  
The supporting electrolyte was 0.1 M [NBu4]ClO4 and the solute concentration was 10
4 
M.  The scan rate used was 50 mV s
1
.  All electrochemical experiments were carried out 
under a nitrogen atmosphere and are uncorrected for junction potentials.  UV-vis spectra 
were recorded in ethanol solutions at 10
5 
M concentration.  TLC plates (20x20 cm, Silica 
gel 60 F254) were purchased from Merck.  Appropriate salts of Na
+
, K
+
, Mg
2+
, Ba
2+
, 
Mn
2+
, Fe
2+
, Co
2+
, Cu
2+
, Zn
2+
, Cd
2+
, Ni
2+
, Hg
2+
 and Pb
2+
 were purchased from Aldrich.  
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[Fe(5-C5H4COCH3)2], [(
5
-C5H5)Fe(
5
-C5H4CHO)], [H2NN(H)C(O)R], (R = -C6H4-
OH, C6H4N-p, C6H5, C6H4N-m) were prepared following reported procedures.[19-21]  
 
5.2.2. Synthesis of [(5-C5H5)Fe{(
5
-C5H4)CH═CHC(O)(
5
-C5H4)}Fe 
{(5-C5H4)C(CH3)═NN(H)C(O)R}] (17 - 20) 
 In a two neck round bottom flask ethanol solution (10 ml) of compound 5 - 8 (0.1 
mmol) was taken and ferrocenyl carboxyaldehyde (21 mg; 0.1 mmol) was added.  The 
reaction mixture was stirred for 15 minutes under inert atmosphere and sodium hydroxide 
(0.2 mmol) solution was added dropwise and the stirring was continued for 5 hours at 
room temperature.  The reaction mixture was then kept under vacuum for 15 minutes to 
increase the amount of the product.  The reaction was continuously monitored using 
TLC.  After the reaction, the solution was vacuum dried and the mixture was subjected to 
chromatographic work up using preparative TLC (10% ethanol:n-hexane solvent 
mixture).  Chromatographic elution afforded the unreacted ferrocenyl carboxyaldehyde, a 
violet colored compound 1,1’-[(5-C5H5)Fe(
5
-C5H4)CH═CHC(O)(
5
-C5H4)Fe{(
5
-
C5H4)C(CH3)═N-N(H)C(O)-R}] {R = C6H5 (17), C6H4-OH (18), C6H4N-p (19), C6H4N-
m (20)} and trace amount of the unreacted compound, [CH3C(O)(
5
-C5H4)Fe{(
5
-
C5H4)C(CH3)═N-N(H)C(O)-R}] in the order of elution.  {Yields: 17, 45 mg (78 %); 18: 
48 mg (80%); 19: 44 mg (74 %); 20: 46 mg (78 %)} 
 
17:  IR(CO, cm
-1 
, CH2Cl2): 1671 (s), 1650 (vs), 1602 (m), 1581(s).  
1
H NMR (, d6-
DMSO): 2.25 (s, 3H, CH3), 4.18 (s, 5H, 
5
-C5H5), 4.42 (t, 2H, 
5
-C5H4), 4.45 (t, 2H, 
5
-
C5H4), 4.69 (t, 2H, 
5
-C5H4), 4.71 (t, 2H, 
5
-C5H4), 4.79 (t, 2H, 
5
-C5H4), 4.98 (t, 2H, 
5
-
C5H4), 6.97 (d, J = 15.6 Hz, 1H, CH═CH), 7.53 (d, J = 15.2 Hz, 1H, CH═CH), 7.59-7.93 
(m, 5H, C6H5), 10.72 (s, 1H, NH).  MS (ESI): m/z 585 [M+H]. 
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18: Anal. calcd. (found): C, 64.03 (64.27); H, 4.70 (4.82); N, 4.67 (4.57).  IR(CO, cm
-1 
, 
CH2Cl2): 3052 (br), 1663 (s), 1647 (vs), 1603 (m), 1585(s).  
1
H NMR (, CDCl3): 2.2 (s, 
3H, CH3), 4.15 (s, 5H, 
5
-C5H5), 4.36 (t, 2H, 
5
-C5H4), 4.45 (t, 2H, 
5
-C5H4), 4.48 (t, 2H, 
5-C5H4), 4.59 (t, 2H, 
5
-C5H4), 4.86 (t, 2H, 
5
-C5H4), 4.96 (t, 2H, 
5
-C5H4), 6.69 (d, J = 
15 Hz, 1H, CH═CH), 6.89-7.45 (m, 4H, C6H4), 7.65 (d, J = 15 Hz, 1H, CH═CH), 12.03 
(s, 1H, OH).  MS (ESI): m/z 601 [M+H]. 
 
19: Anal. calcd. (found): C, 63.62 (63.79); H, 4.65 (4.57); N, 7.18 (7.26).  IR(CO, cm
-1
, 
CH2Cl2): 1666 (s), 1647 (vs), 1588(s, br), 1576(s).  
1
H NMR (, d6-DMSO): 2.24 (s, 3H, 
CH3), 4.18 (s, 5H, 
5
-C5H5), 4.42 (t, 2H, 
5
-C5H4), 4.46 (t, 2H, 
5
-C5H4), 4.72 (t, 2H, 
5
-
C5H4), 4.73 (t, 2H, 
5
-C5H4), 4.78 (t, 2H, 
5
-C5H4), 4.97 (t, 2H, 
5
-C5H4), 6.95 (d, J = 15 
Hz, 1H, CH═CH), 7.53 (d, J = 15 Hz, 1H, CH═CH), 7.80 (m, 2H, C5H4N), 8.78 (m, 2H, 
C5H4N), 10.98 (s, 1H, NH).  MS (ESI): m/z 586 [M+H]. 
 
20:  IR(CO, cm
-1
, CH2Cl2): 1667 (s), 1650 (vs), 1588(s, br), 1575(s).  
1
H NMR (, d6-
DMSO): 2.26 (s, 3H, CH3), 4.18 (s, 5H, 
5
-C5H5), 4.42 (t, 2H, 
5
-C5H4), 4.46 (t, 2H, 
5
-
C5H4), 4.69 (t, 2H, 
5
-C5H4), 4.72 (t, 2H, 
5
-C5H4), 4.79 (t, 2H, 
5
-C5H4), 4.98 (t, 2H, 
5
-
C5H4), 6.96 (d, J = 15 Hz, 1H, CH═CH), 7.53 (d, J = 15 Hz, 1H, CH═CH), 7.56 (m, 1H, 
C5H4N), 8.23 (m, 1H, C5H4N), 8.78 (m, 1H, C5H4N), 9.07 (m, 1H, C5H4N), 10.90 (s, 1H, 
NH).  MS (ESI): m/z 585 [M]. 
 
5.2.3. Crystal structure determination for 18 and 19 
Single crystal X-ray structural studies of 18 and 19 were performed on a CCD 
Oxford Diffraction XCALIBUR-S diffractometer equipped with an Oxford Instruments 
low-temperature attachment.  Data were collected at 150(2) K using graphite-
monochromated Mo Kα radiation (λα = 0.71073 Å).  The strategy for the data collection 
was evaluated by using the CrysAlisPro CCD software.  The data were collected by the 
standard phi-omega scan techniques, and were scaled and reduced using CrysAlisPro 
RED software.  The structures were solved by direct methods using SHELXS-97 and 
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refined by full matrix least-squares with SHELXL-97, refining on F
2
 [22].  The positions 
of all the atoms were obtained by direct methods.  All non-hydrogen atoms were refined 
anisotropically.  The remaining hydrogen atoms were placed in geometrically constrained 
positions and refined with isotropic temperature factors, generally 1.2Ueq of their parent 
atoms.  The crystallographic details are summarized in Table 5.1.  (CCDC Numbers, 18: 
1476350, 19: 1476349) 
Table 5.1. Crystal data and structure refinement parameters for compounds 18 and 19. 
         18         19 
Empirical 
formula 
C32 H28 Fe2 N2 O3 C31 H27 Fe2 N3 O2 
Formula weight 600.27 585.26 
Crystal system Orthorhombic Orthorhombic 
Space group P 21 21 21 P 21 21 21 
a, Å 10.7753(7) 10.4527(8) 
b, Å 10.8504(8) 22.8217(13) 
c, Å  22.4237(15) 10.6484(7) 
 deg 90 90 
 deg 90 90 
 deg 90 90 
V, Å
3
 2621.7(3) 2540.2(3) 
Z 4 4 
Dcalcd, Mg m
-3
 1.523 1.530 
abs coeff, mm
-1
 1.145 1.177 
F(000) 1244 1208 
Cryst size, mm 0.33 x 0.26 x 0.21 0.33 x 0.26 x 0.21 
 range, deg 3.23 to 25.00 deg. 3.26 to 25.00 
index ranges -12  h  12, -12  k  12, 
-26  l  26 
-12  h  12, -23  k  27, 
-12  l  10 
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reflections 
collected/ unique 
20041 / 4615 [R(int) = 
0.1010] 
19106 / 4456 [R(int) = 
0.1157] 
data/ restraints / 
parameters 
4615 / 0 / 358 4456 / 0 / 345 
goodness-of-fit 
on F
2
 
1.076 0.930 
Final R indices 
[I>2(I)] 
R1 = 0.0648, wR2 = 
0.1493 
R1 = 0.0543, wR2 = 
0.1127 
R indices (all 
data) 
R1 = 0.0879, wR2 = 
0.1651 
R1 = 0.0861, wR2 = 
0.1345 
largest diff peak  1.110 0.542 
and hole, eÅ
-3
 -0.409 -0.467 
 
5.2.4. Antibacterial activity 
Compounds 17 - 20 were screened for their antibacterial activity in vitro 
following the protocol described elsewhere [23].  The antibacterial effect was assayed 
against both Gram positive bacteria Bacillus subtilis and Gram negative bacteria 
Escherichia coli and Pseudomonas aeruginosa by the agar well diffusion method [23].  
The compounds were dissolved in DMSO at different concentrations ranging from 250 to 
7.8125 g/ml.  Mueller Hinton-agar (containing 1% peptone, 0.6% yeast extract, 0.5% 
beef extract and 0.5% NaCl, at pH 6.9–7.1) plates were prepared and 0.5 – McFarland 
culture (1.5 X 10
8
 cells/ml) of the test organisms were swabbed onto the agar plate.  9mm 
wells were made in the LB agar petri dishes.  100µl of each of the compound with 
decreasing concentrations was added to separate wells.  DMSO was used as the negative 
control and Chloramphenicol was used as positive control.  The plates were incubated at 
37°C and observed for zones of inhibition around each well after 24 hours.  The results 
were compared with the activity of Chloramphenicol at identical concentrations.  The 
MIC, defined as the lowest concentration of the test compound, which inhibits the visible 
growth, was determined visually after incubation for 24 h at 37ºC. 
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5.2.5. BSA binding experiment 
BSA protein binding study was performed by tryptophan fluorescence quenching 
experiments using a BSA stock solution of 0.01M phosphate buffer of pH 7.2.  The 
fluorescence titrations were performed at the fixed BSA concentration (5 x10
-5
 M).  In 
the fluorescence quenching experiment, quenching of the tryptophan residues of BSA 
was done by keeping the concentration of the BSA constant while increasing the 
compound (quencher) concentration from 0 to 50 M.  The fluorescence spectra were 
recorded at an excitation wavelength of 290 nm and an emission wavelength of 334 nm 
after each addition of the compound.  The excitation and emission slit widths and scan 
rates were maintained constant for all of the experiments.   
 
5.2.6. Computational details 
Geometry optimization of compounds 18 and 19 and their staggered conformers 
were carried out by using density functional theory (DFT) at B3LYP level of theory using 
6-31G (d,p) (for C, N, H and O) and SDD (for Fe) basis sets.[24,25]  In addition to 
optimization, frequency calculation, Time-Dependent Density functional Theory (TD-
DFT) calculations were done at the same level of calculation and using the same basis 
sets.  The absence of imaginary vibrational frequencies in calculated vibrational spectrum 
ensures the presence of a true minimum in the potential energy surface.  The 
spectroscopic and electronic property of these complexes has been computed by time 
dependent DFT (TD-DFT) calculation [26] at the same B3LYP level in gaseous phase.  
The nature and the role of the electronic excitation contributions are rationalized in terms 
of frontier molecular orbitals (FMO).   
 
5.3. Results and Discussion 
Our interest to synthesize multi-ferrocenyl system with diverse functionalization 
directed us to exploit compounds 5-8 for further reaction at the pendant acetyl group 
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attached to the ferrocenyl unit.  As per strategy, compounds 5-8 was condensed with 
ferrocenyl carboxyaldehyde at room temperature in presence of sodium hydroxide to 
obtain a violet colored compound 1,1’-[(5-C5H5)Fe(
5
-C5H4)CH═CHC(O)(
5
-
C5H4)Fe{(
5
-C5H4)C(CH3)═N-N(H)C(O)-R}] {R = C6H5 (17), C6H4-OH (18), C6H4N-p 
(19), C6H4N-m (20)}.  Compounds 17-20 was isolated and purified by preparative TLC 
using n-hexane-ethanol solvent mixture and characterized using IR, NMR and mass 
spectral analysis.  The infrared spectral data for 17 and 18 show bands corresponding to 
ketonic and C=N units at 1671, 1663, 1650, 1647, 1603 and 1602 cm
-1
 region.  
1
H NMR 
spectra reveals the presence of CH3 protons at  2.2 and unsubstituted ferrocenyl Cp 
peaks have been observed at 4.18 and 4.15 region, while peaks at 4.36 – 4.98 
confirm the presence of protons attached to the substituted ferrocenyl Cp rings.  Phenyl 
and olefinic protons have been observed at 6.89 - 7.93 (multiplet) and 6.69 - 7.65 
(doublets) regions respectively.  A broad peak at 12.03 shows the presence of OH 
proton in 18 and a peak at 10.72 in compound 17 has been attributed to NH proton.  Mass 
spectral analysis showed [M+1]
+
 peak at 585 and 601 region for 19 and 18 respectively. 
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Compounds 19 and 20 also showed IR bands at 1666 (s), 1667 (s), 1647 (vs), 1650 (vs) 
and 1580 (vs, br) region due to C=O, C=C and C=N functionalities.  
1
H NMR for each of 
the compounds show the presence of a singlet (equivalent to 5H) at 4.18 due to 
unsubstituted Cp protons and six triplets at 4.42-4.98 due to the presence of substituted 
Cp protons, while methyl peak has been observed at 2.24 and 2.26 region.  Pyridine 
ring protons have been observed as multiplet in the region 7.56 - 9.07 and doublets at 
6.95 and 7.53 reveals the presence of olefinic protons.  NH protons have been 
observed at 10.98 and 10.90 positions for compounds 19 and 20 respectively.  Mass 
spectrometric data for compounds 19 and 20 reveals the presence of [M+H] and [M] peak 
respectively.  
 
5.3.1. Molecular structure of 18 and 19  
Single crystal X-ray diffraction studies have been carried out for 18 and 19 with 
good quality single crystals, grown from dichloromethane / n-hexane solvent mixture at   
-10 ºC using diffusion technique.  The molecular structure of 18 shows the presence of 
two ferrocenyl units linked together via enone type bridge as shown in Figure 5.4.  The 
central ferrocenyl fragment is attached to both hydrazone and enone chain, while the 
terminal ferrocenyl moiety is mono-substituted and connected to the bridged enone chain.  
The hydrazone and the enone chains have been oriented in the same direction of the 
central ferrocene moiety, forming an eclipsed geometry with a dihedral angle of 8.6º.  
The structure also showed that the two ferrocenyl moieties are oriented opposite to each 
other revealing a trans geometry.  Single crystal X-ray diffraction study of 19 also 
showed similar structural identity with two ferrocenyl moieties attached to hydrazone and 
enone chains (Figure 5.5).  The structure of 19 also revealed eclipsed conformation with a 
dihedral angle of 8.3º.  The C═N bond distance between C(14) and N(1) in compounds 
18 and 19 show double bond character (1.281(8) Å (18), 1.299(7) Å (19)), but the 
distance is slightly longer in 19 as compared to that in 18 and some of the previously 
analyzed ferrocenyl hydrazone compounds, [(5-C5H5)Fe{(
5
-C5H4)C(H) 
═NN(H)C(O)C6H4OH}] (1.284(3) Å), [(
5
-C5H5)Fe{(
5
-C5H4)C(H)═NN(H)C(O)C6H5}] 
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(1.277(4) Å), [(5-C5H5)Fe{(
5
-C5H4)C(H) ═NN(H)C(O)C6H4N}] (1.291(4) Å).[16, 27]  
The hydrazone chain in 19 is endcapped with a pyridine ring, while compound 18 shows 
the presence of a o-hydroxyphenyl group at the end position of the hydrazone linkage.   
 
 
Figure 5.4. ORTEP diagram of 18.  Selected bond lengths (Å) and bond angles (º): C(12)-
C(13)= 1.324(9), N(1)-N(2) = 1.378(7), N(1)-C(14) = 1.281(8), O(1)-C(11) = 1.231(8), 
O(3)-C(18) = 1.362(8), N(1)-N(2)-C(16) = 118.7(5), N(1)-C(14)-C(15) = 123.8(6), 
C(13)-C(12)-C(11) = 123.5(7), O(3)-C918) –(C17) = 118.2(6). 
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Figure 5.5. ORTEP diagram of 19.  Selected bond lengths (Å) and bond angles (º): C(14)-
N(1) = 1.299(7), N(1)-N(2) = 1.395(6), C(16)-O(1) = 1.210(6), C(12)-C(13) = 1.334(7), 
O(2)-C(11) = 1.224(6), C(14)-N(1)-N(2) = 116.6(5), C(13)-C(12)-C(11) = 122.0(5), 
C(1)-C(11)-C(12) = 116.2(5), C(6)-C(14)-C(15) = 118.4(5). 
 
Figure 5.6. Intra- and inter-molecular hydrogen bonding Interaction of 18 
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The strctural analysis of 18 also shows the presence of both intra- and inter-molecular 
hydrogen bonding between N2-H∙∙∙O3 (1.929 Å) and O3-H∙∙∙O2 (1.468 Å) respectively 
which creates a zigzag array of alternate molecular units as shown in Figure 5.6, while 
compound 19 does not show any hydrogen bonding interaction.  
 
5.3.2. Redox properties of 17-20 
Compounds 17-20 exhibited two reversible redox processes involving Fe(II) / 
Fe(III) couple due to the presence of two ferrocenyl moieties.  The first redox couple at 
E1/2 in the range 0.42 - 0.44 V is due to the terminal ferrocenyl unit (Fc
T
) while the 
second couple at 0.67 - 0.7 has been due to the disubstituted central ferrocenyl moiety 
(Fc
C
).  Presence of both hydrazone and enone chains attached to the central ferrocenyl 
unit makes the Fe(II) more difficult to oxidize, thereby showing Fe(II)/Fe(III) redox 
couple at much higher potential range compared to the monosubstituted terminal 
ferrocenyl fragment.  The one-electron nature of these oxidations has been established by 
comparing its current height with that of the standard ferrocene/ferrocenium couple under 
the same experimental conditions.  The structural features in compounds 17-20 with two 
ferrocenyl species linked together by enone chain has been anticipated to show coupling 
behavior between the two redox active units.  To understand any such electronic 
communication between the two ferrocenyl units, we carried out cyclic voltammetry and 
differential pulse voltammetry with the phenyl analog of 17, (21) which contains one 
central ferrocenyl unit linked via Cp to a benzoyl hydrazone moiety and an enone chain, 
–C(O)C═CPh attached to the other Cp ring.  Surprisingly, compound 21 showed one 
reversible redox couple at reasonably lower potential (0.66V) as compared to the 
potential for central ferrocenyl moiety in compounds 5 (0.69V) and 17 (0.71V) as shown 
in Table 5.2 and Figure 5.8.  Analyses of the oxidative potential due to the central 
ferrocenyl unit in compounds 5, 17 and 21 revealed that, during the oxidative scan of 17, 
the terminal ferrocene (Fc
T
) gets oxidized first showing the redox couple at 0.436 V 
(E
I
1/2) region (Figure 5.7(II)).  The oxidized terminal ferrocene in II can now act as an 
electron withdrawing center and therefore, relatively more electrons get withdrawn from 
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the central ferrocene (Fc
C
) via the enone chain.  This higher electron withdrawing 
character results in the oxidation of central ferrocene at much higher potential range 
(E
II
1/2=0.71 V) as compared to that for the phenyl analog (E1/2 = 0.66 V).  The above 
potential shift of 50 mV reveals that the two ferrocenes are no more independent to each 
other and shows considerable amount of electronic communication between the two 
electroactive groups.  Apparently, the formation of species II due to the oxidation of 
terminal ferrocenyl group results in the formation of a source (Fc
C
) and a sink (Fc
T
) of 
electrons and probability of electron flow from Fc
C
 to Fc
T
 cannot be ignored Figure 5.7.  
However, the possibility to regulate the flow of electrons by varying the hydrazone end 
group and tuning the electron density at the central ferrocenyl moiety is under 
investigation.   
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C
]-X-[Fc
T
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+
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Figure 5.7 
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Figure 5.8. Cyclic voltammograms () and differential pulse voltammograms (…) of 
compounds 17, 5 and 21 in Acetonitrile / 0.1 M TBAP at 298 K.  Ferrocene / 
Ferrocenium was used as standard. 
 
Table 5.2. Cyclic voltammetric data for 5-8 and 17-21  
Compounds Epa Epc dpv (V) E1/2 (V) (ΔEp (mV)) 
5 0.717 0.657 0.66 0.69 (60) 
6 0.69 0.633 0.634 0.66 (57) 
7 0.708 0.643 0.653 0.676 (65) 
8 0.70 0.638 0.645 0.67 (62) 
17 0.467, 
0.742 
0.405, 
0.68 
0.428, 0.7 0.436(62), 0.71(62) 
178 
 
18 0.45, 0.715 0.39, 0.67 0.395, 0.67 0.42(60), 0.69(45) 
19 0.47, 0.735  0.413, 
0.68 
0.423, 0.68 0.442(57), 0.71(55) 
20 0.46, 0.72 0.42, 
0.686 
0.413, 0.68 0.44(40), 0.703(34) 
21 0.680 0.633 0.629 0.66 (47) 
Fc(COMe)2 0.83 0.77 0.78 0.8(60) 
Fc 0.37 0.286 0.315 0.33(84) 
 
*In acetonitrile at a scan rate of 50 mv s
-1
.   E1/2 (V) = (Epa+Epc)/2, where Epa and Epc are 
the anodic and cathodic peak potentials Vs. Ag/AgCl respectively.  ΔEp (mV) = Epa-Epc 
 
5.3.3. Antibacterial activity of 17-20 
Antibacterial study was carried out for compounds 17-20 which showed potential 
inhibition activity against the bacterial strains as shown in Table 5.3.  Compound 18 and 
19 showed highest antibacterial activity against E. coli and P. aruginosa bacterial strain 
respectively, while MIC values for other compounds and against different bacterial 
strains shows marked inhibition activity, as compared to Chloramphenicol.  Recently 
reported antibacterial study on ferrocene containing compounds showed promising 
results against different types of bacterial strains,[14-16] whereas inhibition activities of 
diferrocenyl system with bifunctional chains have been rarely studied.  Significant 
antibacterial activity for the reported organometallic compound could possibly be due to 
the presence of ferrocenyl and hydrazone-enone moieties that are playing a crucial role to 
increase the cell permeability and lipophilicity of the compounds.  Increased electron 
delocalization and blocking of metal binding sites of the enzyme of microorganism are 
some of the factors that may also result in better inhibition activity.   
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Table 5.3. Minimum inhibitory concentration (MIC) value in g/ml 
Compounds B. subtilis E. coli P. aeruginosa 
17 15.6 15.6 15.6 
18 N 7.8 15.6 
19 N 15.6 7.8 
20 62.5 15.6 15.6 
Chloramphenicol 4 4 31.25 
 
N – Inhibitory activity not observed 
 
5.3.4. BSA Protein binding studies 
 Bovine serum albumins (BSA) are the most widely studied proteins due to their 
ability to transport a variety of endogenous and exogenous moieties such as steroids, drug 
molecules, metabollites etc.  BSA increases the solubility of drugs in plasma and 
modulates their delivery to cells and is usually selected for protein binding studies.[28]  It 
is sometimes very important to study the interaction of a bioactive compound with 
proteins, to gain fundamental insights of the binding mechanism and to understand the 
metabolism and transporting process of a drug compound.  Therefore, to understand the 
protein binding activities of the diferrocenyl compounds 18 and 19, BSA was used to 
study the tryptophan emission-quenching experiment.[29]  Generally, the fluorescence of 
BSA is caused by three intrinsic characteristics of the protein, namely tryptophan, 
tyrosine and phenylalanine.  The majority of the intrinsic fluorescence of BSA is 
provided by the two tryptophan residues, (Trp 134, Trp 213) while the other amino acid 
residues contribute weakly.  The fluorescence from the indole group in tryptophan is 
extremely sensitive to its surrounding environment and has been extensively used as a 
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spectroscopic probe for the structural and conformational changes in the protein.  
Variation in the molecular environment in the vicinity of a fluorophore can be assessed 
by the changes in fluorescence spectra in the presence of a quencher which provide clues 
for the understanding of the binding phenomenon.[30]  In the present study, the 
interaction of BSA with compounds 18 and 19 was studied by fluorescence spectroscopy 
measurement at room temperature.  A fixed solution of BSA (1 μM) was titrated with 
various concentrations of the compound (0−50 μM) and the fluorescence spectra were 
recorded in the range of 300− 450 nm upon excitation at 290 nm.  The effects of the 
compound on the fluorescence emission spectrum of BSA are shown in Figure 5.9.  As 
can be seen from the figure, the fluorescence emission intensities of BSA at 330 nm show 
remarkable decreasing trends with increasing concentration of the ferrocenyl compounds 
18 and 19.  The data indicates that the interaction of the two compounds with BSA could 
cause conformational changes in protein structure, leading to changes in the tryptophan 
environment of BSA.  This result suggested a definite interaction of the compound with 
the BSA protein. 
 Fluorescence quenching data were analyzed with the Stern−Volmer equation and 
Scatchard equation using corrected fluorescence data taking into account the effect of 
dilution.  The Stern-Volmer quenching constant (Ksv) of the compounds have been 
calculated using the plot of F0/F versus [Q], concentration, where F0 and F are the 
emission intensity of BSA in the absence and in the presence of the quencher (eqn. 1).  
The Ksv value obtained as a slope from the plot of F0/F versus [Q] was found to be 1.9 x 
10
5
 M
-1
 and 1.8 x 10
5
 M
-1
 for compound 18 and 19 respectively (Figure 5.9).   
 
  F0/F = 1  +  Ksv [Q]     (1) 
 
 Proteins may interact with molecules using Van der Waals, electrostatic, 
hydrophobic and hydrogen bonding interactions.  The observed quenching of 
fluorescence indicates some binding interactions between the compound and suitable 
sites in the proteins.  Binding of small molecules to a set of equivalent sites on a 
macromolecule can be understood by the Scatchard equation (eqn. 2).[31]  The binding 
constant and the number of binding sites (n) were obtained from the plot of log[(F0-F)/F] 
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vs. log [Q] and the values are shown in Table 5.4.  The value of n is approximately equal 
to 1, indicating the presence of one binding site in BSA and follows 1:1 stoichiometric 
interaction between the compound and BSA protein.[32]  
 
log[(F0-F)/F] = log Kb  +  n log[Q]    (2) 
 
 
 
 
 
  (a)                   (b) 
 
Figure 5.9. Fluorescence spectra of BSA (1M) in the presence of increasing 
concentration of (a) 18 and (b) 19.  The inset shows the linear fit of F0/F vs. [Q]. 
 
Table 5.4   
Compounds Quenching constant, 
Ksv (M
-1
) 
Binding Constant,      
Kb (M
-1
) 
No. of binding sites,      
n 
18 1.9 x 10
5
 4.36 x 10
5
 1.04 
19 1.8 x 10
5
 5.53 x 10
6
 1.23 
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5.3.5. Metal ion interaction study by UV–Visible spectroscopy  
The unique structural identity with an eclipsed configuration for the diferrocenyl 
system (18, 19) prompted us to study metal ion interaction properties by UV-Visible 
spectroscopy.  Single crystal structure and DFT calculation showed that the compounds 
18 and 19 are energetically favorable with the eclipsed conformation, in which the 
hydrazone and enone chains are almost parallel to each other.  We, therefore, anticipated 
the possibility of host-guest type of interaction where the guest molecule/ ion may get 
trapped in-between the two eclipsed chains.  The guest ion matching the size and the 
electronic factors of the cavity may eventually show selective binding with the receptor 
molecule.  To establish the receptor property of these diferrocenyl hydrazone-enone type 
of compounds, we carried out metal ion interaction study using UV-Visible spectroscopy.  
To our knowledge metal ion interaction study with unsymmetrically difunctionalized 
diferrocenyl compounds have been rarely carried out.  In most cases metal ion interaction 
has been studied with receptors having mono substituted ferrocenyl and symmetrically 
disubstituted ferrocenyl fragments,[33-35] while the unsymmetrically difunctionalized 
ferrocenyl systems have been comparatively less focused.[8]  The UV–Visible binding 
interaction studies of receptors 18 and 19 in ethanol (10
-5
 M) against cations such as of 
Na
+
, K
+
, Mg
2+
, Ba
2+
, Mn
2+
, Fe
2+
, Co
2+
, Ni
2+
 Cu
2+
, Zn
2+
, Cd
2+
, Hg
2+
 and Pb
2+
 as 
perchlorate salts have been carried out.  Gradual addition of Pb
2+
 showed marked shift in 
the UV–Visible absorbance spectra of both the receptors in ethanol solvent while minor 
changes have been observed when titration was carried out with copper salt.  All other 
metal ions showed no distinguishable shift in the spectrum during their respective 
titrations.  Addition of upto five equivalents of Pb
2+
 ions to compound 18 result in 
gradual formation of a new peak at around 236 nm, while the intensity of peak at 212 nm 
decreases and the peak at 312 nm gradually red shifted to 334 nm.  Red shift has also 
been observed for peak at 508 nm to 526 nm as shown in Figure 5.10(a).  Similar, 
changes in the absorption spectrum have been observed when Pb
2+
 salt was gradually 
added to compound 19 as shown in Figure 5.10(b).  Binding assays using the method of 
continuous variations (Job’s plot) suggest 1:1 (cation/receptor) interaction with Pb2+ ion 
for both the compounds 18 and 19.  Three well-defined isosbestic points at 267, 327 and 
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469 nm for 18 and 258, 322 and 484 for 19 have been observed revealing a distinct cation 
–receptor interaction.  The addition of increasing amount of Cu2+ ions to a solution of 18 
and 19 showed a slight increase in a low intensity shoulder peaks at 383 nm and 408 nm.  
However, no definite isosbestic point was observed in the UV-Visible absorption 
spectrum in case of Cu
2+
 titration.   
 
 
 
           (a)               (b) 
Figure 5.10. UV-Vis absorbance spectra of  (a) 18 (10
-5
 M) and (b) 19 (10
-5
 M) upon 
gradual addition of Pb
2+
 ion  
The shift of around 20 nm in the spectral bands for both the receptor molecules 18 
and 19 due to the addition of Pb
2+
 may be due to some metal interaction or metal-ligand 
ligation.  To understand Pb
2+
-receptor interaction extensively we carried out DFT study 
with the optimized [19-Pb
2+
] complex.  The optimized geometry, as shown in Figure 
5.11, presents an idea of the interaction of Pb
2+
 with the ketonic oxygen, imine nitrogen 
and the Cp of the receptor molecule.   The distance between Pb
2+
 and ketonic oxygen of 
2.28 Å is within the bonding range while the Pb
2+
- N (imine nitrogen) and Pb
2+
- Cp 
(terminal Fc) are 2.52 Å and 2.84 Å respectively.  Selective interaction of the 
diferrocenyl hydrazone-enone molecules towards lead cation have revealed their potential 
as receptor molecules and can be further used to expand their ability in various host-guest 
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recognition processes.  We are presently undergoing extensive study on some of the host 
–guest interaction processes to establish their application as a sensor system. 
 
Figure 5.11. Optimized geometry of [19-Pb
2+
] complex 
 
5.3.6. DFT Studies 
 DFT calculation was carried out with fully optimized geometry of compounds 18 
and 19 for eclipsed and staggered conformation.  Initial geometry of 18 and 19 for the 
eclipsed conformation was taken from single crystal X-ray analysis data.  Figure 5.12 
depicts the DFT optimized structure of eclipsed and staggered geometry respectively.  
Time-Dependent Density functional Theory (TD-DFT) calculations was performed to 
understand the electronic transitions involved and the relative energies of the highest 
occupied (HOMO), HOMO-1, HOMO-2 and lowest unoccupied molecular orbitals 
(LUMO).  Corresponding absorption bands for the complex in the ground state, oscillator 
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strengths, energies and the involvement of MO in major transitions occurring at a 
particular wavelength has been calculated.  DFT calculated results showed that the 
eclipsed conformation of compound 19 is 0.09 eV more stable than that of the staggered 
conformation, while the eclipsed conformer of 18 is 1.46 eV more stable than the 
staggered conformation.  This reveals that in both the compounds eclipsed conformation 
is energetically more stable than the staggered conformation.  However, in compound 18 
the energy difference between the two conformers is so high that the presence of 
staggered geometry in solution may also be ruled out.   
 
 
 
 
 
 
 
 
 
 
Figure 5.12. Relative energies and the optimized geometry of compound 18 and 19 
 
 Molecular orbital calculation reveals that the HOMO of 19 is metal based and 
mostly localized on terminal ferrocenyl moiety, while the LUMO is ligand based and has 
an antibonding character.  In comparison, compound 18 has HOMO localized on central 
ferrocenyl moiety and partly on hydrazone chain and a ligand based antibonding LUMO.  
HOMO-1 for both the molecules has been localized at the terminal ferrocenyl fragment, 
while HOMO-2 for compound 19 is central ferrocenyl based and that of 18 is localized 
on terminal ferrocenyl fragment (Figure 5.13).   
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Figure 5.13. Selected Frontier Molecular orbital of 18 and 19. 
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 In order to understand the reactivity pattern and the relative charge distribution in 
the molecule, we have computed a popular conceptual density functional theory based 
reactivity descriptors, dual descriptors, which describe the nucleophilic and electrophilic 
centers inside the molecule.  The electron density mapping reveals that compound 19 has 
electron deficient center on central ferrocenyl iron, while the terminal ferrocenyl metal 
has an electron rich center.  Compound 18, on the other hand, shows the opposite 
behavior in which the terminal ferrocenyl moiety is relatively more electron deficient 
than the central ferrocenyl and imine group.  The different electronic behavior can be 
partly explained due to the presence of an electron donating end group (O-
hydroxyphenyl) in compound 18 and an electron withdrawing pyridyl group in 19.  This 
also supports the probability of electronic communication between the two ferrocenyl 
fragments.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.14. Electron density mapping for Compound 18 and 19  
(Red: Electron deficient centers; Blue: Electron rich) 
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 In summary, we have synthesized four analogs of unsymmetrically substituted 
hydrazone – enone diferrocenyl system capable of selectively interact with Pb2+ metal ion 
and shows potential BSA protein binding property.  Structural characterizations of the 
two diferrocenyl hydrazone-enone compounds, 18 and 19 confirm the presence of more 
stable eclipsed conformation.  Selective interaction towards lead cation has revealed their 
potential as receptor molecules which can be further extended to study various host-guest 
recognition processes.  We are presently undergoing extensive study to establish their 
application as sensor molecules in biological system.  Some of the compounds also 
showed excellent antibacterial activity.  However, study may be focused to understand 
the inhibition mechanism and establish the structure –activity relationship on similar 
compounds with varied heterocyclic fragments.  The redox properties for the diferrocenyl 
compounds with variable end group reveals distinct electronic communication between 
the two electroactive groups via the enone chain.   
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[13] J. M. Speck, M. Korb, T. Rüffer, A. Hildebrandt, H. Lang, Organometallics 33 
(2014) 4813. 
[14] (a) M. Patra, G. Gasser, Chembiochem. 13 (2012) 1232; (b) G. Gasser, N. Metzler-
Nolte, Curr. Opin. Chem. Biol. 16 (2012) 84. (c) D. R. V. Staveren, N. Metzler-Nolte, 
Chem. Rev. 104 (2004) 5931; (d) E. Meggers, G. E. A. Gokcumen, H. Bregman, J. 
Maksimoska, S. P. Mulcahy, N. Pagano, D. S. Williams, Synlett (2007) 1177; (e) C. 
Policar, J. B. Waern, M.-A. Plamont, S. Clède, C. Mayet, R. Prazeres, J.-M. Ortega, A 
Vessières, A. Dazzi, Angew. Chem. Int. Ed. 50 (2011) 860; (f) C. G. Hartinger, N. 
Metzler-Nolte, P. J. Dyson, Organometallics 31 (2012) 5677; (g) C. G. Hartinger, P. J. 
Dyson, Chem. Soc. Rev. 38 (2009) 391; (h) R. H. Fish, G. Jaouen, Organometallics 22 
(2003) 2166.  
[15] (a) S. Top, A. Vessières, C. Cabestaing, I. Laios, G. Leclercq, C. Provot, G. Jaouen, 
J. Organomet. Chem. 637–639 (2001) 500. (b) A. Nguyen, A. Vessières, E. A. Hillard, S. 
Top, P. Pigeon, G. Jaouen, Chimia 61 (2007) 716. (c) E. A. Hillard, P. Pigeon, A. 
Vessieres, C. Amatore, G. Jaouen, Dalton Trans. (2007) 5073. (d) E. A. Hillard, A. 
Vessières, L. Thouin, G. Jaouen, C. Amatore, Angew. Chem. Int. Ed. 45 (2006) 285. 
[16] (a) V. Tirkey, S. Mishra, H. R. Dash, S. Das, B. P. Nayak, S. M. Mobin, S. 
Chatterjee, J Organomet. Chem. 732 (2013) 122; (b) S. K. Patel, V. Tirkey, S. Mishra, H. 
R. Dash, S. Das, M. Shukla, S. Saha, S. M. Mobin, S. Chatterjee, J. Organomet. Chem. 
749 (2013) 75; (c) S. Mishra, V. Tirkey, A. Ghosh, H. R. Dash, S. Das, M. Shukla, S. 
Saha, S. M. Mobin, S. Chatterjee, J. Mol. Structure. 1086 (2015) 162; (d) V. Tirkey, R. 
Boddhula, S. Mishra, S. M. Mobin, S. Chatterjee, J. Organomet. Chem. 794 (2015) 88. 
[17] (a) G. Nabi, Z. Q. Liu, Med. Chem. Res. 21 (2012) 3015; (b) K. Kumar, S. C. 
Kremer, L Kremer, Y. Guérardel, C. Biot, V. Kumar, Organometallics 32 (2013) 5713; 
(c) S. Attar, Z. O. Brien, H. Alhadad, M. L. Golden, A. C. A. Urrea, Bioorg. Med. Chem. 
19 (2011) 2055; (d) W. Y. Liu, Y.-S. Xie, B.-X. Zhao, B.-S. Wang, H.-S. Lv, Z.-L. Gong, 
S. Lian, L.-W. Zheng, J. Photochem. Photobio A: Chem. 214 (2010) 135; (e) S. J. Won, 
C. T. Liu, L. T. Tsao, J. R. Weng, H. H. Ko, J. P. Wang, C. N. Lin, Eur. J. Med. Chem. 
40 (2005) 103; (f) S. Vogel, S. Ohmayer, G. Brunner, Heilmann, J. Bioorg. Med. Chem. 
191 
 
16 (2008) 4286; (g) C.-T. Hsieh, T.-J. Hsieh, M. E. Shazly, D.-W. Chuang, Y.-H. Tsai, 
C.-T. Yen, S.-F. Wu, Y.-C. Wu, F.-R. Chang, Bioorg. Med. Chem. Lett. 22 (2012) 3912. 
[18] (a) M. V. Angelusiu, S. F. Barbuceanu, C. Draghici, G. L. Almajan, Eur. J. Med. 
Chem. 45 (2010) 2055; (b) P. Barbazán, R. Carballo, U. Abram, G. P. Gabián, E. M. V. 
López, Polyhedron 25 (2006) 3343; (c) P. Barbazán, R. Carballo, I. Prieto, M. Turnes, E. 
M. V. López, J. Organomet. Chem. 694 (2009) 3102; (d) Á. Gyömöre, A. Csámpai, J. 
Organomet. Chem. 696 (2011) 1626. 
[19] U. T. Mueller-Westerhoff, Z. Yang, G. Ingram, J. Organomet. Chem. 463 (1993) 
163. 
[20] M. Vogel, M. Rausch, H. Rosenberg, J. Org. Chem. 22 (1957) 1016. 
[21] (a) N. S. Navaneetham, R. Kalyanasundaram, S. Soundararajan, Inorg. Chim. Acta 
110 (1985) 169; (b) H. Meyer, J. Mally, Monatshefte fuer Chemie 33 (1912) 393.  
[22] G. M. Sheldrick, Acta Cryst. A 64 (2008) 112.  
[23] Clinical and Laboratory Standards Institute (CLSI, 2006). Methods for Dilution 
Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, Seventh ed. 2006 
Approved Standard M7-A7, CLSI, Wayne, PA, USA. 
[24] A. D. Becke, J. Chem. Phys. 98 (1993) 5648. 
[25] A. Lee, W. Yang, R. G. Parr, Phys. Rev. B 37 (1988) 785. 
[26] A. Ghosh, I. Halvorsen, H. J. Nilsen, E. Steene, T. Wondimagegn, R. Lie, E. 
Caemelbecke, N. Guo, Z. Ou, K. M. Kadish, Phys. Chem. B 105 (2001) 8120. 
[27] P. Barbazán, R. Carballo, U. Abram, G. P. Gabián, E. M. Vázquez-López, 
Polyhedron 25 (2006) 3343. 
[28] (a) Z. G. Yasseen, J. Chem. Pharm. Res. 4 (2012) 3361. (b) D. S. Raja, N. S. P. 
Bhuvanesh, K. Natarajan, Inorg. Chem. 50 (2011) 12852. (c) T. Banerjee, S. K. Singh, N. 
Kishore, J. Phys. Chem. B 110 (2006) 24147. 
[29] T. T. Xing, S. H. Zhan, Y. T. Li, Z. Y. Wu, C. W. Yan, J. Coord. Chem. 66 (2013) 
3149. 
[30] (a) S. Bi, D. Song, Y. Tian, X. Zhou, Z. Liu, H. Zhang, Spectrochim. Acta, Part A 61 
(2005) 629. (b) J. R. Lakowicz, Principles of Fluorescence Spectroscopy, Springer 
Science, New York, 3rd edn, 2003, p. 63. 
[31] P. Banerjee, S. Ghosh, A. Sarkar, S. C. Bhattacharya, J. Lumin. 131 (2011) 316. 
192 
 
[32] X. L. Han, F. F. Tian, Y. S. Ge, F. L. Jiang, L. Lai, D. W. Li, Q. L. Yu, J. Wang, C. 
Lin, Y. Liu, J. Photochem. Photobiol. B 109 (2012) 1. 
[33] (a) C. Arivazhagan, R. Borthakur, S. Ghosh, Organometallics 34 (2015) 1147; (b) T. 
Romero, R. A. Orenes, A. Tárraga, P. Molina, Organometallics 32 (2013) 5740. 
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Summary 
Research on metal cyclopentadienyl chemistry has continued to develop at a rapid 
pace in the last two – three decades giving rise to structurally unique molecules and novel 
compounds containing sandwich, half sandwich and multidecker sandwich entities.  The 
non ending interest on these organometallic moieties is because of their immense 
potential to various applications related to organic synthesis, catalysis, bioorganometallic, 
advance materials, molecular recognition etc.  In spite of their increasing attention the 
synthesis of substituted ferrocene and derivatization of cyclopentadienyl ring in various 
different metallocenes and half sandwich complexes pose numerous challenges in regard 
to reaction condition, reagents and methodologies.  Therefore, it is essential to optimize 
the strategies based upon facile synthetic methods and suitability of the precursors for the 
functionalization of different Cp based organometallic compounds.  Chapter 1 introduces 
various aspects of cyclopentadienyl based metal complexes with significant reactivity and 
unique structural and electronic properties.  Cyclopentadienyl ligand has the ability to 
stabilize a range of different metal complexes with varying hapticity and results in 
extensive complex chemistry with flexible electronic, structural and steric behavior.  
Ferrocene and its derivatives are the most versatile organometallic compounds because of 
their unique structural integrity, reversible redox properties and exclusive nature of their 
chemistry which make them an excellent building block in several processes for their use 
in the field of material science, molecular wires, catalysis, molecular recognition, 
sensing, electronic communication, bio-conjugates and medicinal chemistry.  We have 
been equally interested to explore the synthesis and reactivity of different sandwich and 
half sandwich complexes and recognize their potential in biological and sensor 
applications.   
In Chapter 2, we describe the synthesis of four new cymantrenyl hydrazone Schiff 
base compounds, [(CO)3Mn{(
5
-C5H4)C(CH3)═NN(H)C(O)-C6H4-OH}] (R = C6H5, 
C6H4-OH, C6H4N-p, C6H4N-m) (1-4) by the room temperature reaction of 
[Mn(CO)3{(
5
-C5H4)COCH3}] with the respective hydrazides and investigate their 
structural and biological properties.  The structural analysis, carried out by X-ray 
crystallography, showed the presence of three legged piano stool cymantrenyl fragment 
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functionalized with a hydrazone chain via the cyclopentadienyl ring.  Recently, Schiff-
base type compounds with organometallic tags are increasingly drawing much interest 
due to their distinctive properties and features concerning both organometallic and 
coordination chemistry.  Some of them have been found to be potential therapeutics 
against major diseases and can play a vital role as tracers in immunological analysis 
based on several analytical methods like FTIR, electrochemical, atomic absorption 
techniques etc.  Antibacterial properties of 1-3 have been studied to understand their 
potential towards inhibition behavior of some bacterial strains.   
Chapter 3 describes the synthesis of unsymmetrically 1,1’-disubstituted ferrocenyl 
compounds containing two different hydrazone units by using simple synthetic 
methodology involving selective reaction of one of the Cp substituent.  Synthetic and 
biological studies on ferrocenyl mono- and di-hydrazone compounds have been known in 
the literature, but 1,1’-unsymmetrically substituted ferrocenyl hydrazone compounds 
have not been explored extensively.  Unsymmetrically 1,1’-disubstituted ferrocenyl 
compounds have been of interest due to their multifunctional properties with unique 
structural features and tunable electrochemical responses.  Our synthesis mainly focuses 
on the reaction of 1,1’-diacetylferrocene with hydrazide to give [{(5-
C5H4)COCH3}Fe{(
5
-C5H4)C(CH3)═NN(H)C(O)R}] (R = C6H5, C6H4-OH, C6H4N-p, 
C6H4N-m) (5-8) in which one of the Cp ring of the ferrocenyl moiety is attached to a 
hydrazone chain while the other Cp ring remains unchanged with an acetyl group.  
Compounds 5-8 was further used as precursor molecule to prepare 1,1’ - unsymmetrically 
disubstituted ferrocenyl compounds containing two different hydrazone units (9).  To our 
knowledge 1,1’-unsymmetrically substituted ferrocenyl mixed hydrazone compounds are 
novel and the synthetic method described here can be used to prepare a varied range of 
ferrocenyl hydrazone compounds containing unsymmetrically Cp substituted side chains.  
We also studied the redox properties for some of the ferrocenyl hydrazones and reported 
their redox potential.   
Recently, a bunch of different ferrocenyl chalcones and their derivatives have 
been synthesized which show marked electrochemical and biological properties.  These 
systems have been investigated as precursors for a variety of ferrocene containing 
heterocycles like pyrazoles, pyrimidines etc.  In Chapter 4, we explore the synthesis and 
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properties of different types of ferrocenyl chalcones involving polynuclear bimetallic 
moieties with multiple redox centers and studied their electrochemical and biological 
properties.  We describe here the synthesis of novel hetero-metallic chalcones containing 
both ferrocenyl and cymantrenyl fragments (11-12) and investigate their reactivity 
features towards triphenylphosphine and bis(diphenylferrocenylphosphine) (13-16).  
Anti-malarial and anti-bacterial properties were studied for two bimetallic chalcones 
which showed their moderate inhibition activity.  Electrochemical analysis revealed their 
multi-responsive properties with multiple redox couple during the cyclic voltammetric 
studies of the bimetallic chalcones.  TD-DFT study was also conducted for ferrocenyl-
cymantrenyl hetero-metallic chalcone (11) to predict the molecular orbitals involved for 
various electronic transitions and electronic delocalization.  Structural characterizations 
for two new ferrocenyl-cymantrenyl chalcones have been carried out which revealed 
unique conformational identity of the compounds.   
Chapter 5 describes the synthesis of a novel diferrocenyl bifunctional molecular 
system containing hydrazone and enone units using simple and systematic synthetic 
route.  Recently, functionalization of ferrocene has attracted the synthetic community to 
obtain a range of ferrocene based molecular systems with unique electronic properties 
and structural variety.  Functionalization in the form of mono-substituted and 1,1’-
symmetrically disubstituted ferrocenyl derivatives are well known and has been 
extensively studied, while, unsymmetrical 1,1’-disubstituted ferrocenyl derivatives are 
comparatively less known.  Anticipating improved multifunctional behavior and redox 
properties we synthesized four analogs of the diferrocenyl hydrazone-enone derivatives 
(17-20) with different aromatic end groups by systematic reaction process and describe 
their eclipsed structural identity using single crystal X-ray diffraction study.  The 
antibacterial and BSA binding properties of the diferrocenyl derivatives showed 
reasonable activity and protein binding interaction, while the cyclic-voltammetric study 
confirmed the electronic communication behavior between the electroactive ferrocenyl 
fragments.  Compounds 18 and 19 also showed selective interaction towards lead cation 
and revealed their potential as receptor molecules.  DFT calculation has been performed 
to establish some of the interesting features related to structural stability, metal ion 
interaction and molecular orbital energies. 
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